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Abstract
The identification and treatment of bacterial infections remains a major healthcare 
challenge, especially to ensure appropriate application of a limited spectrum of 
antibiotics. Therefore the development of alternatives to antibiotics and new 
analytical tools to probe pathogenic infection processes and as point-of-care 
biosensors is crucial to combat the spread of infectious diseases.   
Glycopolymers offer many opportunities for interfacing synthetic materials 
with biological systems. However, the nature of the interactions between 
glycopolymers and their biological targets, lectins, and the structural features 
necessary to obtain high-affinity materials are not fully understood. The application 
of synthetic glycopolymers to anti-adhesive therapies has so far been limited by their 
lack of lectin specificity.  
Herein a number of tandem post-polymerisation modification methods are 
utilised to probe the multivalent inhibition of a bacterial toxin as a function of linker 
length, carbohydrate density, and glycopolymer chain length. Guided by structural-
biology information, the binding-pocket depth of the toxin was probed and used as a 
means to specifically improve inhibition of the toxin by the glycopolymer.  
Glycosylated gold nanoparticles that change colour due to lectin-mediated 
aggregation may find use as biosensors to aid in the detection of infectious diseases 
and biological warfare agents such as ricin. Here, carbohydrate-functionalised, gold 
nanoparticles have been used to discriminate between lectins and bacterial 
phenotypes. Optimisation of the particle coating is required to ensure stability in 
complex media, but still allow for rapid detection readouts.   
1 
Chapter 1 
Introduction 
1.1 Infectious diseases 
Infectious diseases are the second-leading cause of death worldwide and the third-
leading cause of death in economically advanced countries.1 Microbial infection 
remains one of the most serious complications in several areas, including medical 
devices, medical equipment and instrumentation, drugs, healthcare and hygiene 
applications, food packaging and food storage. Reisner and Woods found that that 
85-90 % of all clinically reported infections are caused by only seven 
microorganisms with Escherichia coli (E. coli) and Staphylococcus aureus (S. 
aureus) accountable for approximately half of all infections (Table 1.1).2  
Table 1.1: The seven organisms found to be the cause of more than 85 % of all 
clinically reported infections in order of prevalence.2  
Microorganism Example Infections 
Staphylococcus aureus Skin infections, respiratory disease, food poisoning 
Escherichia coli Food poisoning, urinary tract infections 
Klebsiella spp. Pneumonia, urinary tract infections, septicaemia, 
meningitis, diarrhoea 
Enterococcus spp. Urinary tract infections, bacteraemia, bacterial 
endocarditis, diverticulitis, meningitis 
Streptococcus spp.  Pink eye, meningitis, bacterial pneumonia, necrotising 
fasciitis 
Pseudomonas aeruginosa   Urinary tract infections, respiratory infections 
Enterobacter spp. Urinary tract infections 
2 
Despite a steady stream of potential targets being discovered through 
developments in genomics and proteomics, antibiotic development in the 
pharmaceutical industry is steeply declining (Figure 1.1).1, 3, 4 Due to the intense use 
and misuse of antibiotics, antibiotic resistance is now one of the most pressing global 
healthcare problems facing today’s society (Figure 1.1).3, 5, 6 Since the introduction 
of effective antibiotics for infectious diseases in the mid-20th century it is difficult to 
imagine a life without them, however, this is becoming a very real possibility for 
some infections.7 Therefore, there is a very pressing need for new methods to combat 
these bacterial pathogens, faster point-of-care diagnostic techniques and a better 
understanding of the host interactions required.  
Figure 1.1: Decline in antibiotic development and increase in antibiotic resistance 
(MRSA = methicillin resistant Staphlococcus aureus, VRE = vancomycin resistant 
Enterococcus, FQRP = fluoroquinolone-resistant Pseudomonas aeruginosa). Figure 
adapted from Infectious Disease Society of America 2004 report.   
3 
1.2 Protein-carbohydrate interactions 
Carbohydrates are one of the four major classes of biomolecules in addition to 
nucleic acids, protein and lipids. In nature, carbohydrates exist mostly as 
polysaccharides. These highly complex macromolecules fulfil a variety of tasks 
ranging from structural and metabolic function	   to regulating development, cell 
signalling, cell adhesion, and host–pathogen interactions. Carbohydrates coat most 
cell types in nature and are used mostly in recognition pathways and signal 
transduction.8 The wide range of functions carried out by carbohydrates is reflected 
in the structural diversity of carbohydrate molecules. Glycan structural and chemical 
diversity is determined by the specific combination of selected elements from a set 
of monosaccharide building blocks: the different glycosidic linkages used to link 
these monosaccharides, the stereochemical configuration of the glycosidic bonds, 
branching and site-specific modifications lead to the complexity of the glycome.9 
Carbohydrates are challenging to analyse due to their complex nature, thus 
technologies to rapidly assess glycan structures are still in the developmental stages. 
Significant challenges in analysing the glycome come from its enormous structural 
diversity; of the major classes of biomolecule, carbohydrates are the most 
structurally diverse, due to different enantiomers, diastereoisomers, anomers and 
linkages and branching (Figure 1.2). This heterogeneity makes isolation of pure 
samples, and in sufficient amounts, from biological sources extremely difficult.10 No 
single technique can be used to define all aspects of the glycome. Several techniques 
are typically employed in parallel such as high-performance liquid chromatography 
(HPLC), mass spectroscopy (MS), and array technologies.8, 11-16 In contrast, a single 
technique can be used to interrogate	   RNA, DNA or proteins. Molecular biology 
techniques, such as gene mutation, over expression, and silencing allow the 
4 
perturbation of specific proteins and their subsequent functional assignment. 
Fluorescent labelling can be used to tag proteins for visualisation to study 
localisation.12 Protease enzymes are available to digest proteins and assignment of 
the protein sequence can be carried out by MS. A difficulty of MS for glycan 
characterisation is the discrimination of a number of structural isomers, such as 
enantiomers (e.g. D/L-glucose), diastereoisomers (e.g. glucose/mannose), anomers 
(α/β), and linkages and branching (e.g. 1-4/1-6) (Figure 1.2).14 For DNA, sequencing 
and microarray technologies can be used. Amplification methods, analogous to the 
polymerase chain reaction (PCR) for DNA are not available for carbohydrates.17  
5 
Figure 1.2: Isomerisation complexity of carbohydrates. 
Due to the presence of multiple functional groups (most commonly hydroxyl 
groups), carbohydrates are capable of forming many different combinatorial 
structures, including branching, from relatively small number of sugar units.18 
Mammalian glycans rely on a group of ten common monosaccharide units (Figure 
1.3).9 These monosaccharides assemble into linear and branched polymer structures, 
which are made more complex by the possible stereochemical linkages between the 
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units (α or β), resulting in a high degree of potential complexity.16 These ten 
mammalian building blocks can give rise to a tremendous number of possible 
glycans compared to linear macromolecules like nucleic acids or proteins.9 Therefore 
information density in carbohydrates is huge, far greater than with DNA and proteins 
where DNA has four nucleotide building blocks and proteins have 20 amino acid 
building blocks. Theoretical calculations on the number of different hexamers of 
amino acids have yielded 46,656 structure whereas for mammalian glycans, which 
have a limited monosaccharide pool, the number of possible hexasaccharides 
structures has been calculated to be greater than 1012.8, 19 These structures are not all 
possible, due to only certain linkages and branching patterns being accessible, but 
the current list of known N-linked glycans contains more than 2000 structures and 
this list is constantly growing.8 
7 
Figure 1.3: The ten mammalian monosaccharides. Symbols are the CFG20 
nomenclature.  
Due to their high information density, protein-carbohydrate interactions are 
employed in nature to mediate many critical biological recognition processes, such 
as those involved in cell signalling, fertilisation, and inflammation, as well as the 
adhesion of viruses, bacteria and toxins (Figure 1.4).21 Proteins that interact with 
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carbohydrates non-covalently occur widely in nature. Prominent examples are 
carbohydrate-specific enzymes, anti-carbohydrate antibodies, and lectins.22  
Figure 1.4: Protein-carbohydrate interactions, figure adapted from reference 23.23 
The proteins responsible for deciphering this information are known as 
lectins. They specifically (and noncovalently) bind carbohydrates based on their 
branching pattern, stereochemistry, and chemical functionality.24, 25 Carbohydrate-
binding sites are often shallow depressions on the surface of the protein. In all cases 
the combining site appears to be pre-formed, since few conformational changes 
occur upon binding. Lectins are found in plants, animals and on bacteria. 
9 
1.2.1 Plant lectins 
Legume lectins represent the largest and most thoroughly studied family of lectins. 
Around 100 members have been characterised, almost all isolated from the seeds of 
the plants in which they are present. Concanavalin A (Con A), the lectin from the 
jack beans, is the prototype member of the family. The relative abundance of this 
protein in jack bean, the ease of its preparation and the large number of saccharides 
with which it can interact, have led to numerous studies on Con A. Con A is a dimer 
at low pH (<5.5) and a tetramer at high pH (>7). Each subunit contains a binding site 
that binds specifically to α-mannosyl and α-glucosyl residues. In all legume lectins, 
irrespective of their specificity, four invariant amino acid residues participate in the 
ligand binding: an aspartic acid, an asparagine, a glycine and an aromatic amino acid 
or leucine.24 For peanut agglutinin (PNA), the lectin from Arachis hypogaea, which 
recognises the T-antigen (Galβ1-3GalNAc) these amino acids are Asp83, Gly104,
Asn127 and Tyr125. (Figure 1.5).
Figure 1.5: Schematic of the peanut agglutinin carbohydrate-binding site 
coordinating Galβ1-3GalNAc, figure adapted from reference 24.  
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Cations such as Ca2+ and Mn2+ are situated in close proximity to the carbohydrate-
binding pocket, they are not always directly involved in carbohydrate binding, but 
help the positioning of the amino acid residues interacting with the carbohydrate. 
The aspartic acid and asparagine residues participate in coordinating Ca2+. The 
carbohydrate is complexed to the protein by forming coordination bonds with a 
conserved Ca2+ as well as by hydrogen bonding with the acid and amide side chains 
that coordinate the Ca2+.26, 27 Water molecules also mediate the binding between the 
carbohydrate and the binding site. 
1.2.1.1 Plant toxins 
Several plant lectins are also toxins.  Ricin is a toxic lectin that presents a potential 
security threat. It is a lethal, type 2 ribosome-inactivating protein found in the castor 
bean plant Ricinus communis. It is an A-B toxin whereby its B-chain adheres to 
terminal galactose residues on mammalian cell surfaces, facilitating the delivery of 
the toxic A-chain into the cytosol of the cell. The A-chain catalyses the hydrolytic 
cleavage of a single base from eukaryotic ribosomal RNA, leading to a shutdown in 
protein synthesis and ultimately cell death.28 Ricin is several thousand times more 
toxic to man than cyanide, with the median lethal dose (LD50) for an adult estimated 
to be around 22 µg.kg-1 of body weight (> 1.8 mg for an average adult). Ricinus 
communis agglutinin (RCA120) is a non-toxic surrogate for ricin. It is also found in 
the Ricinus communis plant, has an 80 % homology with ricin and also binds to 
galactose residues in the same manner and can be used as a ricin substitute for 
research purposes. 
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1.2.2 Bacterial toxins 
Protein toxins constitute an important part of the virulence factors that mediate the 
harmful effects of several species of pathogenic bacteria.29, 30 Bacterial toxins have 
an impressive variety of mechanisms of action: they can act on receptors at the cell 
surface, disrupt the plasma membrane, or enzymatically modify intracellular targets. 
The latter type are know as A-B toxins, with the binding (B) moiety mediating 
receptor binding and toxin translocation, and the active (A) subunit containing an 
enzymatic domain, which disrupts cellular homeostasis. Examples of these include, 
the shiga-like toxins, cholera toxin and heat-labile enterotoxin.  
Enterohemorrhagic E. coli is a pathogen transmitted through food and water 
that causes severe gastroenteritis. It produces the shiga-like toxin (SLT) as its main 
virulence factor. SLTs are released by the bacteria in the lumen of the 
gastrointestinal tract, causing diarrhea. SLTs are AB5-type toxins that interact with 
the globotriaosylceramide Gb3 on the cell surface, where it is endocytosed.29 SLTs 
bind only weakly to individual Gb3 oligosaccharides, up to 15 copies of the Gb3 
ligand can simultaneously bind an SLT B pentamer.31 
Cholera is still a life-threatening disease in many parts of the world. It is a 
diarrheal disease caused by Vibrio cholerae (V. cholerae), a bacteria transmitted by 
contaminated food and water. Cholera is endemic in many regions of the world and 
it is estimated that it is attributable to 120,000 deaths each year. The cholera toxin 
(CTx) secreted by V. cholerae is the causative agent of the cholera symptoms and is 
a multimeric AB5 lectin-like complex. (Figure 1.6).32  
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Figure 1.6: Structure of the cholera toxin (PDB entry 1xtc). The toxic A-subunit is 
shown in blue (left) and the five B subunits (right).  
The five B-subunits bind GM1 gangliosides (Galβ1-3GalNAcβ1- 4(Neu5Acα2-3)-
Gal-β1-4Glc ceramide) present on the surface of the intestinal epithelium cells.33 The 
complex of CTx and GM1 is one of the highest affinity protein-carbohydrate 
interactions known.34 Following initial adhesion of the B-pentamer, the toxins enter 
the cells by endocytosis. They are then transported through the cell to the 
endoplasmic reticulum where the toxic A-subunit is released into the cytosol to have 
its cytotoxic effect. CTx ADP-ribosylates the Gsα protein, which leads to a rise in 
cAMP concentration in the cell and a complex series of events that result in release 
of water into the intestine.29, 35  
Heat labile enterotoxin (LT) also recognises the GM1 ganglioside and shares 
80 % homology with CTx. It acts similarly to CTx by raising cAMP levels 
through ADP-ribosylation of the Gsα protein leading to the activation of adenylate
cyclase.  
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1.2.3 Bacterial surface lectins 
Another virulence factor, in addition to toxins secreted by bacteria, is surface lectins. 
Adhesion of pathogenic organisms to host tissues is the prerequisite for the initiation 
of the majority of infectious diseases.36 The proteins that mediate adhesion are called 
adhesins. Adhesins are often part of bacterial appendages called pili or fimbriae, 
although adhesins have been identified on the cell surface. Urinary tract infections in 
humans are strongly associated with E. coli producing type 1, P, S and F1C fimbriae. 
The type 1 fimbriae are the most studied; an example of this is the FimH adhesin. 
Type 1 fimbriae, or pili, are the most abundant surface structure both in pathogenic 
and non-pathogenic gram-negative bacteria. The FimH adhesins are mannose-
specific and found at the tip of the fimbriae. Fimbriae are uniformly distributed on 
Enterobacteriaceae, commonly between 100 and 400 per cell. Their length varies 
between 1-2 µm and their width is approximately 7 nm and made up of largely 
repeating immunoglobulin-like FimA subunits that are helically arranged.37 Type 1 
fimbriae are expressed by a large number of E. coli strains, and are found in more 
that 95 % of E. coli isolates from intestinal and extra-intestinal infections such as 
urinary ones.36, 38 Whilst type 1 fimbriated E. coli are involved in lower urinary tract 
infections, E. coli presenting P-fimbriae cause bladder infections resulting in acute 
pyelonephritis. P-fimbriae are terminated by PapG, a tip-associated adhesin that 
recognises the Galα(1-4)Gal (galabiose) moiety.39  
Pulmonary pathogens such as Pseudomonas aeruginosa, Streptococcus 
pneumoniae and Klebsiella pneumoniae are opportunistic pathogens associated with 
chronic airway infections, typically affecting cystic fibrosis patients, and require 
GalNAcβ(1-4)Gal as a minimal binding sequence. The GalNAcβ(1-4)Gal sequence 
was shown to be present in lung tissue in higher abundance in cystic fibrosis-affected 
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lung epithelia. This strain also synthesises two lectins, LecA and LecB, which bind 
galactose and fucose respectively. Both are tetrameric, known virulence factors 
under quorum sensing control, and while non-classical adhesins, these lectins do 
appear to mediate adhesion.  
1.3 Multivalency in protein-carbohydrate interactions 
Despite their role in signalling, the actual binding affinity of a monosaccharide to its 
target lectin is typically very weak (Kd = 10-3-10-6 M) compared to antibody antigen 
interaction, which are typically < 10-9 M. This is circumvented in nature by the 
presentation of multiple copies of the target carbohydrate on the cell surfaces which 
gives rise to an increase in affinity greater than that of the linear sum of the 
individual sugars, this is known as the `cluster glycoside effect’.18, 40, 41  
In 1983, Lee et al.40 synthesised a series of oligosaccharides, resembling 
natural N-acetyllactosamine type glycans and tested them for their ability to inhibit 
the binding to the mammalian hepatic lectin on rabbit hepatocytes. A dramatic 
hierarchy of inhibitory potency over several orders of magnitude in the order, 
tetraantennary > triantennary >> biantennary >> monoantennary.  An inhibitory 
potency of ~1 mM was noted for the monoantennary oligosaccharides, whereas ~1 
nM was noted for the triantennary oligosaccharides, even though the absolute 
galactose concentration increased only 3-fold. It was found that the number of 
galactose residues per cluster and their branching mode are major determinants of 
binding affinity of ligands to the hepatic lectin on the surface of hepatocytes.  
Multivalent assemblies provide a distinct advantage over monovalent ligands 
by enhancing binding strength through multiple interactions with their corresponding 
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target.42 There are a number of mechanisms of action of multivalent ligand binding, 
that are inaccessible to monovalent compounds, that contribute to their potency, such 
as; chelation, subsite binding, clustering and statistical rebinding. (Figure 1.7).  
Figure 1.7: Multivalent ligand binding mechanisms, figure adapted from reference 
43.   
The chelate effect is observed when carbohydrates can bridge multiple 
binding sites on a single oligomeric receptor. The cost for translational entropy is 
paid with the first protein-ligand interaction and subsequent binding interactions 
proceed without additional translational entropy penalties. Similarly, some 
carbohydrate binding proteins possess binding subsites in proximity to their primary 
binding site, these can be occupied by multivalent ligands. Even with receptors that 
are not oligomeric, multivalent ligands can bind to multiple receptors on the cell 
surface. This clustering process is facilitated in the fluid lipid bilayer by the two-
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dimensional diffusion of receptors. Additionally, in statistical rebinding, the 
effective local concentration of ligand near the receptor is increased, producing an 
overall gain in binding affinity.43 Collectively, these modes of multivalent binding 
prevent the disassociation of ligand upon individual unbinding events.42  
1.4 Anti-adhesion therapy 
Antibiotics have long been the preferred treatment for bacterial diseases. However, 
there are several advantages in targeting the virulence factors rather than the bacteria 
themselves.29 The development of such resistance is inherent to antibiotics that kill 
pathogens and provide selection pressure. It is widely accepted that alternative 
approaches against bacterial pathogens should be explored. Strategies that do not kill 
the pathogens yet interfere with their pathogenicity may provide the much needed 
alternative. One such strategy is anti-adhesion therapy (Figure 1.8).44  
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Figure 1.8: Concept of anti-adhesion therapy figure adapted from reference 44. 
As protein–carbohydrate interactions are an essential prerequisite for cell 
entry and toxin activity, the development of inhibitors for these interactions has 
attracted much interest over recent years.31 Inhibition of these lectins, by suitable 
carbohydrate or their analogues, for the prevention and treatment of microbial 
diseases is the aim of anti-adhesion therapy. Carbohydrates are ideal for this purpose 
as they are unlikely to be toxic or immunogenic.  
Anti-adhesion therapy has many potential advantages; since anti-adhesive 
agents do not act by killing or arresting growth of the pathogens, it is very likely that 
strains resistant to such agents will emerge at a markedly lower rate than those that 
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are resistant to antibiotics, and their spread in the environment will be minimal.36 
Toxins can also continue to cause symptoms even after bacteria have been cleared 
from the host. Additionally, non-antibiotic treatments circumvent the disruption of 
the normal microbiota that is typically associated with antibiotic treatments.29	  	  
In general it is very challenging to make low molecular weight inhibitors of 
carbohydrate-binding proteins as the binding sites are typically shallow and highly 
solvated. Monovalent receptor-binding approaches focus on strong binding 
interactions and are based on the design and synthesis of ligands that closely mimic 
the natural ligand action at the cell surface.28, 45, 46 An excellent example of 
monovalent inhibitor specificity was described by Thépaut et al..47 In their work they 
designed inhibitors of DC-SIGN. DC-SIGN is a carbohydrate-binding protein 
involved in HIV transmission, langerin is a related lectin with selectivity for the 
same binding partner gp120 but exhibits an opposing role in blocking HIV 
transmission. Therefore, it is important to inhibit DC-SIGN, without blocking 
langerin. NMR, X-ray crystallography and surface plasmon resonance (SPR) studies 
were used to determine the binding mode of monovalent inhibitors that showed 
selectivity for DC-SIGN over langerin. 
Due to the challenges that lie in making low molecular weight, monovalent 
inhibitors, researchers have instead focussed their attention on making multivalent 
inhibitors that can engage multiple carbohydrate binding sites simultaneously. 
Chemists have overcome the low binding affinities of monovalent glycosides by 
successfully conjugating synthetic oligosaccharides to a number of multivalent 
scaffolds.48 The design, synthesis and testing of glycoconjugates for the inhibition of 
bacteria and toxins has been extensively reviewed.10, 24, 31, 36, 44, 49-53  
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1.5 Potent inhibition using multivalency 
1.5.1 Multivalency for specific targeting of lectins 
Rational design of multivalent inhibitors to specifically interact with lectins is 
important in order to interact with multi-binding site proteins. Pentavalent ligands 
designed to interact with all five binding site of an AB5 toxin have been explored. 
Structural information about the spatial arrangement of the target binding sites is 
taken into account when designing ligands ideal for maximising the interaction with 
the receptor.  
The modular synthesis of multivalent ligands of LT, an AB5 toxin similar to 
that of CTx, from E. coli was reported by Fan and co-workers.54 In this study, 
pentavalent ligands of β-amidated D-galactose attached to a semi-rigid core by 
flexible linkers to interact with the 5 binding sites of the pentamer were synthesised. 
Different lengths of the linker were tested and the inhibitory activity determined by 
an enzyme-linked immunosorbent assay (ELISA). All pentavalent ligands led to 
significant affinity gains over the monovalent ones; the best showing an IC50 105-
fold lower than galactose, approaching the affinity of the natural ligand GM1. It was 
also found that the pentavalent ligands formed a 1:1 complex with the toxin and no 
large-scale aggregates were observed. Higher affinity inhibitors were produced by 
incorporating m-nitrophenyl-α-galactose as a ligand group and improving the linker 
solubility. The resulting compound had an IC50 of 6 nM, which was about 3 times 
more potent than the GM1 oligosaccharide.    
Arguably one of the most elegant examples of inhibitory activity using 
structurally relevant arrangement of multivalent ligands was reported by Kitov et 
al.55 A decavalent inhibitor was developed, nicknamed STARFISH, whose structure 
	  20 
was complementary to the AB5 structure of SLT-I and SLT-II. STARFISH exhibited 
more than a 106-fold increase in inhibition over the native Gb3 trisaccharide. 
STARFISH was designed to achieve high affinity by simultaneously binding all of 
the five peripheral bridged dimers to the sites 1 and 2 of the B-pentamer. However, 
crystallographic studies of the formed complex revealed a different binding mode. 
One STARFISH molecule was found to bind to two B-subunit monomers from 
separate toxin molecules (Figure 1.9).  
Figure 1.9: STARFISH synthesised by Kitov et al. bound to SLT-I, figure adapted 
from reference 55. 
Two further examples of pentavalent inhibitors were reported by Zuilhof et 
al. both presenting GM1 oligosaccharide (GM1os) ligands with flexible 
polyethylene glycol (PEG) linkers on scaffolds with 5-fold symmetry, corannulene56 
and calix-[5]-arene.57 Both showed IC50 values of 5 nM and 405 pM respectively, 
determined by an ELISA-type assay.  
The synthesis of large multivalent scaffolds is very challenging; therefore 
Branson et al.58 developed a highly potent pentavalent inhibitor for CTx based on an 
inactive mutant of the B subunit of CTx (CTxB), modified with GM1os ligands. 
They were designed to match exactly to the size for the target CTx protein. This was 
found to be a highly potent inhibitor by enzyme-linked lectin assay (ELLA), 104 
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pM, which is the most potent pentavalent ligand reported to date. A 1:1 complex 
between the inhibitor and the target CTxB was observed as determined by dynamic 
light scattering (DLS) and analytical ultracentrifugation. 
1.5.2 Glycodendrimer inhibitors 
Dendrimers are perfectly branched, monodisperse synthetic macromolecules that 
generally feature symmetrical spherical architectures, that, in principle, combine the 
advantages of homogenous small molecular inhibitors with the dimensions and high 
valencies of glycopolymers (see section 1.5.4).59 Dendrimers contain a relatively 
high density of functionalisable termini that are typically positioned on the exterior 
of the structure. However, they can be highly challenging to synthesise. 
Thompson and Schengrund60 designed glycodendrimer inhibitors to prevent 
toxins such as CTx and LT.  Polypropyleneimine (PI) and polyamidoamine 
(PAMAM) cores were used presenting GM1os carbohydrate moieties. The 
multivalent glycodendrimers were capable of inhibiting binding at 1000-fold lower 
concentration than the monovalent GM1 ganglioside.   
The Pieters group synthesised a set of dendrimers, prepared by a convergent 
approach, with a variety of carbohydrate end groups as CTxB inhibitors. Their first 
scaffolds were prepared with two, four and eight arms with terminal lactose 
moieties.61 It was found that the multivalent dendrimers gave an increase in 
inhibition, with the octavalent ligand having the strongest binding with a Kd of 33 
µM as measured by a fluorescence titration assay. Increasing the linker lengths, 
improved the reach of their ligands as determined by SPR.62 Pieters and co-workers 
also synthesised an octameric galabiose derivative anchored to a PAMAM 
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dendrimer core (Figure 1.10),63 which showed a 256-fold improvement over the 
monovalent galabiose.  
Figure 1.10: (Galabiose)8 glycodendrimer based on a PAMAM core as a multivalent 
inhibitor of PapG adhesins of E. coli. Figure adapted from reference 63.  
While most dendrimers are made up of organic polymer building bocks, 
peptide dendrimers are assembled from amino acids using diamino acids such as 
lysine as branching points. These peptides arms can then be capped with 
carbohydrate derivatives.64 It has been shown that galactosylated and fucosylated 
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dendrimers are potent inhibitors of P. aeruginosa biofilm formation by inhibition of 
LecA and Lec B proteins.65, 66  
1.5.3 Glycopeptide inhibitors 
Glycopeptide materials can be used to study and manipulate interactions between 
saccharides and their receptors. They provide advantages such as manipulation of the 
backbone conformation and functional group location.48 The Kiick group has 
extensively investigated the effect of carbohydrate density, the specific distance 
between carbohydrates on a polypeptide chain, spacer length from the polypeptide 
backbone and secondary structure of the peptide. Galactosylated peptides were 
prepared as inhibitors for CTxB. Interestingly, it was found that as the density of 
ligands increases, the inhibitory effect decreases in terms of absolute peptide 
amount.67 It was also concluded that the best inhibition was achieved when the 
spacing between ligands on the polymer chain was matched to the distance between 
binding pockets of the toxin; this distance being 35 Å for CTxB. It was proposed that 
when the density was sufficiently high that spacing between carbohydrates was 
smaller than the distance between binding sites, steric hindrance created by unbound 
ligands decreased overall binding. Inhibition was greater when the spacer matched 
the natural ligand length of GM1 (16 Å). A longer ligand could therefore fully 
penetrate the binding site as opposed to a reduced accessibility when a shorter spacer 
is used. Kiick and co-workers also found that random coil backbones were better 
suited than those with restricted α-helical conformations, as flexibility of the 
polymers allows higher accessibility of the ligand groups.68, 69, 70 
Fan and co-workers synthesised cycloglycopeptides with five galactosamines 
as inhibitors of CTx.71 The effect of ring size and linker was investigated. 
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Interestingly, a 100,000-fold increase in inhibitory activity over monovalent 
galactose was noted for cyclopeptides containing short flexible linkers.  
Wittmann et al.72 presented the first example of a split-and-mix approach to 
the synthesis of a library of glycoclusters presenting two to six GlcNAc residues on a 
cyclopeptide scaffold made of alternating L- and D-amino acids with variable side 
chains. This library of GlcNAc glycopeptides were screened for their binding 
affinity to the GlcNAc specific wheat germ agglutinin (WGA) lectin. Penta- and 
hexavalent glycopeptides were found to have over 600-fold stronger binding than 
free GlcNAc as determined by an ELLA.  
Lindhorst and co-workers73 developed effective inhibitors of type 1 
fimbriated bacteria based on α-D-mannopyrannoside functional glycopeptides. The 
conformational properties, as well as the spatial arrangement of the pendant 
mannosyl residues were investigated. Inhibitory potency was determined by the 
glycopeptides ability to prevent GFP-tagged FimH expressing bacteria from binding 
to a mannan-functional 96-well microtitre plate. Greater inhibitory potency was 
observed for glycopeptides exhibiting a phenylmannoside and when a greater 
distance between carbohydrate moieties is used.  
1.5.4 Glycopolymers 
Multivalent inhibitors can engage multiple carbohydrate binding sites 
simultaneously. Synthetic glycopolymers with pendant and/or terminal 
carbohydrates are being increasingly explored as biomaterials for medicinal 
applications.51, 74 The vast chemical versatility polymer platforms provide for 
generating multivalent architecture gives them huge possible potential as potent anti-
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adhesion therapies. In contrast to dendrimers, glycopolymers have a degree of 
dispersity, however, they are easy to synthesise and polymerisations are easily 
scalable.  
Synthetic glycopolymers mimic the function of the cell-surface saccharides 
and efficiently interact with proteins, cells and pathogens based on the multivalent 
effect. The relative ease of synthesis and variability of structure and length make 
them ideal for use as scaffolds for multivalent presentation. Polymers can easily span 
large distances, which provides a distinct advantage over many other scaffolds for 
targeting lectins. Modern polymer chemistry is providing new opportunities for the 
synthesis of tailored, biologically active polymeric (or oligomeric) ligands.75 The 
multivalent ligands derived from polymers are typically composed of a central 
backbone that presents multiple copies of a carbohydrate. Ligands of this type can be 
produced by using a variety of synthetic methods. Polymers are generally assembled 
in a single step by methods such as radical, ionic, or ring-opening metathesis 
polymerisation (ROMP) of carbohydrate bearing monomers. Certain polymerisation 
reactions are more tolerant of biologically active functionality than others; the types 
of epitopes to be incorporated will determine the most effective synthetic strategy.  
Roy and co-workers76 reported a new method of synthesising acrylamide 
monomers that contained carbohydrate residues. 4-nitrophenol was reacted with 
glycosyl bromide, which gave 4-nitrophenol-β-glycoside with total anomeric 
stereocontrol, this was easily converted to an acrylamide-based monomer by reaction 
with the appropriate amine. These monomers were polymerised using free radical 
polymerisation using acrylamide as a co-monomer. These copolymers proved to bind 
lectin effectively as determined by an ELLA. 
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Living polymerisation reactions, in which the rates of chain termination are 
low, are powerful methods for generating well-defined multivalent ligands. Polymers 
of narrow dispersity can be generated when the polymerisations have fast initiation 
and slow propagation rates. The architecture of glycopolymers is vital to their 
application due to factors such as; orientation of the carbohydrate, scaffold shape, 
flexibility, size and valency, which can influence biological activity and their 
interaction with lectins. It is therefore necessary to consider appropriate synthetic 
approaches to these. Controlled polymerisation techniques (Figure 1.11) such as 
reversible addition fragmentation chain transfer (RAFT) polymerisation, atom 
transfer radical polymerisation (ATRP), Nitroxide-mediated polymerisation (NMP), 
ROMP, together with click chemistries have been widely used in the synthesis of 
glycopolymers.    
Figure 1.11: Mediating agents and general reaction scheme of controlled 
polymerisation techniques.  
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Linear glycopolymers of targeted molecular weights and dispersities (Đ) can 
be prepared directly from the controlled polymerisation of glyco-monomers.77 
ROMP provides the benefits of living polymerisation and can thus produce well-
defined polymers of various architectures, however, the limitations are that there are 
only a small number of monomer types available, they are not easily functionalised 
and the transition metal catalyst can be expensive to remove. Fraser and Grubbs 
synthesised several carbohydrate functional norbornene derivatives with a series of 
protected glucose functionalities attached via an amide linkage.78 Kiessling and co-
workers,79, 80 synthesised 7-oxanorbenene derivatives carrying one or two saccharide 
moieties attached via C-glycoside or O-glycoside linkages. They studied the 
dependence of Con A binding on the length of the glycopolymers. A plateau in the 
heamagglutinin inhibition was noted with polymers of degree of polymerisation 
(DP) > 50.81  
Nitroxide-mediated polymerisation has the desirable attribute that the 
products contain no inorganic residues and it only requires a single compound, 
unlike RAFT and ATRP. The most commonly used nitroxide is TEMPO, which is 
relatively inexpensive, however, it is not suited to all systems. Synthesis of specific 
nitroxides can be challenging and time consuming. Nitroxide polymerisations are 
generally carried out in bulk or at high concentration, which can lead to heat transfer 
problems and issues with product extraction. There are very few examples in the 
literature of glycopolymers synthesised by NMP. Ohno et al.82 reported the synthesis 
of the first glycopolymers by NMP in 1998. The polymerisation of a non-protected 
carbohydrate monomer was controlled and gave relatively narrow dispersity 
polymers, however did not proceed to high conversion due to retardative transfer to 
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the hydroxyl groups, determined due to polymerisation of the acetylated monomer 
reaching 90 % conversion.  
Copper-mediated living radical polymerisation (CMLRP) is a versatile 
technique; it is tolerant to a wide variety of monomers, almost all functionalities and 
can be performed in any solvent and at any temperature. It produces polymers with 
good control over molecular weight and low dispersities, however residual copper 
often resides after polymerisation and can be an issue for biological applications. 
Narain and Armes83, 84 reported the first synthesis of glycopolymers by CMLRP 
using unprotected carbohydrate-containing monomers. Low dispersity polymers 
were obtained, under mild conditions.     
RAFT is a versatile controlled radical polymerisation (CRP) technique, 
applicable to a wide range of monomers, functionalities and conditions and can be 
carried out in aqueous media. Lowe et al.85 presented the first example of the direct 
polymerisation of a carbohydrate containing monomer (2-methylacryloxyethyl 
glucoside) via RAFT, without the need for protecting groups. Albertin et al. used a 
chemoenzymatic route to the synthesis of 6-O-vinyladipoyl-D-glucopyranose 
monomer86 and synthesised narrow dispersity glycopolymers using RAFT in 
aqueous media.87, 88 
Whilst the direct polymerisation of carbohydrate functional monomers by 
CRP techniques is useful, there still remains the challenge of obtaining well-defined 
libraries of polymers with sequential modifications and identical DPs, particularly 
for exploring protein-carbohydrate interactions in which valency plays such an 
important role in the activity of multivalent assemblies. To address this, the concept 
of post-polymerisation modification is frequently employed, whereby a reactive 
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polymeric precursor is directly functionalised ensuring all members of the library 
have identical DPs.89  
1.5.4.1 Post polymerisation modification 
Post-polymerisation modification gives access to functional polymers that may be 
difficult to access by direct polymerisation. Polymers made by a post-polymerisation 
modification, whereby a single batch of a precursor polymer results in all derivative 
polymers having the same dispersity and DP leads to functional polymers that can be 
more directly compared. Polymer scaffolds can be tailored to be compatible with a 
wide range of chemical conjugation strategies. Libraries of polymers with similar 
molecular weights and molecular weight distributions can facilitate identification of 
structure-property relationships.89 Reactive polymers are often synthesised directly 
from monomers containing functionalities that are inert to the polymerisation 
conditions but that can be used post-polymerisation to introduce additional 
functionality (Figure 1.12). Highly efficient functionalisation strategies are essential 
for this, examples of these reactive precursor scaffolds are active esters and ‘click’-
functionalities.  
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Figure 1.12: Concept of post-polymerisation modification. 
Advantages of active ester-type monomers are their easy accessibility, and 
the use of amines as functionalisation moieties that are commercially available. 
Activated esters of N-hydroxysuccinimide, pentafluorophenol (PFP) and 4-
nitrophenol have been exploited for the introduction of functionality to polymers 
with nucleophilic groups such as amines and alcohols. Polymeric active esters can be 
obtained from a variety of monomers using controlled radical polymerisations.89 
Amides are reacted with active esters because of their good nucleophilicity 
compared to other functional groups such as alcohols.  
Whitesides and co-workers90, 91 synthesised sialic acid containing 
glycopolymeric inhibitors of influenza virus X-31 using a poly(N-acrylyloxy 
succinimide (pNAS) reactive scaffold. Using heamagglutination and ELISA assays, 
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the inhibitory activity of theses polymers were found to be between 103 and 106 
times greater than the α-methyl-sialoside.  
The Théato group has shown the potential of PFP ester groups.92, 93 Gibson et 
al.94 used RAFT polymerisation to synthesis poly(pentafluorophenyl methacrylate) 
(pPFMA) as reactive scaffold towards many functionalities including glycopolymers 
for determining structure-activity relationships from the same starting scaffold and 
therefore the same chain length distribution.  
The post-modification techniques described above have proven to be 
successful, but still suffer from very low atom efficiency (either due to displacement 
reactions or protecting group removal) as well as side reactions and competitive 
hydrolysis which can impede this approach. Azlactones are an interesting alternative; 
they are lactone-based functional groups that undergo ring-opening reactions in the 
presence of nucleophiles such as primary amines, alcohols, or thiols. They react 
rapidly at room temperature with primary amines, making it a useful approach for 
the rapid synthesis of side-chain functionalised poly(acrylamide)s.95, 96 Despite this, 
until now, azlactones have not been used to synthesise glycopolymers (See Chapter 
3). 
Sharpless97 introduced the concept of ‘click’ chemistry which describe highly 
efficient coupling reactions that proceed to quantitative conversion without any side 
products and are conducted in benign media. Cu(I)-mediated Huisgen 1,3-dipolar 
cycloaddition reaction has been extensively used for post-polymerisation 
modification because it gave high yielding conversion under mild condition in 
aqueous or organic media. The radical addition of thiols to vinyl groups is another 
highly efficient, widely used post polymerisation technique.98, 99 Alkyne/azide and 
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thiolated carbohydrates have been synthesised to afford ‘clickable’ carbohydrate 
units (Figure 1.13).100, 101  
Figure 1.13: Schematic of glycopolymers from ‘clickable’ scaffolds. 
A key challenge associated with the synthesis of ‘clickable’ scaffolds is that 
the pendant functionality, typically alkenes and alkynes, are incompatible with 
controlled radical polymerisations and require protection/deprotection chemistry 
which itself must be 100 % efficient.102 Haddleton and co-workers prepared hetero-
neoglycopolymers by ‘co-clicking’ two different sugar azides by copper catalysed 
alkyne-azide cycloaddition (CuAAC) on to a propargyl-functionalised polymer. The 
poly(propargyl) scaffold was obtained by CMLRP of trimethylsilyl-protected 
propargyl methacrylate precursors.  
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1.5.5 Glycopolymer inhibitors 
Glycopolymers provide a simple route to high affinity, multivalent inhibitors of 
carbohydrate proteins. Haddleton et al. synthesised a small library of 
heteroglycopolymers bearing variable relative proportions of mannose (αMan) and 
galactose (βGal) motifs, prepared as detailed above.102 Multichannel SPR was used 
to investigate the binding affinity of this library of glycopolymers with recombinant 
human DC-SIGN tetramers. 100 % αMan polymers have sub-nanomolar affinity 
(4.96 x 10-10 M). The presentation of mannose in clustered polymeric form was 
essential for high-affinity binding, as the equivalent mass of free D-mannose gave no 
binding signal.  No significant binding was observed with the βGal-polymer, 
highlighting the specificity of the binding site for terminal mannose residue and as 
expected, βGal density correlated negatively with the binding affinity to DC-SIGN. 
A competition assay showed that an IC50 value of 37 nM was observed for DC-SIGN 
towards gp120 (Figure 1.14).103  
Figure 1.14: Mannose and galactose functional polymers that competitively interact 
with DC-SIGN. Figure adapted from reference 103.  
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The procedure for the post-polymerisation modification of alkyne- bearing 
polymer scaffolds with glycosyl azides was optimised by Gibson and co-workers.104 
This involved a one-pot synthesis of glycosyl azides, in aqueous solution, without 
the need for protecting groups and in multi-gram scale. Through an optimisation 
study, it was determined that the ideal ligand for alkyne-azide ‘click’ reaction was 
tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA). 
In addition to the terminal βGal residue, the neuraminic acid moiety 
(NeuNAc) is important for affinity and selectivity of GM1 towards CTx34 and 
therefore a target for precision polymers. Bundle and co-workers have reported a 
novel approach to generate libraries of CTx inhibitors. The synthesis and inhibitory 
activities of a series of heterobifunctional ligands conjugated to two polymer carriers 
(polyacrylamide and dextran) were described (Figure 1.15).105 Since multivalent 
presentations of βGal residues been have demonstrated to exhibit exceptional high 
activity towards CTxB, all the conjugates contained an invariable βGal fragment and 
variable non-galactose fragment incorporated by CuAAC reaction. The inhibitory 
potencies of the heterobifunctional neoglycopolymers were assessed by an ELISA. 
Conjugation of a second fragment resulted in nanomolar inhibitors of CTx, far 
greater than galactose alone. High potencies resulted from aromatic secondary 
binding groups with electron withdrawing groups such as fluorine. The length of the 
linker is sufficient for both βGal and the secondary binder to reach their respective 
positions in the GM1 binding site on the surface of CTx.  
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Figure 1.15: Synthetic rationale of heterobifuntional glycopolymers synthesised by 
Bundle and co-workers. Figure adapted from reference 105. 
Singha et al.106 introduced the concept of tandem post-polymerisation 
modification as a versatile route to synthesise well-defined highly functional 
polymers. A poly(pentafluorophenyl methacrylate) (pPFMA) scaffold was 
functionalised with allylamine to achieve pendant alkene functionality that would 
not be achievable by direct polymerisation. This was further modified using thiol-
ene ‘click’ chemistry to introduce biofunctionality. To date, this methodology has 
not been used to explore glyco-functionality (See Chapter 2). 
1.6 Detection of bacteria and lectins 
The problem of antibiotic resistant bacteria is being exacerbated by the lack of rapid 
point-of-care diagnostics tools for detection of the bacterial species responsible for 
an infection. Detection and quantification of bacteria is important in clinical, 
environmental, and public health sectors. In clinical diagnostics, conventional 
plating and culturing is generally used to identify causative bacterial pathogens,2 an 
effective and accurate method, however, it is time-consuming (more than 24 hours). 
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While several high-tech methods, including PCR, have been used to detect specific 
microorganisms, these are complex and require expensive, sophisticated equipment. 
Therefore, a facile and rapid detection method for the identification of the most 
prevalent pathogens would be of great value for providing effective therapeutics. If 
used as a point-of-care diagnostic tool they could not only increase the therapeutic 
efficacy but also go towards reducing the occurrence of drug-resistant bacteria 
arising due to the inappropriate administration of antibiotics.  
The nature of carbohydrates can differ considerably between diseased and 
normal cells. Unique glycan markers of diseased cells can be exploited for early 
diagnosis, prevention and treatment of illnesses.10 Surface glycans appear to be 
modulated depending on the physiological status, such as during developmental 
processes and oncological transformations.18 The glycans on proteins have emerged 
as important biomarkers in the diagnosis of diseases such as cancer and play a 
significant role in how pathogenic viruses gain entry into cells.  
In recent years, advancements in carbohydrate synthesis, analysis and 
glycoarray technology have facilitated the development of chemical approaches to 
‘glycomics’ that provide a better understanding of the biological processes involving 
complex carbohydrates.14, 107, 108 For instance databases such as the Consortium for 
Functional Glycomics (CFG)20 are large research initiatives that provide resources 
and bioinformatics tools for the scientific community and sources of reference and 
information on the glycan-binding proteins. 
Proper design of the synthetic multivalent systems used in molecular 
recognition studies is critical. Control of clustering, selection of adequate spacers 
and scaffolds, stability of the whole construction, and solubility in biological media 
are important to achieve high affinity and specificity.  
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1.6.1 Glycopolymers for bacteria and lectin detection 
Polymer-based detection methods for cells have the advantage of simulating multiple 
interactions through the display of many ligands on a single polymer. The Seeberger 
group developed a fluorescent detection method for bacteria based on a water-
soluble fluorescent-conjugated glycopolymer.109 Carbohydrate-functionalised 
poly(p-phenylene ethynylene) (PPE), synthesised using a post-polymerisation 
modification method, were used to detect E. coli by exploiting the interaction 
between FimH and mannosides. Incubation of the polymers with FimH expressing 
E. coli showed that the glycopolymers binds to the bacteria and yield brightly 
fluorescent cell clusters due to multivalent interactions between the mannosylated 
polymer and the FimH on bacterial pili, as determined by microscopy. The presence 
of the bacteria was detected in less than 15 min, but requires an isolation step. 
Similarly, Phillips et al.110 synthesised water-soluble carbohydrate functionalised 
PPE for detection of Con A and type 1 fimbriated E. coli. They found that when the 
carbohydrate moiety was placed further away from the conjugated backbone, or 
there is an increase in carbohydrate density, there was an increased propensity to 
induce aggregation of E. coli.  
Pasparakis et al.111 synthesised thermoresponsive glycopolymers that could 
control the reversible aggregation of a specific bacterial strain, with a view to 
developing a reusable cell-sensing material. Aggregation of fluorescently labelled 
FimH expressing E. coli was observed. TOP10 was used as a control strain that does 
not express the FimH adhesin, no aggregation behaviour was noted with this strain.  
Pasparakis et al. also synthesised glycopolymers vesicles that presented glucose as a 
first step towards artificial cell mimics.112  
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1.5.2 Glyconanoparticles 
Glyconanoparticles are rapidly emerging as biosensors, in imaging, and in 
therapeutics.113 They can be coupled with multiple carbohydrate moieties, which 
provides an increased potential for the enhancement of biomolecular interactions. 
Thus, glyconanoparticles constitute a good biomimetic model of carbohydrate 
presentation at the cell surface, and are excellent tools for glycobiology.  
1.5.2.1 Gold nanoparticles 
Gold nanoparticles (AuNPs) exhibit characteristic optical properties that are 
dependant on surface plasmon resonance, which arises due to the collective 
oscillation of the conduction electrons. The maximum wavelength and shape of the 
local surface plasmon resonance (LSPR) are determined by the particle size and 
shape. AuNPs have extremely high extinction coefficients, which are three to five 
orders of magnitude greater than those of traditional molecular dyes.  
Monodisperse AuNPs between 10 nm and 80 nm appear red in colour, when 
the interparticle is greater than that of the particle diameter. As the interparticle 
distance decreases to less than that of the particle diameter, coupling and dipole-
dipole interactions between the plasmons of neighbouring particles result in a 
broadening and a shift to longer wavelengths of the surface plasmon absorption 
band, resulting in the AuNPs appearing blue (Figure 1.16). It is this colourimetric 
aggregation that is exploited for the use in bioassays. This colourimetric change can 
be detected spectrophotometrically and visually.114  
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Figure 1.16: Red/pink to blue/purple colour change of AuNPs. 
Colourimetric assays for investigating biomolecular interactions using 
AuNPs functionalised with biomolecules such as proteins,115, 116 peptides,117 
antibodies,118-123 and DNA124, 125 have been developed. The detection of bacterial 
DNA using AuNPs originated in the pioneering work of Mirkin et al.124 who 
demonstrated that as little as 10 fmol of an oligonucleotide analyte could be detected 
by exploiting the aggregation phenomenon of AuNPs. 
Carbohydrate-functionalised AuNPs (glycoAuNPs) are emerging as an 
important tool for colourimetric bioassay of protein-carbohydrate interactions. They 
present a multivalent array of carbohydrates and provide a glycocalyx-like surface. 
They mimic carbohydrate presentation at the cell surface and can be used to study 
protein-carbohydrate interaction and to interfere with carbohydrate mediated 
biological processes. GlycoAuNPs are advantageous as they can also allow direct 
visualisation without the need for laborious protein labelling steps. GlycoAuNPs are 
typically prepared by treating pre-synthesised AuNPs with thiol-ending 
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glycoconjugates in order to displace the protecting shell ligands, typically citrates or 
thiols, on the gold surface by insertion of other ligands.  
1.6.3 Glyconanoparticles for bacteria and lectin detection. 
 The influence of linkers (lengths, aliphatic/hydrophilic), density, and gold core size 
on AuNPs-lectin interactions has been studied by several groups. The influence of 
carbohydrate density on the aggregation of bivalent Ricinus communis agglutinin 
(RCA120) was investigated by Otsuka et al.126 on 9 nm AuNPs bearing lactose. It was 
found that more than 20 % lactose was required for aggregation to occur.  
The influence of carbohydrate linker and core size (6 and 20 nm) on 
mannose-AuNP aggregation induced by Con A was studied by Lin et al.127 The 20 
nm AuNPs showed the highest affinity as determined by SPR. Lin et al. also 
synthesised mannose-functionalised particles (6 nm) to specifically bind to FimH 
adhesin of bacterial type 1 pili and not to a strain of E. coli that do not express FimH, 
as observed by transmission electron microscopy (TEM) (Figure 1.17).128 Due to the 
small core size of the particles colourimetric aggregation of the particles was not 
investigated in this work (See Chapter 7).  
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Figure 1.17: TEM of glycoAuNPs interacting with FimH expressing fimbriae on E. 
coli (A) and no interaction observed with a mutant that does not express FimH (B). 
Figure adapted from reference 128.  
Schofield et al.129 developed a colourimetric bioassay based on the 
aggregation of carbohydrate-stabilised gold nanoparticles for the detection of 
RCA120 – a ricin surrogate. AuNPs were stabilised with either a thiolated galactose 
derivative (9-mercapto-3,6-diaoxaoctyl-β-D-galactoside) and a thiolated triethylene 
glycol derivative as a dilutant to investigate the effect of carbohydrate surface 
coverage. Interestingly, it was found that a 70 % coverage of galactose was optimum 
for RCA120 detection, they also noted that a short linker between the particle and the 
pendant galactose gave greater aggregation, however, the longer chain gave a more 
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stable sensing systems. The same was carried out for Con A, it was found that 100 % 
carbohydrate coverage was optimum for this protein.  
The preparation of thiolated carbohydrate derivatives requires multiple 
modification steps that can be difficult and time consuming. Chuang et al.130 used a 
simple and versatile method for the preparation of glycoAuNPs using underivatised 
carbohydrates on hydrazide functionalised particles, utilising microwave irradiation. 
The strength of the interaction between Con A and maltose, mannose, glucose, 
lactose and Man5 functionalised particles was determined.    
 GlycoAuNPs are typically synthesised by the preparation of AuNPs, such as 
by the citrate reduction method of Turkevich et al.131 followed by the introduction of 
carbohydrate functionality by Au-S ligand exchange. Watanabe et al.132 developed a 
simple one-pot synthesis of thioglucose stabilised AuNPs. A diameter of 40-50 nm 
was considered to be optimum for the colourimetric bioassay of Con A. The ligands 
must be immobilised with a short linker in order to ensure aggregated particles are in 
the closest proximity to each other to maximise coupling between the particles.   
Marín et al.133 synthesised glycoAuNPs presenting a trivalent α2-6-thio-
linked sialic acid that can detect strains of human influenza within 30 min using a 
simple colourimetric assay. It was found that a ratio of 25:75 trivalent ligand to PEG 
ligand was optimum for the detection of human influenza virus X31. The trivalent 
ligand provided significantly superior results to a monovalent α-thio-linked sialic 
acid. Impressively, these particles also showed specificity for human influenza virus 
over avian influenza virus. 
Jayawardena et al.134 employed glycoAuNPs to differentiate between plant 
lectins. Various carbohydrates were conjugated on AuNPs using a previously 
developed photocoupling chemistry.135 The changes in LSPR upon lectin binding 
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were recorded and the data were subjected to the statistical analysis method of linear 
discriminant analysis (LDA). The glycoAuNPs successfully differentiated all the 
lectins.  
1.7 Summary 
Multivalent presentation of carbohydrate moieties is critical for high affinity 
inhibition of protein-carbohydrate interactions. Important considerations for 
designing multivalent architectures to target carbohydrate-binding proteins include: 
the multivalent scaffold used, ligand valency and density, linker length between the 
pendant carbohydrate moiety and the multivalent scaffold, the three-dimensional 
spatial arrangement of the carbohydrate ligands and ability to complement the 
binding site of the target protein. Excellent affinity gains can be achieved by 
designing multivalent inhibitors that interact with the target based on the structural 
arrangement of the binding sites and engineering an inhibitor that interacts with its 
target. However, multivalent scaffolds that exactly complement the binding site 
arrangements can be highly challenging to synthesise. Glycopolymers provide a 
simple alternative to these and show good affinity for the target lectin. However, 
most of the currently synthesised polymeric multivalent ligands show a ‘random’ 
multivalency, which rarely allows an affinity enhancement higher than 1000-fold. 
Therefore, there is a real need for high affinity glycopolymeric inhibitors that show 
good affinity but also high selectivity for the target lectin.  
GlycoAuNPs have shown promise as tools for understanding and detecting 
protein-carbohydrate interactions. However, it appears that the core size and ligand 
density needs to be tuned to the target. Also little regard for their stability in 
biological, saline-rich media has been paid, which is important for applications in 
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biological media. GlycoAuNPs have been shown to interact with bacteria in 
response to carbohydrate-binding proteins expressed on their fimbriae however, the 
colourimetric detection of bacteria using glycoAuNPs has not yet been explored. 
Therefore the development of fast, saline stable, target specific glycoAuNPs is 
important.   
1.8 Aims and thesis summary 
Considering the above, this thesis aimed to achieve two main targets: firstly the 
development of high affinity glycopolymeric inhibitors of CTx, that also showed 
specificity for the target over other carbohydrate binding proteins with similar 
specificities. The second aim was the development of a colourimetric detection 
method for lectins and type 1 fimbriated bacteria based on glycoAuNPs. 
This thesis is split into two sections: Inhibition and Detection. Section 1 
concerns glycopolymeric inhibitors of lectins and bacterial toxins and comparing and 
developing techniques for determining their inhibitory activity. Chapter 2 describes 
the development of galactose-functionalised polymers synthesised using a newly 
developed tandem post-polymerisation modification method as inhibitors of CTx. 
The role of linker length between the pendant galactose and the polymer scaffold and 
the density of the galactose on the polymer scaffold were investigated on their 
inhibitory activity and lectin specificity for CTx. Chapter 3 develops a route to 
these glycopolymeric inhibitors that used a more efficient one-pot method opposed 
to the two step, PFP/alkyne azide method used in the previous chapter. This provides 
the first example of the use of a poly(azlactone) reactive scaffold for the synthesis of 
glycopolymers. This versatile method was probed in depth and the inhibitory 
activities of the resulting polymers were determined by a fluorescent-linked sorbent 
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assay (FLSA) on the inhibition of Con A and CTx. Chapter 4 shows the 
development of glycopolymers to target CTx more specifically by introducing a 
secondary unit along with the pendant saccharide to target the neuramimic acid site 
of CTx. The post-polymerisation method uses a poly(glycidyl methacrylate) 
precursor that can be ring opened using sodium azide resulting in a polymer with 
pendant azide and alcohol functionality. A galactose moiety can be installed using 
CuAAC chemistry and a variable functional group was installed using the pendant 
alcohol group. The inhibitory potency and specificity for CTx over another galactose 
specific lectin, PNA was determined using FLSA. Chapter 5 probes the methods 
used for assessing carbohydrate-protein interactions and poses the question: which 
method is best for determining inhibitory activity? QCM-d and FLSA were used to 
determine the inhibitory activity of mannose functional polymers towards Con A.   
Chapter 6 looks at an alternative method to assessing protein-carbohydrate 
interactions. Citrate stabilised AuNPs were employed as a developing agent for 
carbohydrate-binding proteins bound to 96-well microtitre plates. Due to the high 
extinction coefficient of AuNPs, the extent of a protein-carbohydrate interaction 
could be determined by a simple combination of a mobile phone camera and open 
source image software leading to a low technology/low cost method to analysing 
protein-carbohydrate interactions. 
Section 2 concerns the development, optimisation and application of 
glycoAuNPs for the detection and discrimination of bacteria and lectins. Chapter 7 
proves the concept that glycoAuNPs can be used to discriminate between bacterial 
phenotypes of E. coli. However, there are limitations to this in the saline stability of 
these particles and methods to counteract this lead to particles with slower and 
limited readout potentials. Due to the delicate balance between saline stability and 
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speed of colourimetric readout, the development of an optimised method for the 
rapid, saline stable, and selective detection of lectins is described in Chapter 8. This 
optimised method is then improved upon in Chapter 9 using a more versatile 
conjugation chemistry that can be used with any reducing sugar therefore removing 
the need for derivatisation. Finally, lectin discrimination was carried using a 
statistical method, linear discriminate analysis.  
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Section 1: Inhibition 
Chapter 2 
Probing bacterial-toxin inhibition with 
synthetic glycopolymers prepared by 
tandem post-polymerisation 
modification: role of linker length and 
carbohydrate density 
S-J. Richards, M. W. Jones, M. Hunaban, D. M. Haddleton, M. I. Gibson, Angew. 
Chem. Int. Ed., 2012, 51, 7932-7936 
This chapter contains the paper on inhibiting cholera toxin using synthetic 
glycopolymers synthesised using a newly developed tandem post-polymerisation 
method. This work aimed to produce polymeric inhibitors that had not only good 
affinity but also specificity for the target toxin.  
Mathew Jones synthesised the poly(pentafluorophenol methacrylate) scaffold 
polymers and the longer alkyne linker. I carried out the post-polymerisation 
modifications of the polymers to produce glycopolymeric inhibitors of the cholera 
toxin. I also tested the inhibitory activity of the polymers using a fluorescence-linked 
sorbent assay. Mark Hunabun was an MChem student I supervised and he modified 
the polymers with different carbohydrate densities and I carried out the inhibition 
testing of these polymers. I was responsible for the preparation of the manuscript.  
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2.1 Abstract 
A tandem post-polymerisation modification strategy was used to systematically 
probe the multivalent inhibition of a bacterial toxin as a function of linker length, 
carbohydrate density, and glycopolymer chain length. Guided by structural-biology 
information, the binding-pocket depth of the toxin was probed and used as a means 
to specifically improve inhibition of the toxin by the glycopolymer. 
2.2 Introduction 
Carbohydrate-protein interactions mediate many critical biological recognition 
processes, such as those involved in cell signalling, fertilisation, and inflammation, 
as well as the adhesion of viruses and bacterial toxins.1 The proteins responsible for 
deciphering this information are termed lectins, which specifically (and 
noncovalently) bind carbohydrates based on their branching pattern, stereochemistry, 
and chemical functionality.2, 3 The protein–saccharide interactions are usually weak, 
but are amplified by clustered saccharides, resulting in a binding constant that is 
greater than the simple sum of the total number of ligands. This observation is 
referred to as the ‘cluster glycoside’ effect.4 Considering this information, 
glycopolymers are attractive materials to interact with lectins and have been shown 
to display binding affinities several orders of magnitude greater than a single 
carbohydrate molecule.2, 5-9 One of the most attractive applications of glycopolymers 
is to interfere with the binding of lectins from a pathogen to the host organism and 
therefore prevent infection from occurring; this is known as anti-adhesion therapy.10-
14
Anti-adhesion therapy is not limited to polymeric glycoconjugates, and many 
high-affinity, small-molecule inhibitors of lectin binding are known.15 The increased 
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affinity of these small-molecule inhibitors is often because of favourable interactions 
within the sugar-binding pocket, obtained by structural biology studies.15, 16 Despite 
the wealth of structural information available, this design approach has rarely been 
applied to the design of polymeric inhibitors.13 The cholera toxin (CTx), secreted by 
Vibrio cholerae, which is the causative agent of cholera, is a multimeric AB5 lectin-
like complex. The five B subunits bind GM1 gangliosides (Galβ1-3GalNAcβ1- 
4(Neu5Acα2-3)-Gal-β1-4Glc ceramide) present on the surface of the intestinal 
epithelium cells, initiating a series of events that results in the cholera symptoms. 
Multivalent, glycosylated STARFISH dendrimers successfully protected cells from 
similar toxins.17 Polizzotti and Kiick have demonstrated that galactose-functionalised 
poly(L-glutamic acid) (PLG) is an effective inhibitor of CTx.18 Interestingly, 
lowering the density of the galactose residues on the PLG backbone from 
approximately 50 % to 10 % gave a dramatic increase in activity. The inhibitory 
activity was further enhanced when the spacing between PLG and galactose was 
increased, making the binding site more accessible, and was also related to the depth 
of the CTx galactose binding pocket, which was estimated as being 16 Å. Others 
have speculated that longer linkers could enhance binding affinity, but these studies 
were not systematic or relied on a simple turbidimetry-based assay. The 
thermodynamics of this process have been evaluated in detail by Kane.19  
A challenge associated with studying multivalent interactions is the synthesis 
of libraries of glycopolymers with precise control over the chain length, 
carbohydrate density, and nature of the linker. Direct polymerisation of two 
glycosylated monomers is unlikely to lead to polymers with identical degrees of 
polymerisation, which considering the importance of valency in carbohydrate-lectin 
interactions, is a major challenge.20 The synthesis of glycopolymers by post-
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polymerisation modification has attracted much interest, especially with the 
development of “click”-type reactions.21-23 Haddleton et al. have synthesised several 
classes of glycopolymers through cycloaddition of glycosyl azides with 
poly(propargylmethacrylate) scaffolds5, 24 and used these to inhibit the binding of 
gp120 (derived from HIV) to DC-SIGN (one of its targets in humans)25 The direct 
polymerisation of alkyne (or alkene) monomers by radical methods is generally not 
possible because of competing side reactions, due to competing reactivity of the 
alkynyl/vinyl bonds leading to loss of polymerisation control and polymer 
branching.22 Also, the incorporation of co-monomers has the problem of obtaining 
identical length polymers. To address this, Shigha et al. introduced tandem post-
polymerisation modification to introduce incompatible functionality and control 
functional group density.26 Using poly(pentafluorophenyl methacrylate) as the 
template scaffold, allylamine was introduced as a reactive, orthogonal “handle” and 
the remaining ester groups reacted with 2-hydroxypropylamine to give a water-
soluble backbone. This powerful method allows precise control over of a wide range 
of chemical space. 
Herein, we use tandem post-polymerisation modification to obtain 
glycopolymers with precisely controlled chain length, carbohydrate density, and 
crucially, defined backbone–carbohydrate linker lengths. This series of polymers 
was used to study the multivalent interactions between CTx and peanut agglutinin 
(PNA) another ‘galactose specific’ lectin, to probe the impact of modulating the 
binding site complementarity on the inhibitory activity of the glycopolymers. This 
unique combination of structural biology with materials science gives insights into 
the cluster glycoside effect and will allow design of active inhibitors. 
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2.3 Results and Discussion 
The tandem post-polymerisation modification strategy is outlined in Scheme 2.1. 
This approach is advantageous because it allows us to explore a large area of 
chemical space (through side-chain modification) while ensuring that the average 
degree of polymerisation (DP) is identical within each series. 
Scheme 2.1: Synthesis of glycopolymer libraries. i) amine (variable 
amounts)/triethylamine (TEA; 1 equiv.)/dimethylformamide (DMF), 5 h.; ii) GalN3 
(1.5 equiv)/CuBr/TBTA, DMSO 
Two different amino-functional alkynes were selected as the polymer-
carbohydrate spacers. Propargylamine (Alkyne 1) acts as a short linker and a 
diethylene glycol group acts as a longer spacer (Alkyne 2). The reactive polymeric 
precursor, poly(pentafluorophenyl methacrylate), pPFMA, was synthesised by 
copper-mediated controlled-radical polymerisation to give a series of polymers with 
varying DPs, Table 2.1. As previously reported,27 size exclusion chromatographic 
(SEC) analysis of pPFMA gave values of Mn in disagreement with the theoretical 
Mn, due to elution volumes being different to the calibration standard, it being a non-
ideal solvent or interactions with the column. pPFMA reacts readily with sterically 
unhindered amines, such as those used here.27  
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Table 2.1. pPFMA precursor polymers. 
Polymer [M]:[I][a] Conversion[b] 
(%) 
Mn(theo)[c] Mn, (SEC)[d] Mw/Mn[d] DP[e] 
P1 25 71 4500 7800 1.19 18 
P2 50 65 8200 8800 1.20 33 
P3 100 70 17640 11400 1.16 70 
[a] Feed ratio of monomer to initiator. [b] Determined by 1H NMR. [c] Theoretical 
Mn, calculated from feed ratio and conversion. [d] Determined by SEC in THF using 
polystyrene standards. [e] Theoretical number-average degree of polymerisation. 
Homopolymers were synthesised by addition of a three-fold molar excess of 
Alkyne 1 or 2, as well as several copolymers (see below for rationale) by addition of 
10, 25, and 50 mol % of Alkyne 2, followed by a three molar excess of 3-
aminopropanol. Conversion of the pentafluorophenyl (PFP) groups into amides was 
confirmed by IR spectroscopy as the desired amide product (1675 cm-1) and PFP 
ester (1786 cm-1) have unique vibrational frequencies. In all cases, a small amount (< 
5 %) of carboxylic acid units can be seen at 1730cm-1, Figure 2.1. Fluorine NMR 
spectroscopy is often used to determine conversion of PFP groups, but does not 
discriminate between functionalisation and hydrolysis, and therefore can give false 
positive results. 
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Figure 2.1: Infrared spectra showing conversion of the PFP groups (1786 cm-1) into 
amides (1675 cm-1). Carboxylic acid impurities are also indicated. Copolymer (blue 
line) has two distinct amide peaks. 
The alkyne functional (co)polymers were subsequently functionalised with 1-
azido-β-D-galactose (GalN3) (synthesis procedure of GalN3 can be found in appendix 
1) using the CuI/tris(benzyltriazolylmethyl)amine (TBTA) catalyst system, in
dimethyl sulfoxide (DMSO)5 to yield homogenous glycopolymers, with no 
detectable alkyne or azide groups by NMR or IR spectroscopy. Over the course of 
the tandem post-polymerisation functionalisation, there was no evidence of 
fractionation, and all the polymers obtained were well defined with dispersities (Đ) 
below 1.3 (SEC data are included in Appendix 1). Table 2.2 summarises the diverse 
glycopolymer library that was synthesised and used for biological evaluation, below. 
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Table 2.2: Glycopolymers obtained by tandem modification. 
Polymer DP[a] Linker[b] Density[c] Mn (g.mol-1)[d] Mw/Mn[d]
GP1 18 Alkyne 1 100 5100 1.29 
GP2 33 Alkyne 1 100 5340 1.27 
GP3 70 Alkyne 1 100 6000 1.26 
GP4 18 Alkyne 2 100 7250 1.32 
GP5 33 Alkyne 2 100 10000 1.28 
GP6 70 Alkyne 2 100 11900 1.27 
GP7 33 Alkyne 2 50 10800 1.23 
GP8 33 Alkyne 2 25 10700 1.21 
GP9 33 Alkyne 2 10 10500 1.2 
[a] Theoretical number-average degree of polymerisation. [b] Alkyne used to modify 
pPFMA scaffold. [c] Percentage of repeat units functionalised with a galactose unit. 
[d] Determined by SEC in DMF. 
The aim of this investigation was to probe the effect of carbohydrate-binding 
site accessibility on the measured affinity between multivalent glycopolymers and 
their target lectins. The B subunit domain of CTx (CTxB) was chosen because it is 
nontoxic, and a report by Polizzotti and Kiick showed that longer linkers resulted in 
increased inhibitory activity of CTx.18 Peanut agglutinin (PNA) was used as a 
control as it also binds β-galactose, but its binding sites are surface exposed.28, 29 It is 
critical to include this second lectin, because it allows us to separate the effect of 
binding-site accessibility from increased side chain flexibility; the latter has been 
suggested to alter the binding of glycopolymers by allowing access to a larger 
number of possible conformations and leading to increased clustering. A recent 
study found that longer polymer–carbohydrate linkers showed increased affinity for 
the lectin, but the valency of each structure was not identical and there was no 
consideration of the depth of the lectin binding site.30 Figure 2.2 shows schematic 
depictions of the galactose-binding domains of CTx and PNA in comparison to the 
two-linker systems used herein, which were selected to mimic these distances. 
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Figure 2.2: Binding sites of PNA (A) and CTx (B). W = water ligand. C, D) 
Polymer side-chain linkers. Arrows indicate the distance from the terminal β-Gal 
residue to the far end of the native ligand. Distances for the protein-binding site of 
CTx are taken from literature values.18  
Fluorescence-linked sorbent assays were used to measure the inhibitory 
activity of the polymers. Briefly, microtitre plates were functionalised with GM1 
ganglioside, which binds strongly to both lectins.31 Fluorescein-labelled lectins (0.5 
µM) were then incubated with a dilution series of the polymers for 30 minutes at 37 
°C, and the unbound lectins were washed away. The total fluorescence was 
measured and inhibitory curves constructed. Data is presented as the minimum 
concentration required to inhibit 50 % binding of the lectin (MIC50), Figure 2.3. 
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Figure 2.3: Inhibitory activity of glycopolymers GP1-GP6 with A) PNA and B) 
CTx. MIC50 values are expressed as total galactose concentration. 
For PNA (Figure 2.3A), there was a very weak effect of polymer chain length 
on inhibitory activity, but the differences were not statistically significant. The 
inhibitory activity of all the polymers is greatly increased relative to monovalent 
galactose (circa 100-fold). Although there are many reports of longer polymers 
having increased association constants with lectins, we recently demonstrated that 
this does not necessarily translate into improved inhibitory activity, in agreement 
with the data presented herein (See Chapter 5).32 Our previous work also showed 
that above a certain chain length, no improved inhibition (based on carbohydrate 
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concentration) was measured, as seen with the current results. For CTx inhibition 
(Figure 2.3B), there was a similarly weak dependence on polymer chain length, and 
no statistically significant differences were recorded. However, there was a 
significant decrease in the MIC50 values upon increasing the length of the linker. 
This result agrees with the hypothesis that the longer linker better mimics the native 
ligand, GM1. The use of a hydrophilic ethylene glycol linker allows us to rule out 
any hydrophobic interactions in the binding pocket. These carefully chosen 
conditions and the use of a control lectin (PNA) ensure that binding-pocket depth is 
the only parameter contributing to increased activity. Control experiments with an α-
manno-polymer showed no inhibition in the concentration range tested (less than 100 
µM carbohydrate), highlighting the specificity of the interaction. 
Previous research has shown that a decrease in galactose density on the 
polymer backbone is accompanied by an increase in CTx inhibition.18, 33 However, 
rigid α-helical polypeptide scaffolds were used, which cannot easily be reconfigured, 
and they also had a net-negative charge, which might promote electrostatic 
interactions. P2 was functionalised with 10, 25, or 50 mol % of the longer linker 
(because of its higher binding affinity) followed by an excess of 3-aminopropanol to 
give variable density, and uncharged glycopolymers (GP7–9). Inhibition data are 
shown in Figure 2.4. 
 67 
Figure 2.4: Inhibitory activity of variable density glycopolymers expressed in terms 
of A) polymer mass concentration and B) galactose concentration. Percentages on 
the x-axis indicate the percentage of repeat units on the polymer chain that have a 
galactose moiety. 
Figure 2.4A shows inhibition data in terms of polymer mass concentration. 
For PNA, decreasing the saccharide density gives a concurrent increase in MIC50 
(i.e. less activity), which can be interpreted as lower galactose densities leading to a 
relative decrease in binding affinity/inhibitory activity. For CTx, the 50 % 
functionalised polymer was the least active. However, this analysis is oversimplified, 
and it is necessary to consider the data in terms of relative activity per saccharide 
unit (Figure 2.4B). In this manner, the 10 % and 100 % functionalised polymers are 
the most active on a per-carbohydrate basis for both lectins, suggesting several 
features of the macromolecules contribute to inhibitory activity. The control 
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experiments with PNA, also showed a clear decrease in affinity as the galactose 
density decreased, implying that spanning of multiple sites is not the most important 
feature for inhibition. This result agrees with our previous findings using the Con 
A/mannose pairing that indicated the spanning of multiple sites contributed to higher 
association constants, but not to increased inhibition (Chapter 5).32 A second 
component of this result could be steric hindrance of adjacent galactose residues; 
crowding may reduce rebinding of galactose into the deep binding pocket of CTx 
resulting in lower inhibitory activity for 50 % polymers compared to the 10 % 
functionalised polymers. These data fit with the hypothesis that the binding site in 
CTx limits accessibility, relative to the shallow binding site on PNA, for which the 
polymers with the highest valency showed highest inhibitory activity. The high 
activity (on a per-sugar basis) of the 100 % versus 50 % functionalised polymers 
would seem to contradict the above hypothesis. However, in this case the density of 
the 100 % functionalised polymers might be sufficiently high to overcome the 
limitations of steric crowding and benefit from a higher rate of statistical rebinding, 
or slower rate of dissociation.  
2.4 Conclusion 
In summary, a series of glycopolymers with varying saccharide density, linker 
length, and chain length were synthesised by tandem post-polymerisation 
modification. Longer linkers were shown to result in increased inhibition of CTxB, 
which is attributed to the depth of the binding pocket. Comparison with PNA, which 
has a shallower binding pocket, revealed no difference in inhibitory activity as a 
function of linker length. The tandem post-polymerisation modification strategy also 
allowed the effect of carbohydrate density to be studied. A nonlinear relationship 
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was measured, in which the highest and lowest density polymers tested (100 % and 
10 %) were most active, on a per-sugar basis, highlighting the complexity of these 
interactions. These measurements demonstrate that in the design of biomimetic 
macromolecules for anti-adhesion or other therapeutic applications, structural 
biological information must be considered, in conjunction with using the relevant 
assays. Furthermore, the best polymer structure for a particular lectin is not 
necessarily the optimum structure for other lectins, even those with the same 
carbohydrate specificity.  
2.5 Experimental 
2.5.1 Materials 
Tris-(benzyltriazolylmethyl)amine (TBTA) and pentafluorophenyl methacrylate 
(PFMA) was synthesised according to literature procedures.27 N,N,N',N',N"-
pentamethyldiethylenetriamine (PMDETA) was purchased from Sigma Aldrich, 
degassed and stored in an ampoule under a N2 atmosphere. 1,2,3,4,6-Pentaacetyl 
galactose, hydrogen bromide (33 %) in acetic acid, sodium azide, pentafluorophenol 
and methacryloyl chloride were all obtained from Sigma-Aldrich and used as 
supplied. Pentaflurophenyl methacrylate was synthesised according to previously 
published procedures.27 Peanut agglutinin and the B-sub unit of the cholera toxin 
were obtained from Sigma Aldrich and made into 0.1 mg.mL-1 solutions in HEPES 
buffer immediately before use. The HEPES buffer used, unless indicated, contained 
the following: 0.10 M HEPES, 0.15 M NaCl, 1 mM MgCl2, 1 mM CaCl2 and 1 mM 
MnCl2, pH 7.4. Ultrahigh quality water with a resistance of 18.2 MΩ.cm (at 25 °C) 
was obtained from a Millipore Milli-Q gradient machine fitted with a 0.22 µm filter.  
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2.5.2 Physical and analytical methods 
NMR spectra were recorded on Bruker DPX-300 and DPX-400 spectrometers for 1H 
NMR (400 MHz) and 13C NMR (125 MHz). Chemical shifts are reported in ppm 
relative to the deuterated solvent resonances and spectra analysed with WIN-NMR 
software. SEC (THF) was performed on a Varian 390-LC MDS system equipped 
with a PL-AS RT/MT autosampler, a PL-gel 3 µm (50 × 7.5 mm) guard column, two 
PL-gel 5 µm (300 × 7.5 mm) mixed-D columns equipped with a differential 
refractive index and a Shimadzu SPD-M20A diode array detector, using THF as the 
eluent with a flow rate of 1.0 mL min-1. Narrow molecular weight PMMA standards 
(200 - 1.0 × 106 g mol-1) were used for calibration using a second order polynomial 
fit. GPC (DMF) was performed on a Varian 390-LC MDS system equipped with a 
PL-AS RT/MT autosampler, a PL-gel 3 µm (50 × 7.5 mm) guard column, two PL-
gel 5 µm (300 × 7.5 mm) mixed-D columns equipped with a differential refractive 
index, using DMF (with 1 mg mL-1 LiBr) as the eluent with a flow rate of 1.0 mL 
min-1 at 50 °C. Narrow molecular weight PMMA standards (200 - 1.0 × 106 g mol-1) 
were used for calibration using a second order polynomial fit. SEC (aqueous) was 
performed on a Varian 390-LC MDS system equipped with a PL-AS RT/MT 
autosampler, a PL-aquagel-OH 8 µm (50 × 7.5 mm) guard column, a PLaquagel-OH 
column set consisting of two 8 µm (300 × 7.5 mm) columns equipped with a 
differential refractive index detector using phosphate buffer (pH 8.2) as the eluent at 
a flow rate of 1.0 mL min-1. Narrow molecular weight PEO standards (100 - 1.26 × 
106 g mol-1) were used for calibration using a second order polynomial fit. Infrared 
absorption spectra were recorded on a Bruker VECTOR-22 FTIR spectrometer using 
a Golden Gate diamond attenuated total reflection cell. Mass spectra were recorded 
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using a Micromass Autospec apparatus. Polymer-carbohydrate linker lengths were 
determined by assuming bond angle of 109.4° and bond lengths of 0.154 nm. 
2.5.3 Synthetic procedures 
Poly(pentafluorophenylmethacrylate), pPFMA: Ethyl 2-bromoisobutyrate (0.247 
g, 1.27 mmol), pentafluorophenyl methacrylate (8.00 g, 31.7 mmol), Cu(I)Br (0.182 
g, 1.27 mmol), mesitylene (1.14 g, 9.51 mmol) and toluene (16 mL) were added to 
an oven dried Schlenk tube and subjected to four freeze pump thaw cycles. 
PDMETA (0.40 mL, 1.9 mmol) was added to the solution via degassed syringe and 
the Schlenk tube immersed in and oil bath at 60 °C. Samples were taken periodically 
via degassed syringe for analysis by 1H NMR and GPC. After 7 hours, the 
polymerisation was quenched by exposing the solution to air and bubbling for a 
further 4 hours. The solution was the diluted with toluene (200 mL) and passed 
through a column of neutral alumina to remove solids. The remaining solution was 
concentrated under reduced pressure and the final product isolated by precipitation 
into petroleum ether as an off-white solid.  
Mn = 7800 g.mol-1, PDi = 1.22 (THF SEC).; 1H NMR (400 MHz, CDCl3) δppm: 1.53 
(3H, CH3), 2.53 (2H, CH2); 13C NMR (100 MHz, 1H decoupled, CDCl3) δppm: 25.6 
(CH3), 45.36 (CH2), 124.1 (C-O), 136.1 – 141.7 (C-F), 172.0 (C=O); IR (neat) ! = 
3150 (C-H), 1786 (C=O active ester) cm-1.  
2-(2-(Prop-2-ynyloxy)ethoxy)ethanamine:  
Tert-butyl 2-(2-(prop-2-ynyloxy)ethoxy)ethylcarbamate (1.58 g, 6.49 mmol) was 
dissolved in 50 mL of dichloromethane and TFA added (5 mL). The solution was 
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allowed to stir at room temperature for 24 h and the solvents removed under reduced 
pressure to yield the product as a viscous oil (0.874 g, 94 % yield). 
1H NMR (300 MHz, CDCl3) δ = 4.18 (d, J = 2.3 Hz, 2H), 3.72 (t, J = 4.7 Hz, 2H), 
3.70 - 3.66 (m, 4H), 3.15 (t, J = 4.7 Hz, 2H), 2.47 (t, J = 2.4 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ = 79.3, 75.2, 70.2, 69.0, 66.8, 58.4, 39.6; IR (neat) ν = 3251, 2110, 
1590, 1444, 1092 cm-1; HRMS (ES+) calcd for C7H13NO2 [M+  Na]+ 166.0838, 
observed 166.084. 
Synthesis of 1-Azido-1-deoxy-β-D-galactopyranoside 
2,3,4,6,-tetra-O-acetyl-α-D-galactopyranosyl bromide: 1,2,3,4,6-Pentaacetyl 
galactose (40 g, 102.4 mmol) was dissolved in DCM (240 mL) To this, hydrogen 
bromide (33% in acetic acid, 200 mL) was added. The reaction mixture was stirred 
at room temperature and after 3 hours, T.L.C. (ethyl acetate/petroleum ether 1:2) 
indicated the formation of product (Rf > 0.5) with complete consumption of the 
starting material (Rf 0.5). The reaction mixture was partitioned between DCM (200 
mL) and H2O (200 mL) and the aqueous phase was re-extracted with DCM (2 x 100 
mL). The combined organics were washed with a saturated sodium carbonate 
solution and the organic phase dried over magnesium sulphate, filtered and 
concentrated under vacuum to afford the product as a yellow oil (40.7 g, 99.3 mmol, 
97 %). 
1H NMR (400 MHz, CDCl3) δ = 1.95, 2.00, 2.05, 2.15 (4s, 4 × COCH3), 4.05 (dd, 
1H, J = 6.3 Hz, CH2), 4.15 (dd, 1H, J = 6.5 Hz, CH2), 4.45 (dd, 1H, J = 6.7 Hz, CH), 
5.00 (dd, 1H, J1 = 10.5 Hz J2 = 4 Hz, CH), 5.35 (dd, 1H, J1 = 10.7 Hz J2 = 3.4 Hz, 
CH), 5.50 (dd, 1H, J1 = 11.3 Hz J2 = 3.5 Hz, CH) 6.65 (d, 1H J  = 4 Hz, CH); 13C 
NMR (125 MHz, CDCl3) δ = 20.6, 20.6, 20.7, 20.8 (4s, 4 × COCH3), 60.8 (s, 1C, 
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CH2 C-6), 67.0 (s, 1C, CH, C-4), 67.8 (s, 1C, CH, C-2), 68.0 (s, 1C, CH, C-3), 71.1 
(s, 1C, CH, C-5), 88.2 (s, 1C CH, C-1), 169.8, 169.9, 170.1, 170.3 (4s, 4 × COCH3).  
2,3,4,6,-tetra-O-acetyl-β-D-galactopyranosyl azide: To 2,3,4,6,-tetra-O-acetyl-α-D-
galactopyranosyl bromide (20.18 g, 49.2 mmol, 1 eq.), Bu4NHSO4 (16.7 g, 49.2 
mmol, 1 eq.), NaN3 (16.0 g, 246 mmol, 5 eq.) in DCM (200 mL) and saturated 
aqueous NaHCO3 (200 mL) was added. The biphasic solution was allowed to stir 
vigorously at room temperature for 16 hours. T.L.C. (1:2 ethyl acetate : petroleum 
ether) of the solution showed complete consumption of the starting material and the 
reaction mixture was extracted with ethyl acetate and the organic phase was washed 
successively with NaHCO3. The organic layer was dried over anhydrous MgSO4, 
filtered and the solvent removed to afford 2,3,4,6-tetra-O-acetyl-β-D-
galactopyranosyl azide as a white powder (12.78 g, 34.5 mmol, 70%). 
1H NMR (400 MHz, CDCl3) δ = 2.00, 2.05, 2.10, 2.20 (4s 4 × COCH3), 4.00 (m, 1H, 
CH), 4.10-4.25 (m, 2H, CH2 and CH), 4.60 (d, 1H, J = 8.8 Hz, CH, H-1), 5.05 (dd, 
1H, J = 3.3 Hz CH), 5.15 (dd, 1H, J = 8.5 Hz CH) 5.45 (dd, 1H J1 = 1.4 Hz J2 = 3.4 
Hz, CH); 13C NMR (125 MHz, CDCl3) δ = 20.52, 20.61, 20.67, (4s, 4 × COCH3), 
61.23, (s, 1C, CH2, C-6), 66.86 (s, 1C, CH, C-4), 68.06 (1C, CH, C-2), 70.73 (s, 1C, 
CH, C-3), 72.87 (s, 1C, CH, C-5), 88.30, (s, 1C, CH, C-1), 169.37, 169.99, 190.12, 
120.37 (4s, 4 × COCH3).  
1-Azido-1-deoxy-β-D-galactopyranoside: To a solution of 2,3,4,6-tetra-O-acetyl-β-
D-galactopyranosyl azide (12.78g, 34.5 mmol) in methanol (120 mL), sodium 
methoxide (3 mL) was added. The resulting mixture was stirred at room temperature 
overnight. This solution was neutralised with Amberlite IR-120H+ and the ion 
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exchange resin removed by filtration. The solvent was evaporated under vacuum to 
afford a yellow oil which crystallised to the product (6.18 g, 30.1 mmol, 88 %). 
1H NMR (400 MHz, CDCl3) δ = 3.35 (1H, dd, CH, J1 = 9.8 Hz J2 = 3.4 Hz, H-2), 
3.50 (1H, dd, CH, J1 = 9.9 Hz J2 = 3.4 Hz, H-3), 3.60 - 3.70 (3H, m, CH2 and CH, 
H6a, H6b,  H-5), 3.80 (1H, d, CH, J = 3.3 Hz H-4), 4.50 (1H, d, CH,  J = 8.5, H-1); 
13C NMR (125 MHz, CDCl3) δ = 60.94, (s, 1C, CH2, C-6), 68.51 (s, 1C, CH, C-4), 
70.32 (s, 1C, CH, C-2), 72.65 (s, 1C, CH, C-3), 77.20 (s, 1C, CH, C-5), 90.54, (s, 
1C, CH, C-1). 
Functionalisation of pPFMA with amino-functional alkynes:  
Poly(pentafluorophenyl methacrylate) (100 mg, 0.39 mmol PFP), alkyne linker 
(propargyl amine or 2-[2-(prop-2-ynyloxy)ethoxy]ethanamine (varying amounts)), 
and TEA (80 mg, 0.79 mmol) in DMF (5 mL) were stirred at 50 °C for 16 h. After 
this time, a three molar excess (relative to PFP groups) of 3-aminopropanol was 
added, when copolymers were desired, and stirred for a further 16 h at 50 °C. The 
solution was twice precipitated into diethyl ether, then centrifuged and dried under 
vacuum to afford the alkynyl-functionalised polymers. 
Alkyne 1: 1H NMR (400 MHz, MeOD): δ = 1.2 (CH3 backbone), 1.8 (CH2 
backbone), 3.2 (C≡CH), 4.4 ppm (s, NH-CH2) ; IR : ν  =1650 cm-1 (amide C=O). 
Alkyne 2: 1H NMR (400 MHz, MeOD): δ = 1.2 (CH3 backbone), 1.8 (CH2 
backbone), 3.1  (CH2), 3.2 (C≡CH), 3.5 (CH2), 3.7 (CH2), 4.2 ppm (s, NH-CH2); IR: ν = 1720 cm-1 (CO2H), 1650 cm-1 (amide C=O). 
Copper-catalysed [3+2] cycloaddition of GalN3 with alkyne-functionalised 
polymers: Alkynyl functionalised polymer (20 mg, 0.18 mmol), 1-azido-β-D-
galactose (80 mg, 0.36 mmol), TEA (10 mg, 0.072 mmol), and CuBr (2 mg, 0.014 
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mmol) dissolved in [D6]-DMSO (4 mL) were charged in an ampoule and 
deoxygenated through three freeze–pump–thaw cycles before being placed under 
nitrogen. TBTA (8 mg, 0.015 mmol) was added and the reaction was degassed and 
left under nitrogen for 48 h. The glycopolymer was purified by dialysis against water 
using 1000 Da MWCO tubing and freeze-dried. GP1: 1H NMR (400 MHz, MeOD): 
δ = 1.2 (CH3 backbone), 1.8 (CH2 backbone), 4.4 (s, NH-CH2), 3.4–3.5 (2 H, H-2 + 
H-3), 3.60–3.80 (3 H, CH2 and CH, H-6a, H-6b, H-5, H-4), 4.7 ppm (1H, H-1); IR ν 
= 3100–3300 cm-1 (OH), 3050 cm-1 (C-H), 1650 cm-1 (amide C=O); SEC (DMF): 
Mn = 5100 g.mol-1, Mw/ Mn = 1.29. 
2.5.4 Inhibitory assays 
Fluorescence-linked sorbent assay for inhibitory activity: 96-Well microtitre 
plates were incubated for 16 hr with 180 µL of 100 mg.mL-1 GM-1 ganglioside
dissolved in phosphate-buffered saline (PBS), per well. Unattached GM-1 was 
removed by washing extensively with PBS. Polymer solutions were made up as 
serial dilutions in HEPES from 100 µg.mL-1. 20 µL of 0.3 mg.mL-1 PNA-FITC in
HEPES was added to 80 µL of each polymer solution to result in 0.5 µM PNA-FITC. 
100 µL of the polymer PNA-FITC solutions were added to the GM-1 surfaces and
incubated at 37 °C for 30 mins. Fluorescence was then measured at 
excitation/emission wavelengths of 485/528 nm. All experiments were carried out in 
triplicate. Percentage inhibition was compared to relative to controls of pure PNA-
FITC (with no polymer). Identical procedures were used using the cholera toxin B-
subunit, with a final concentration of 0.5 µM used. Non-linear regression analysis
was carried out in Origin. 
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Chapter 3 
 Poly(azlactone)s: versatile scaffolds for 
tandem post-polymerisation 
modification and glycopolymer 
synthesis 
M. W. Jones, S-J. Richards, D. M. Haddleton, M. I. Gibson, Polym. Chem. 2013, 4, 
717 
This chapter contains the paper that built on the findings from Chapter 2, in which 
was found that a longer linker is required for effective inhibition of the cholera toxin 
due to its relatively deep binding site. In this chapter a poly(azlactone) scaffold is 
used which leads to a linker of the correct length being formed in a one-pot reaction.  
This is a simpler method for the one-step synthesis of glycopolymer inhibitors 
compared to the two-step system used previously.  The versatility of this technique is 
outlined in this chapter and the inhibitory activity against Con A and CTx were 
assessed using a fluorescent-linked sorbent assay.   
Mathew Jones synthesised the polymers and I tested them for their inhibitory 
activity. I also helped with the manuscript preparation.  
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3.1 Abstract 
The synthesis of polymers with latent reactivity suitable for ‘click’ type 
modifications in a tandem post-polymerisation modification process starting with 
poly(azlactone) precursors is investigated. Poly(azlactones), obtained by copper(I) 
mediated radical polymerisation, were functionalised in a one-pot process with 
amines bearing functional groups which are incompatible with controlled radical 
polymerisation: alkynes, alkenes, furfuryl and phenol. The reaction is quantitative 
and 100 % atom efficient presenting an efficient route to clickable scaffolds without 
the need for protecting group chemistry. Additionally, the poly(azlactones) were 
exploited to obtain synthetic glycopolymers. The ring opening procedure introduces 
a 5-atom spacer between glycan and backbone, which provides improved access to 
carbohydrate-binding proteins with deep binding pockets, such as the cholera toxin, 
for anti-adhesion applications. 
3.2 Introduction 
There are two conceptual methodologies for obtaining side-chain functionalised 
polymers. The first is direct polymerisation of functional monomers, which has been 
enabled by the advent of modern, tolerant, controlled polymerisation processes such 
as ring opening metathesis polymerisation (ROMP) and controlled radical 
polymerisation. Whilst this methodology is useful, there still remains the challenge 
of obtaining well-defined libraries of polymers with sequential modifications and 
identical degrees of polymerisation (DPs), particularly for exploring biological 
interactions, and even the most tolerant polymerisation methodologies also have 
some incompatibilities. To address this, the concept of post-polymerisation 
modification is frequently employed, whereby a reactive polymeric precursor is 
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directly functionalised ensuring all members of the library have identical DPs.1 
Highly efficient functionalisation strategies are essential for this, with those based on 
‘click’ reactions proving to be the most useful. A key challenge associated with the 
synthesis of ‘clickable’ scaffolds is that the latent functionality (typically alkenes and 
alkynes) are incompatible with controlled radical polymerisations and require 
protection/deprotection chemistry which itself must be 100 % efficient.2 To 
circumvent this, Singha et al. introduced the concept of tandem post-polymerisation 
modification whereby poly(pentafluorophenyl methacrylate), with an activated ester 
side-chain is first modified by allyl (or propargyl) amine with high efficiency, 
generating a reactive scaffold with variable side chain density.3 This has been 
exploited to generate polypeptide hybrid materials and also to probe the affinity of 
multivalent galactosides for the toxin secreted by Vibrio cholerae (See Chapter 2).4 
Advantages of active ester-type monomers are their easy accessibility, and the use of 
amines as functionalisation moieties that are commercially available. Activated 
esters of N-hydroxysuccinimide,5 pentafluorophenol,6, 7 and 4-nitrophenol have been 
exploited for the introduction of functionality to polymers with nucleophilic groups 
such as amines and alcohols.6, 8 Synthetic glycopolymers, with side-chain 
carbohydrate moieties have been prepared by post-polymerisation modification by 
both ‘click’ and active ester type reactions.2, 8, 9 This allows for the side chain 
composition to be varied while ensuring identical DPs, which is required when 
studying multivalent glycosides due to the cluster glycoside effect: multivalent 
presentation of carbohydrates results in an increase in avidity greater than the linear 
sum of the individual carbohydrates. In order to understand carbohydrate–protein 
interactions it is therefore important to control every aspect of the macromolecular 
architecture8, 10, 11 with the aim of obtaining highly active anti-adhesion therapies.12  
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The post-modification techniques described above have proven to be 
successful, but still suffer from very low atom efficiency (either due to displacement 
reactions or protecting group removal) as well as side reactions and competitive 
hydrolysis which can impede this approach.7, 13 Alkenyl azlactones14 such as 2-vinyl-
4,4-dimethylazlactone (VDMA) (1) are particularly interesting as an alternative to 
activated esters due to the electrophilic nature of the ring, which readily undergoes 
ring opening in the presence of nucleophiles such as primary amines, alcohols and 
thiols.15, 16 Early reports of VDMA-based polymers were centered on their synthesis 
via free radical polymerisation although advances in controlled radical 
polymerisation (CRP) techniques such as nitroxide-mediated polymerisation 
(NMP),17 atom transfer polymerisation (ATRP)18, 19 and reversible-addition–
fragmentation chain transfer (RAFT)20 polymerisation have enabled the synthesis of 
well-defined polymers with predetermined molecular weights. The first report of the 
controlled polymerisation (NMP) of VDMA was by Tully et al.,21 with high 
conversions and narrow molecular weight distributions achieved in homo- and co-
polymerisations with a number of co-monomers. ATRP of VDMA was first 
described by Fontaine et al.,22 and used to prepare well-defined pVDMA solid 
supports which proved effective primary amine scavengers from solution. The 
polymerisation of VDMA by RAFT has been investigated by Kilbey et al.23 and 
Fontaine et al.24 with these polymers readily crosslinked with diamines to yield 
stable nanoparticles.25 The reactivity of azlactones has been widely explored by 
Lynn and Buck for a wide range of applications.26 Exploiting the “spring-loaded” 
reactivity of pVDMA has enabled the ready synthesis of thin films using a layer-by-
layer assembly approach27, 28 in order to synthesise hollow microcapsules,29 super 
hydrophobic surfaces30 and to modify hair and cellulose.31 The pVDMA scaffold 
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also presents a robust platform for the introduction of multiple amino functionalities 
to the same polymer on a one- pot system.32, 33 A recent report by Fournier et al. 
describes the modification of azlactone-functional styrenic copolymers synthesised 
by RAFT. A range of commercially available functional amines were employed to 
introduce diverse functionality to the polymer chains.34 RAFT has also been 
employed by Fontaine et al. as a route to end-functional polymers where an 
azlactone functional RAFT agent was employed for the chain end modification of 
polymers with functional amines.35  
The aim of this current work was to probe the use of pVDMA scaffolds as 
reactive precursors for direct and tandem post-polymerisation modification as an 
alternative to traditional scaffolds. In particular, these scaffolds are investigated for 
the preparation of synthetic glycopolymers as novel anti-adhesion therapies against 
pathogenic toxins. 
3.3 Results and Discussion 
The introduction of both alkyne- and alkene-functionalities to polymer backbones is 
highly desirable for subsequent functionalisation but the intrinsic reactivity of these 
functionalities towards radicals can hamper their direct utilisation under CRP 
conditions. A key aim of this work is using pVDMA as the reactive scaffold for 
tandem post-polymerisation modification procedures in a one-pot system.1 The 100 
% atom efficiency observed upon nucleophilic ring opening of the azlactone was 
also particularly desirable, since traditional approaches to these reactive scaffolds 
usually involve protecting groups or the loss of bulky groups in the case of activated 
esters. In order to quantify the efficiency of ring opening, our initial approach 
involved analysis of the ring opening of the azlactone ring using functional primary 
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amines. VDMA (1) was synthesised as described by Fontaine et al.25 and used in a 
number of preliminary reactions with propargyl and allyl amine. 
Equimolar quantities of propargylamine and allylamine were added to a 
solution of VDMA in toluene and stirred at ambient temperature overnight (Scheme 
3.1). In both cases, precipitation of white crystalline solids was observed, and 
following isolation by filtration, analysis by 1H and 13C NMR, FT-IR and mass 
spectrometry confirmed the presence of the desired product in quantitative yield, 
with no observable side reactions (characterisation data is included in Appendix 2). 
Scheme 3.1: Ring opening of VDMA with primary amines, propargyl amine and 
allyl amine at ambient temperature and in the absence of a catalyst. 
Encouraged by the successful monomer functionalisation, pVDMA was 
obtained by polymerisation at 25 °C using the optimised conditions described by 
Fontaine et al.22 Conversion was monitored by 1H NMR and upon reaching 80 % 
conversion (140 minutes) the polymerisation was quenched by bubbling with air for 
10 minutes. Pseudo-living characteristics were observed throughout the 
polymerisation, with a linear increase in molecular weight against conversion, 1st 
order kinetics and relatively narrow molecular weight distributions indicating a 
controlled radical polymerisation process, Figure 3.1 (Scheme 3.2).  
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Figure 3.1: Kinetic and SEC analysis of the polymerisation of VDMA (left). Kinetic 
measurements determined by 1H NMR by monitoring conversion of vinyl groups 
(right).
Scheme 3.2: Polymerisation of VDMA (1) by ATRP. 
There was some increase in Mw/Mn at high conversions we do not believe this was 
due to chain transfer or crosslinking due to evidence shown in Figure 3.1. The 
observed values for Mn were greater than expected from the monomer : initiator feed 
ratio indicating non-quantitative initiator efficiency, or that the SEC solvent was 
non-ideal (Table 3.1). 
O
O
Br O N
O
O
O
Br
n
O N
O
Cu(I)Br
Me6TREN
Toluene
25 °C
86 
Table 3.1: Initial polymer and those obtained by post-polymerisation modification. 
Polymer Conversion 
(%) 
Mn(Theo)
(g.mol-1) 
Mn(SEC)[e] 
(g.mol-1) 
Mw/Mn[e]
pVDMA  89[a] 6280[c] 3500 1.32 
Post 
Modifications 
> 95[b] 8760[d] 12500 1.20 
> 95[b] 8850[d] 12800 1.15 
> 95[b] 12500[d] 11700 1.28 
> 95[b] 10660[d] 10200 1.35 
[a] Conversion of monomer into polymer, determined by 1H NMR; [b] Conversion 
of VDMA units into ring-opened form. Estimated by 1H NMR and IR; [c] 
Determined from the [monomer]:[initiator] feed ratio and conversion; [d] 
Determined from the theoretical molecular weight of the precursor pVDMA and the 
degree of incorporation of amine side chains; [e] Determined by SEC in DMF 
against PMMA standards. 
The direct one-pot functionalisation of the synthesised pVDMA was 
investigated with a range of commercially available amines bearing functional 
groups not compatible with CRP techniques. Allylamine and propargylamine, were 
investigated for the synthesis of poly(alkyne) and poly(alkene) homo-polymers 
derived from the same pre-scaffold. These functionalities are desired for further 
post-polymerisation modification via ‘thiol–ene’ and ‘alkyne–azide’ click-type 
reactions. The amines were added to the crude polymer solution (1.5 eq. of amine 
relative to azlactone), along with DMSO in order to fully solubilise the obtained 
polymers and left to stir overnight at room temperature, in the absence of any added 
catalysts (Table 3.1). Each solution was then diluted and twice precipitated into ethyl 
acetate to yield white solids. 1H NMR analysis of the obtained polymers revealed 
complete consumption of the signals corresponding to pVDMA, with the appearance 
of broad signals derived from both alkene and alkyne functionalities in each case. 
SEC analysis (Figure 3.2) of the obtained polymers showed the expected increase in 
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molecular weight following ring opening. Infrared (IR) spectroscopy (Figure 3.3) 
also confirmed complete functionalisation of the pre-scaffold, with no trace of the 
azlactone cyclic ester and a strong signal from the two amide groups generated upon 
ring opening. (Additional characterisation in Appendix 2). 
Figure 3.2: SEC analysis of pVDMA before (red) and after (green) modification 
with propargylamine. 
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Figure 3.3: Infrared analysis of post-polymerisation modification of pVDMA 
(green) and after addition of propargylamine (red). 
Following the successful synthesis of alkene- and alkyne- functional 
homopolymers, this one-pot approach was used to introduce additional functionality 
that is often not compatible with radical polymerisation (Table 3.1). Phenols are 
commonly used as radical polymerisation inhibitors although they have been shown 
to enhance the rate of ATRP36 and SET-LRP.37 The direct synthesis of poly(phenols) 
can however be problematic and they are usually synthesised by deprotection of 
masked phenolic functionalities such as acetoxystyrene following polymerisation.38,
39 As above, pVDMA was obtained and upon reaching 80 % conversion, the 
polymerisation was quenched and a solution of tyramine in DMSO added. Following 
isolation complete disappearance of the original signal for the azlactone ring was 
observed by IR spectroscopy, with the formation of the new amide signal, 
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confirming quantitative ring opening. SEC analysis of the purified polymer revealed 
the expected mass increase upon modification of the pre-polymer with formation of 
a well-defined product. 1H NMR also supported the formation of the desired 
polymers (Appendix 2). 
We were also interested in the introduction of other functionalities, namely 
furan groups, since these are commonly employed in Diels–Alder reactions and may 
yield materials with reversible crosslinking capabilities.40 As previously, the 
quenched crude polymerisation solution of pVDMA was added to furfurylamine in 
DMSO and allowed to stir at room temperature overnight. Following isolation, IR 
analysis of the resulting polymer showed, as expected, complete disappearance of 
the original ester derived from pVDMA, as well as formation of the newly generated 
amide groups. SEC analysis showed the expected mass increase upon modification 
of the scaffold, with a well-defined polymer observed. The above results 
demonstrate that pVDMA is an excellent scaffold for tandem-post-polymerisation 
modification as an alternative to either active ester precursor polymers, or the direct 
polymerisation of protected alkyne/alkenes. 
3.3.1 Glycopolymer Synthesis and Inhibitory Activity 
Encouraged by the quantitative conversion observed using relatively unhindered 
amines, the pVDMA scaffold was subsequently investigated for the one-pot 
synthesis of glycopolymers. Synthetic glycopolymers have been demonstrated to be 
useful in anti-adhesion therapies, but in order to fully understand the cluster 
glycoside effect sequentially modified glycopolymers with identical valencies (DPs) 
are required.4, 41, 42 Additionally, we have demonstrated that increasing the separation 
between polymer backbone and carbohydrate can specifically increase the inhibitory 
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activity of β-D-galactose functional polymers against the cholera toxin (CTx), owing 
to its deep carbohydrate binding pocket,43 while not affecting its avidity for other 
galactose-binding lectins.4 Upon ring opening of a VDMA unit, a longer spacer is 
generated (5 atoms) compared to direct substitution of an activated ester which only 
gives 2 carbon atoms,7 and therefore pVDMA offers a practical route to obtain these 
potent multivalent inhibitors. To probe this, VDMA was polymerised using identical 
conditions as described above, and upon quenching the solution was split into three 
portions. To each of the portions, solutions of 2-deoxy, 2-amino- gluco-/manno-
/galacto-pyranoside hydrochloride salts in DMSO with triethylamine were added and 
the mixtures allowed to stir at room temperature for 16 hours. Each solution was 
subsequently diluted with 1 : 1 H2O–methanol and dialysed against the same mixture 
for 3 days. Removal of the solvent by lyophilisation yielded each product as a white 
powder, Figure 3.4 (Scheme 3.3). 
Scheme 3.3: Glycopolymers obtained by post-polymerisation modification of 
pVDMA with 2-aminoglycosides. 
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Figure 3.4: Infrared spectrum of 2-deoxy, 2-amino-mannopyranoside modified 
pVDMA. Assignments of carbonyl vibrations as described in the main text are 
indicated. 
Aqueous SEC indicated well defined polymers were obtained in each case, 
with monomodal distributions. This would seem to rule out crosslinking side-
reactions, but pVDMA is known to react with alcohols. Analysis of the 
glycopolymers by IR revealed complete disappearance of the signal corresponding to 
the original azlactone ring, with the expected appearance of the amide signals 
derived from ring opening with the amino functionality of the saccharides (Figure 
3.4). In each case however, a smaller carboxyl signal was also observed (ca. 1730 
cm-1), and was postulated to be either a product of ring hydrolysis or ester formation 
following ring opening with the sugar hydroxyl groups. In order to identify the 
secondary signals, pVDMA was subjected to ring opening in the presence of sodium 
hydroxide as well as ring opening by methanol in the presence of DBU as a catalyst. 
Following ring opening at 50 °C overnight, the solutions were dialysed against water 
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for 3 days and lyophilised. IR analysis of the obtained polymers confirmed that 
alcohol ring opening of the azlactone ring was the source of the second carbonylic 
signal, due to the similarity of the signal obtained to that from ring opening with 
methanol (Appendix 2). The ring opening of azlactone rings with alcohols is well 
established44 but since monomodal, relatively well defined polymers were obtained, 
intermolecular crosslinking of chains is expected to be minimal and the ester signals 
are expected to be derived from intramolecular reactions with adjacent sugar 
moieties. 
With this panel of glycopolymers obtained, their biological activity was 
assessed using fluorescence-linked inhibitory assays. Inhibitory assays are predictive 
of the ability of the glycopolymers to function as anti-adhesives, as opposed to the 
extremely limited turbidimetry methodologies that give limited information45 and 
require large quantities of lectins (not typically possible for medically relevant 
proteins). Briefly, the surface of microtitre plates was functionalised with an 
appropriate carbohydrate and the corresponding fluorescently labelled lectin was 
added with various concentrations of the glycopolymers. The minimum 
concentration required to inhibit 50 % of the lectin binding (MIC50) was determined 
by fluorescent measurements. Concanavalin A (Con A) which binds gluco- and 
manno-pyranoside terminal carbohydrates and the B-subunit of CTx (CTxB), which 
binds β-D-galactopyranoside residues were used in these assays. An example 
inhibitory curve for Con A by the glucose-functional polymer and CTx by galactose-
functional polymer are shown in Figure 3.5, and the values obtained in Table 3.2. 
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Figure 3.5: Inhibition of Con A binding to mannan-functional surface by glucose- 
containing glycopolymer (left) and of cholera toxin (CTx) to GM1 by galactose- 
containing glycopolymer (right). Values shown are average of 3 measurements. Red 
line is line of best fit. 
Table 3.2: Inhibitory potency of synthetic glycopolymers. 
Polymer[a] Lectin MIC50 (µg.mL-1)[b] 
Galactose (GP2) Cholera Toxin B subunit 3.2 ± 0.3 
Glucose (GP1) Concanavalin A 19.7 ± 0.37 
Mannose (GP3) Concanavalin A 0.51 + 0.07 
[a] Refers to the side chain functionality of the polymer. [b] Minimum concentration 
of polymer required to inhibit 50 % of the lectin from binding to a surface-
immobilised carbohydrate. 
All the polymers tested had sub 20 µg mL-1 MIC50 values indicating their 
high affinity due to the cluster glycoside effect. The mannose-functional polymer 
was 40 times more potent than the glucose polymer indicating Con A’s preference 
for manno- versus gluco-units. The galactose functional polymer displayed 
significant activity against the CTx comparable to other polymers we have used,4 but 
was obtained in a far simpler fashion. Such inhibitors may find application as non-
antibiotic prophylactic treatments.12 Mismatched glycopolymer lectin pairs (i.e. with 
the wrong carbohydrate) displayed no appreciable inhibition in the concentration 
ranges tested. 
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3.4 Conclusions 
In summary, we have demonstrated the use of poly(azlactone)s as versatile scaffolds 
for both direct, and tandem, post-polymerisation modification. In particular, the 100 
% atom efficiency and the ability to conduct polymerisation and functionalisation in 
a one-pot, two-step process is highlighted. Vinyl, alkyne, phenol and furanyl side 
chain polymers were obtained in quantitative yield, which is not possible by direct 
radical polymerisation of the functional monomers. 
Secondly, a series of synthetic glycopolymers with 5-atom spacers between 
carbohydrate and backbone were obtained by direct post-polymerisation 
modification of the poly(azlactone) scaffold. The glycopolymers inhibitory activity 
was measured to demonstrate they retained their lectin-specificity. Due to the 
increased linker length, poly(galactose) functional polymers were demonstrated to be 
particularly active against CTx, and hence the polymers’ potential as prophylactic 
anti-adhesion therapies has been demonstrated. 
3.5 Experimental 
3.5.1 Materials 
2-Aminoisobutyric acid, acryloyl chloride, sodium hydroxide, ethyl chloroformate, 
copper(I) bromide, ethyl-2-bromoisobutyrate, propargyl amine, allylamine, tyramine, 
furfuryl amine, glucosamine hydrochloride, mannosamine hydrochloride, 
galactosamine hydrochloride, triethylamine and diazabicyclo[5.4.0]undec-7-ene 
(DBU) were all purchased from Sigma Aldrich and used as received. Me6TREN was 
synthesised as described by Percec et al.46 
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3.5.2 Physical and analytical methods 
1H and 13C NMR spectra were recorded on Bruker DPX-300 and DPX-400 
spectrometers using deuterated solvents obtained from Sigma Aldrich. Chloroform 
SEC was performed on a Varian 390-LC MDS system equipped with a PL-AS 
RT/MT auto- sampler, a PL-gel 3 mm (50 x 7.5 mm) guard column, two PL-gel 5 
mm (300 x 7.5 mm) mixed-D columns equipped with a differential refractive index 
detector, using CHCl3 as the eluent with a flow rate of 1.0 mL min-1. Narrow 
molecular weight PMMA standards (200–1.0 106 g.mol-1) were used for calibration 
using a second order polynomial fit. DMF SEC was performed on a Varian 390-LC 
MDS system equipped with a PL-AS RT/MT autosampler, a PL-gel 3 mm (50 x 7.5 
mm) guard column, two PL-gel 5 mm (300 x 7.5 mm) mixed-D columns using DMF 
with 0.1% LiBr at 50 °C as the eluent at a flow rate of 1.0 mL min-1. The SEC 
system was equipped with ultraviolet (UV) (set at 280 nm) and differential refractive 
index (DRI) detectors. Narrow molecular weight PMMA standards (200–1.0 x 106 
g.mol-1) were used for calibration using a second order polynomial fit. Infrared
absorption spectra were recorded on a Bruker VECTOR-22 FTIR spectrometer using 
a Golden Gate diamond attenuated total reflection cell. 
3.5.3 Synthetic procedures 
VDMA (1) was synthesised according to a procedure by Fontaine et al.47 
N-(2-methyl-1-oxo-1-(prop-2-ynylamino)propan-2-yl)acrylamide: 2-Vinyl-4,4-
dimethyl azlactone (VDMA) (30 mg, 216 µmol) and propargyl amine (11.9 mg, 216 
µmol) were dissolved in 3 mL of toluene and left to stir overnight at room 
temperature. Precipitation of a white crystalline solid was observed and the product 
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was isolated upon removal of the solvent under reduced pressure (41.8 mg, 
quantitative yield). 
1H NMR (400.03 MHz, CDCl3, 298 K) δ = 7.02 (br s, 1H, NH), 6.39 (br s, 1H, NH), 
6.28 (dd, 1H, J = 16.6, 1.5 Hz, CH), 6.13 (dd, 1H, J = 17.1, 10.4 Hz, CH), 5.66 (dd, 
1H, J = 10.4, 1.5 Hz, CH), 4.03 (dd, 2H, J = 2.5 Hz, CH2), 2.21 (t, 1H, J = 2.5 Hz), 
1.61 (s, 6H). 13C NMR (100.59 MHz, CDCl3 , 298 K) δ = 174.2, 165.6, 131.0, 127.2, 
79.5, 71.6, 57.5, 29.6, 25.2. ). IR (solid) ν = 3263, 2437, 2391, 1650, 1607, 1544, 
1438, 1218, 959 cm-1. HRMS (ES+) calculated for C10H14N2O2 [M + Na]+ 217.0947, 
observed 217.0953. 
N-(1-(allylamino)-2-methyl-1-oxopropan-2-yl)acrylamide: 2-Vinyl-4,4-dimethyl 
azlactone (VMDA) (30 mg, 216 µmol) and allyllamine (12.3 mg, 216 µmol) were 
dissolved in 3 mL of toluene and left to stir overnight at room temperature. 
Precipitation of a white crystalline solid was observed and the product was isolated 
upon removal of the solvent under reduced pressure (42.3 mg, quantitative yield). 
1H NMR (400.03 MHz, CDCl3, 298 K) δ = 6.79 (br s, 1H, NH), 6.55 (br s, 1H, NH), 
6.26 (dd, 1H, J = 16.6, 1.5 Hz, CH), 6.12 (dd, 1H, J = 16.6, 10.4 Hz, CH), 5.81 (tq, 
1H, J = 10.5, 5.0 Hz, CH), 5.63 (dd, 1H, J = 10.4, 1.5 Hz, CH), 5.13 (qdd, 1H, J = 
23.1, 17.1, 1.5 Hz, CH), 3.87 (tt, 2H, J = 5.5, 1.5 Hz, CH2), 1.61 (s, 6H). 13C NMR 
(100.59 MHz, CDCl3, 298 K) δ = 174.4, 165.4, 134.0, 131.2, 126.9, 116.1, 57.5, 
42.1, 25.3. IR (solid) ν = 3276, 3060, 2979, 2928, 1655, 1620, 1536, 1251 cm-1. 
HRMS (ES+) calcd for C10H16N2O2 [M + Na]+ 219.1104, observed 219.1109. 
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Synthesis of pVDMA by ATRP: VDMA (3.00 g, 21.6 mmol), ethyl 2-
bromoisobutyrate (0.0841 g, 0.43 mmol), Cu(I)Br (0.0619 g, 0.43 mmol), mesitylene 
(0.518 g, 4.31 mmol) and toluene (6 mL) were added to an oven dried Schlenk tube 
and subjected to four freeze-pump-thaw cycles and left under a blanket of nitrogen. 
Me6TREN was added to the Schlenk tube via a degassed syringe and the brown 
solution immersed in an oil bath at 30 °C. Samples were taken periodically for 
analysis by 1H NMR and SEC and after 140 minutes (89 % monomer conversion) 
the polymerisation was quenched by exposing the solution to air.  SEC analysis 
(Quenched at 140 min) – Mn = 5900 gmol-1, Đ =1.32. The solution was immediately 
employed for the ring opening of various amines to yield the desired functionalised 
polymers. 
 
Propargyl Amine Modification of pVDMA: 4.5 mL of the crude pVDMA solution 
(containing 10.8 mmol of azlactone functionality) was added to a round bottomed 
flask and diluted with 5 mL of DMSO. Propargylamine (0.891 g, 16.2 mmol) was 
added to the polymer solution in 10 mL of DMSO and the solution allowed to stir at 
room temperature overnight. The solution was added dropwise into ethyl acetate, 
with precipitation of the polymer. The solid was collected by centrifugation and 
isolated as a crystalline solid. Infra-red analysis of the obtained polymer showed 
complete disappearance of the signals corresponding to the azlactone ring, along 
with the appearance of a strong signal corresponding to the two amide moieties 
generated upon ring opening. SEC analysis revealed a clear mass increase upon ring 
opening with propargyl amine, and a well-defined final polymer observed. SEC 
Analysis (DMF) – Mn = 12,500 gmol-1, Đ = 1.20. 
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Allyl Amine Modification of pVDMA: 4.5 mL of the crude pVDMA solution 
(containing 10.8 mmol of azlactone functionality) was added to a round-bottomed 
flask and diluted with 5 mL of DMSO. Allylamine (0.92 g, 16.2 mmol) was added to 
the polymer solution in 10 mL of DMSO and the solution allowed to stir at room 
temperature overnight. The solution was added dropwise into ethyl acetate, with 
precipitation of the polymer. The solid was collected by centrifugation and isolated 
as a crystalline solid. Infra-red analysis of the obtained polymer showed complete 
disappearance of the signals corresponding to the azlactone ring, along with the 
appearance of a strong signal corresponding to the two amide moieties generated 
upon ring opening. SEC analysis revealed a clear mass increase upon ring opening 
with allylamine, and a well-defined final polymer observed. SEC Analysis (DMF) – 
Mn = 12,800 gmol-1, Đ = 1.15. 
 
Tyramine Modification of pVDMA: 4.5 mL of the crude pVDMA solution 
(containing 10.8 mmol of azlactone functionality) was added to a round-bottomed 
flask and diluted with 5 mL of DMSO. Tyramine (2.218 g, 16.2 mmol) was added to 
the polymer solution in 10 mL of DMSO and the solution allowed to stir at room 
temperature overnight. The solution was added dropwise into ethyl acetate, with 
precipitation of the polymer. The solid was collected by centrifugation and isolated 
as a crystalline solid. Infra-red analysis of the obtained polymer showed complete 
disappearance of the signals corresponding to the azlactone ring, along with the 
appearance of a strong signal corresponding to the two amide moieties generated 
upon ring opening. SEC analysis revealed a clear mass increase upon ring opening 
with tyramine, and a well-defined final polymer observed. A strong UV absorbance 
(280 nm) was also observed for the functionalised polymer, further evidence of 
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incorporation of the aromatic group to the polymer backbone. SEC Analysis (DMF) 
– Mn = 11,700 gmol-1, Đ = 1.28. 
 
Furfuryl amine modification of pVDMA: 4.5 mL of the crude pVDMA solution 
(containing 10.8 mmol of azlactone functionality) was added to a round-bottomed 
flask and diluted with 5 mL of DMSO. Furfurylamine (1.570 g, 16.2 mmol) was 
added to the polymer solution in 10 mL of DMSO and the solution allowed to stir at 
room temperature overnight. The solution was added dropwise into ethyl acetate, 
with precipitation of the polymer. The solid was collected by centrifugation and 
isolated as a crystalline solid. Infra-red analysis of the obtained polymer showed 
complete disappearance of the signals corresponding to the azlactone ring, along 
with the appearance of a strong signal corresponding to the two amide moieties 
generated upon ring opening. SEC analysis revealed a clear mass increase upon ring 
opening with furfurylamine, and a well-defined final polymer observed. SEC 
Analysis (DMF) – Mn = 10,200 gmol-1, Đ = 1.35. 
 
Glucosamine modified pVDMA: 4.5 mL of the crude pVDMA solution (containing 
10.8 mmol of azlactone functionality) was added to a round-bottomed flask and 
diluted with 5 mL of DMSO. Glucosamine hydrochloride (3.49 g, 16.2 mmol) was 
added to the polymer solution in 10 mL of DMSO, along with triethylamine (1.63 g, 
16.2 mmol) and the solution allowed to stir at room temperature overnight. Volatiles 
were then removed and the crude polymer solution diluted with water and dialysed 
against water (MWCO 1000 Da) for 3 days to remove low molecular weight species. 
The water was removed by lyophilisation to yield the product as a white fluffy 
powder. Infra-red analysis of the obtained polymer showed complete disappearance 
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of the signals corresponding to the azlactone ring, along with the appearance of a 
strong signal corresponding to the two amide moieties generated upon ring opening. 
SEC analysis revealed a clear mass increase upon ring opening with glucosamine. 
SEC Analysis (Aqueous) – Mn 11,900 gmol-1, PDi 1.40. 
 
3.5.4 Inhibitory assays 
Concanavalin A (Con A): Microtitre plates were incubated for 16 h with 180 µL of 
100 µg.mL-1 mannan dissolved in phosphate-buffered saline (PBS) per well. 
Unattached mannan was removed by washing extensively with PBS. Polymer 
solutions were made up as serial dilutions in 10 mM HEPES buffer with 0.5 mM 
CaCl2, 0.5 mM MgCl2 and 0.5 mM MnCl2 from 1 mg.mL-1. 20 µL of 12.5 µg.mL-1 
Con A–FITC in HEPES was added to 100 mL of each polymer solution to result in 2 
µg mL-1 ConA– FITC. 100 µL of the polymer ConA–FITC solutions were added to 
the mannosylated surfaces and incubated at 37 °C for 30 min. Fluorescence was then 
measured at excitation/emission wavelengths of 485/528 nm. All experiments were 
carried out in triplicate. 
 
Cholera toxin B sub unit (CTxB):  96-Well microtitre plates were incubated for 16 
h with 180 µL of 100 µg.mL-1 GM1 ganglioside dissolved in phosphate-buffered 
saline (PBS), per well. Unattached GM1 was removed by washing extensively with 
PBS. Polymer solutions were made up as serial dilutions in PBS from 1 mg mL-1. 20 
µL of 12.5 µg.mL-1 CTxB–FITC in PBS was added to 100 µL of each polymer 
solution to result in 2 µg.mL-1 CTxB– FITC. 100 µL of the polymer CTxB–FITC 
solutions were added to the GM1 surfaces and incubated at 37 °C for 30 min. 
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Fluorescence was then measured at excitation/emission wavelengths of 485/528 nm. 
All experiments were carried out in triplicate. 
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Chapter 4 
 
 Glycopolymers with secondary binding 
motifs mimic glycan branching and 
display bacterial lectin selectivity in 
addition to affinity 
 
 
M. W. Jones, L. Otten, S-J. Richards, R. Lowery, D. J. Phillips, D. M. 
Haddleton, M. I. Gibson, Chem. Sci., 2014, 5, 1611-1616 
 
 
 
This chapter further builds on the first two chapters and aimed to develop more 
potent polymeric inhibitors of the cholera toxin that also display good specificity for 
their target. A new versatile post-polymerisation modification technique was 
developed to identify potent glycopolymer inhibitors of the cholera toxin that along 
with a galactose moiety, also contain a variable side groups with the view to creating 
favourable interactions with the binding site of the cholera toxin.  
 
Mathew Jones and Daniel Phillips made the glycopolymers. Lucienne Otten, Richard 
Lowery and I did the inhibitor testing. Richard was a project student under the 
supervision of Lucienne and me. Lucienne and I performed crude protein docking 
experiments. Daniel, Lucienne and I helped prepare the manuscript.  	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4.1 Abstract 
 
The application of synthetic glycopolymers to anti-adhesive therapies has so far been 
limited by their lack of lectin specificity. Here we employ a macromolecular 
engineering approach to mimic glycan architecture. A new, three-step tandem post-
polymerisation methodology was developed which afforded precise control over 
both chain length and carbohydrate-polymer backbone linker distance. This route 
also allowed a secondary binding (branched) motif to be introduced onto the linker, 
increasing specificity and affinity towards bacterial toxins without the need for 
extensive carbohydrate or organic chemistry. Sequential variation of this motif was 
found to dramatically alter both the affinity and the specificity of the glycopolymers 
towards two lectins, cholera toxin and peanut agglutinin, by up to 20-fold either via 
direct binding, or increased steric constraints. Using this method, a glycopolymer 
that showed increased specificity towards cholera toxin was identified. 
 
4.2 Introduction 
Protein-carbohydrate interactions dictate the outcomes of a large and varied number 
of cellular recognition processes, controlling immune responses, tumour metastasis, 
gamete fertilisation and many more.1 The structure, function or even identity of 
many glycans remains unknown. It is estimated that 50 % of human proteins are 
glycosylated and there remains significant analytical challenges associated with the 
isolation and characterisation of complex glycans.2 Proteins which recognise and 
process the signals associated with carbohydrates are termed lectins: carbohydrate 
binding proteins which are neither antibodies nor enzymes and they are widely 
distributed in nature.3 Despite their role in normal physiology, lectins/glycans can 
also act as a potential site for infection, which can be exploited by pathogenic 
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organisms to interface with their host. For example, pathogenic Escherichia coli, E. 
coli, expresses the FimH adhesin, which can bind mannose residues in the urinary 
tract, influenza has sialic acid binding lectin (heamagglutinins) for adhesion to 
erythrocytes and Vibrio cholerae secretes a toxin that binds to intestinal epithelial 
cells.1, 4-6 Conversely, HIV expresses high-mannose structures on its envelope that 
enables it to bind to DC-SIGN lectin on the surface of dendritic cells in the human 
immune system.7 With the widespread emergence of antibiotic resistance, new 
interventions to prevent and detect infectious disease are urgently required.8, 9 Anti-
adhesion therapy, which seeks to use compounds that have higher affinity than the 
pathogen for the target binding site, thus preventing the adhesion step and hence 
reducing the infectivity, has emerged as a promising potential treatment.4, 10-14 As 
this process does not involve killing the pathogen, there should be no evolutionary 
stress, hence reducing resistance development and could be administered 
prophylactically.  
The binding affinity of a monosaccharide to its target lectin is typically very 
weak (Kd = 10-3 – 10-6 M), limiting their use in anti-adhesion therapy. The sugars’ 
weak affinity is overcome in nature by the presentation of multiple copies on cell 
surfaces which gives rise to an increase in affinity which is greater than the linear 
sum of the individual sugars, the so-called cluster glycoside effect.15-19 Lee et al. first 
demonstrated that multivalent N-acetyllactosamine with one to four carbohydrates 
showed progressively increasing binding affinities, over several orders of magnitude, 
towards rabbit hepatocytes.15 Kiessling and co-workers have elegantly shown that 
polymer architecture (linear, branched, dendritic) has profound effects on lectin 
binding affinity, with particular focus on their ability to cluster receptors.20 Ambrosi 
et al. found that galacto-functional polymers have a 100-fold increase in binding 
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affinity compared to free galactose.21 STARFISH-based monodisperse 
glycodendrimers were shown by Kitov et al. to neutralise Shiga-like toxins, with a 
measured affinity over 106-fold greater than the monovalent carbohydrate.22 
Exploitation of the high affinity of glycopolymer-lectin interactions also has 
applications in biosensing.23, 24  
Advances in controlled (radical) polymerisation methods11, 25, 26 together with 
the development of highly efficient and orthogonal ‘click’27 reactions has facilitated 
the synthesis of glycopolymers by pre- and post-polymerisation modification thus 
widening the chemical and architecture diversity of glycopolymers.25, 28 Despite the 
interest in developing synthetic glycopolymers with high affinity for their respective 
lectins, there has been significantly less focus placed on their specificity.6 What is 
often not studied is the relative affinity of the glycopolymer for various lectins with 
similar specificities, which is essential to avoid unwanted therapeutic side effects or 
to enable precise diagnostics. An important target for multivalent anti-adhesion 
therapies/diagnostics is the cholera toxin (CTx), secreted by Vibrio cholerae, the 
causative agent of cholera infection that is estimated to cause over 100,000 deaths 
per year, and infects more than 3 million people. β-galactose functional inhibitors 
have been shown to have high affinity to CTx, but there is a need to avoid unwanted 
interactions with other mammalian lectins, such as the galectins, which also bind β-
galactose and could lead to immune responses such as cytokine production.29 Lectin 
targets for which selective anti-adhesive therapies have been studied include DC-
SIGN/langerin in HIV therapy, or BmbL/DC-SIGN to treat Burkholderia 
ambifaria.30-33 The relative affinity of a series of bivalent galactosides towards 
chicken galectins has also been studied.34 Moreover, selectivity presents a challenge 
when identifying biological warfare agents based on lectins such as ricin.35 
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Oligosaccharide-mimetic agents have also been developed with high specificity 
based on tuning their 3-D structure to fit the lectin binding site but without the need 
for total oligosaccharide synthesis.36 
Examples of synthetic polymers that have demonstrated lectin selectivity are 
rare, despite the obvious benefits of their multivalent nature.37 We have 
demonstrated that galactose-functional polymers can be engineered to have increased 
selectivity for CTx B-subunit (CTxB) (See Chapter 2).38 This was achieved by 
modulating the distance between backbone and carbohydrate to match the relatively 
deep cleft of the CTx binding domain, compared to other galactose-binding lectins 
with shallower domains.39 Selectivity is required here to discriminate between other 
pathogenic lectins (or bacteria) that bind galactose including ricin35 or indeed dietary 
lectins which can reduce the inhibitor’s potency as this would need to function in the 
intestinal tract. 
 In this work, we present a macromolecular engineering approach to introduce 
specificity into glycopolymers, inspired by glycan branching and guided by 
structural biology information. In particular, we were motivated to achieve 
selectivity without resorting to multi-step total glycan synthesis, which is non-trivial. 
Using a new, three-step, tandem post-polymerisation process, secondary motifs are 
introduced on to the polymer side chain, to increase specificity and affinity towards 
bacterial toxins. 
 
4.3 Results and Discussion 
As the first step, microarray data were extracted from the Consortium for Functional 
Glycomics (CFG) database to enable a short bioinformatics study to probe lectin 
affinity and specificity.40 The relative affinity of CTx and a model galactose-binding 
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non-pathogenic lectin, peanut agglutinin (PNA), to several oligosaccharides was 
measured and the most relevant results are shown in Figure 4.1A (full analysis in 
Appendix 3). PNA was found to bind the disaccharide Gal-β-GalNAc 100-fold more 
than CTx. However, changing this to a branched oligosaccharide (GM1), which 
retains the Gal-β-GalNAc unit but also introduces a neuraminic acid branch results 
in the CTx affinity increasing approximately 100-fold, but with no change in PNA 
affinity. The increased binding affinity of CTx to the branched saccharide is 
attributable to allosteric interactions of the neuraminic acid with a secondary binding 
pocket within CTx, which is not present in PNA41 We therefore reasoned that if a 
secondary motif could be installed on the linker between galactose and backbone on 
a polymer it would be possible to attenuate the binding affinity of the polymer to 
CTx as shown by Bundle and co-workers,42 but also selectivity towards the CTx 
over PNA. Figure 4.1B shows the crystal structure of CTx binding to the branched 
glycan unit from GM1 showing both the primary and secondary binding pockets, 
which is simplified in Figure 4.1C using standard glycan notation. Figure 4.1D 
shows the proposed polymer, with a sufficiently long linker to penetrate the cleft in 
CTx and a secondary motif to target the allosteric neuraminic acid site. 
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Figure 4.1: A) Glycan microarray analysis showing relative affinity of CTx and 
PNA to two related glycans. B) Crystal structure of CTx binding to the 
oligosaccharide portion of GM1. C) CTx crystal structure with glycan drawn in 
standard ball/stick notation. (Appendix 3 for key). D) Synthetic polymer design 
concept with idealised polymer shown (schematic, not simulation). 	  
To enable installation of branched motifs in a semi-combinatorial manner, we 
have developed a new synthetic methodology based on three tandem post-
polymerisation modifications.19, 43 This introduces large chemical diversity that is 
not normally found on glycans, but ensures chain length (and hence valency) 
homogeneity across all samples overcoming a common challenge in functional 
polymers, Figure 4.2. 
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Figure 4.2: Glycopolymer design principle and the newly developed synthetic route. 
Glycan structure is shown in standard notation (Appendix 3). 
 
The synthetic method fulfilled the following criteria: i) sufficient separation 
between backbone and carbohydrate to enable penetration into the CTx binding site; 
ii) an azide group for subsequent glycosylation with β-D-propargyl galactose; iii) 
esterification of the hydroxyl group, generated during epoxide ring-opening. 
Poly(glycidyl methacrylate) was synthesised by Cu(I)-mediated polymerisation to 
produce a well-defined polymer with a degree of polymerisation (DP) ~ 100 and 
Mw/Mn = 1.2. This molecular weight was targeted as our previous results have 
shown that above DP of ~30, no further increase in avidity towards CTx was 
observed.38 The polymer was produced by controlled radical polymerisation to 
ensure a lack of low molecular weight tail that would confuse the interpretation of 
the activity measurements (vide infra). Installation of the azide was achieved by 
addition of sodium azide in DMF at 50 °C, which simultaneously, and quantitatively, 
installed the necessary orthogonal handle and produced a secondary alcohol as 
confirmed by infrared spectroscopy (IR), Figure 4.3. In the second step a range of 
acyl chlorides were reacted with the alcohol to install secondary motifs as confirmed 
by the disappearance of the OH stretch at 3400 cm-1 and the addition of a second 
carbonyl stretching frequency. The acyl chlorides were chosen based on evidence 
that aromatic groups can bind the sialic acid site.42 In the final modification reaction, 
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β-D-propargyl galactose was installed by Cu(I)-catalysed cycloaddition, which could 
be monitored by the reduction in the azide vibration at 2100 cm-1.  
	  
Figure 4.3: Infrared analysis of the three-stage, glycan mimetic, tandem post-
polymerisation strategy used here. IR analysis was of purified product.  
 
Table 4.1 summarises the polymer library obtained, the side chains installed and the 
calculated logP values of a single repeat unit of the polymer (vide infra). LogP 
values are included as an estimate of the relative hydrophobicity of the binding units. 
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Table 4.1: Side chains installed on to the polymers and LogP values[a]. 
	  
[a] LogP values are based on a single repeat unit of the polymer, with the methyl 
capping at each chain end. 
 
With this panel of sequentially modified glycopolymers in hand, a 
fluorescence-liked sorbent assay was used to evaluate the affinity of the polymers 
towards each of the lectins.44-46 Briefly, the glycopolymers were incubated at various 
concentrations with fluorescently labelled lectins. The solutions were then added to 
galactose-functionalised microtitre plates. The concentration of polymer required to 
inhibit 50 % of binding to the plates was reported as the MIC50 value. Upon initial 
testing it was found that several members of the library were insufficiently soluble in 
buffer to be used in the assays. It was possible to solubilise the polymers in 5 % (v/v) 
aq. DMSO, but we found this compromised the CTx-assay giving false positive 
results and hence only the polymers which could be directly dissolved into buffer 
were tested. The less soluble polymers are still shown in Table 4.1 to highlight the 
synthetic diversity achieved by this approach. As predicted, addition of the 
secondary motifs had a dramatic influence on the inhibitory potential of the 
glycopolymers against both of the lectins, Figure 4.4. 
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Figure 4.4: Inhibition of lectin binding by synthetic glycopolymers. Values shown 
are the average of at least 3 measurements, and errors are the standard deviation. 
 
Figure 4.4 reveals some general trends between molecular structure and lectin 
affinity. Three of the secondary units, P8, P9 and P10 gave rise to large 10-fold 
decreases in the MIC50 towards both lectins, compared to P1. Whilst these groups 
were relatively diverse, the common theme was that they did not contain an aromatic 
group, but P8 and P10 did contain halogenated alkanes. P8 and P10 side chains are 
significantly larger than in P9 which suggests that their affinity modulation was not 
entirely due to steric constraints and may indicate that branching at the side chain 
increases affinity to CTx. Polymers P11, P5 and P6, led to either no changes, or 
significantly increased the MIC50 values. Due to the size and rigidity of these 
functional groups, steric constraints might be crucial, preventing access of the 
polymer to both lectins, or limiting conformational flexibility. Polymer P4, which 
had a linear, but flexible, hexamethylene group gave modest improvements (lower 
MIC50) in binding to both lectins. Our observations are in contrast to those of Bundle 
and coworkers who have observed that pendant aromatic units can enhance the 
binding to CTx via interactions with the neuraminic acid binding pocket, but they 
used polymers with a very low density of carbohydrate side chains and different 
length side chains on polydisperse scaffolds, making comparisons difficult.42 Here 
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we have densely packed side-chains that impose additional steric restraints. The high 
affinity of CTx to GM1 in nature is attributable to the intrinsic rigidity of GM1, 
which has also been found to be important in small-molecule GM1 mimics and is 
probably contributing here.47, 48 Comparison of the observed inhibitory values 
against the calculated partition coefficient did not reveal any obvious trend 
suggesting simple hydrophobic/hydrophilic interactions are not responsible 
(Appendix 3).  
As indicated in the introduction, the key aim of this study was to use glycan-
mimetic branching to introduce specificity/selectivity as well as affinity into synthetic 
glycopolymers. Analysis of the data in Figure 4.4 revealed that P1 and P5 
(chlorobenzyl) showed the most dramatic differences in terms of relative affinities 
for each lectin. Figure 4.5 shows the relative affinity (shown as 1/MIC50 for 
convenience), for P1 and P5 against the two lectins.  
	  
Figure 4.5: Relative affinity (1/MIC50) of P1 and P5 for CTx and PNA. 
 
P1 shows similar affinity for both PNA and CTx indicating that it cannot 
discriminate/select between two different galactose-binding lectins. However, 
addition of 4-chlorobenzyl unit (P5) leads to dramatic differentiation in response to 
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PNA and CTx, with a significant decrease in affinity towards PNA, but essentially 
no change in affinity to CTx. This demonstrates that P5 displays lectin selectivity, 
using biomimetic macromolecular engineering, but without multistep carbohydrate 
chemistry. The exact mechanism of binding which leads to selectivity cannot be 
rationalised at this stage, but the additional bulk of the chlorobenzyl group may 
prevent access to the PNA binding site, but still be of correct dimensions to fit the 
neuraminic acid site in CTx. Furthermore, the influence of substituting the chloro- 
for a bromo- group (P5 – P6) cannot be explained. P6 has vastly increased MIC50 
values towards CTx relative to P5, but less effect on PNA binding. The additional 
steric bulk of a bromide might simply be too large for a good fit into the binding 
cleft in CTx. P1/P5 also displayed similar affinities for RCA120, another galactose-
binding lectin indicating that the structural motifs added here only affect the target 
lectins (Appendix 3). This supports our hypothesis that the secondary motif is 
causing an obstruction to the binding site of PNA giving us the specificity CTx, 
which can accommodate it in its binding site, and hence the polymers have 
decreased affinity to both of these lectins. These observations rule out non-specific 
hydrophobic association between polymer/lectins as this would be expected to give 
enhancements to all test lectins.  
4.4 Conclusions 
We have demonstrated a new bio-inspired approach to mimicking glycan 
architecture by using macromolecular engineering, guided by structural biology, and 
without the need for multi-step oligosaccharide synthesis. Bioinformatics revealed 
that the addition of branched side chains to galacto-terminal carbohydrates could 
increase binding affinity to their corresponding lectins, relative to simple 
monosaccharides. To mimic this branched structure a new, three-step, tandem post-
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polymerisation methodology was developed. This enabled precise control over not 
only chain length, but also carbohydrate-polymer backbone linker distance and the 
introduction of secondary branched motifs onto the linker. Sequential variation of 
this motif was found to dramatically (up to 20-fold) alter both the affinity and the 
selectivity of the glycopolymers towards two lectins; CTx and PNA. Using this 
method, a glycopolymer was identified which showed increased specificity towards 
CTx. Glycopolymers with high selectivity may feature in the development of 
sensitive and precise sensors or anti-adhesive therapies, which has so far limited the 
application of synthetic glycopolymers. These results show that combining structural 
biology tools with macromolecular chemistry enables the creation of synthetic 
glycans which can mimic, or outperform their natural counterparts and will find 
applications in anti-adhesive therapy and biomolecular sensors. 
 
4.5 Experimental  
4.5.1 Materials 
Dichloromethane, diethyl ether, tetrahydrofuran, dichloromethane, triethylamine and 
dimethyl sulfoxide were all purchased from Fisher Scientific at laboratory reagent 
grade. Ethyl 2-bromoisobutyrate (99.0 %), glycidyl methacrylate (≥ 97.0 %), copper 
(I) bromide (98.0 %), anisole (≥ 99.0 %), benzoyl chloride (99.0 %), 1-naphthoyl 
chloride (97.0%), 2,4,6-trichlorobenzoyl chloride (97.0 %), decanoyl chloride (98.0 
%), 4-chlorobenzoyl chloride (99.0 %), 4-bromobenzoyl chloride (98.0 %), 4-
fluorobenzoyl chloride (98.0 %), α-bromoisobutyryl bromide (98.0 %), acetyl 
chloride (98.0 %), dichloroacetyl chloride (98.0 %), and 2,2’-bipyridyl (≥99.0 %) 
were all purchased from Sigma-Aldrich. N-ethyl-2-pyridylmethanimine1 and β-D-1-
propargyl galactose2 were synthesised using previously reported methods. 
Fluorescein isothiocyanate (FITC) labelled peanut agglutinin (PNA) from Arachis 
	  	  
 
 
119 
hypogaea was purchased from Vector Laboratories. Galactocerebrosides (GCS), 
FITC labelled cholera toxin subunit B (CTxB), calcium chloride (CaCl2), Sodium 
chloride (NaCl), manganese (II) chloride, HEPES powder, and Tris buffer were all 
purchased from Sigma-Aldrich, UK. 96-well high binding microtitre plates were 
purchased from Greiner Bio-one. Tris buffer containing 0.1 mmol CaCl2 and 0.5 
mmol NaCl (pH 8, TBS) was prepared in 250 mL of 119illiQ water (with a 
resistance >19 mOhms), and 10 mmol HEPES buffer containing 0.15M NaCl, 
0.1mM CaCl2 and 0.01mM Mn2+  (pH 7.5, HEPES) was prepared in 250 mL of 
119illiQ water (with a resistance >19 MΩ.cm). 
 
4.5.2 Physical and analytical methods 
NMR spectra were recorded on Bruker DPX-300 and DPX-400 spectrometers for 1H 
NMR (400 MHz) and 13C NMR (125 MHz). Chemical shifts are reported in ppm 
relative to the deuterated solvent resonances and spectra analysed with WIN-NMR 
software. GPC (DMF) was performed on a Varian 390-LC MDS system equipped 
with a PL-AS RT/MT autosampler, a PL-gel 3 µm (50 × 7.5 mm) guard column, two 
PL-gel 5 µm (300 × 7.5 mm) mixed-D columns equipped with a differential 
refractive index, using DMF (with 1 mg.mL-1 LiBr) as the eluent with a flow rate of 
1.0 mL.min-1 at 50 °C. Narrow molecular weight PMMA standards (200 - 1.0 × 106 
g.mol-1) were used for calibration using a second order polynomial fit. SEC 
(aqueous) was performed on a Varian 390-LC MDS system equipped with a PL-AS 
RT/MT autosampler, a PL-aquagel-OH 8 µm (50 × 7.5 mm) guard column, a 
PLaquagel-OH column set consisting of two 8 µm (300 × 7.5 mm) columns 
equipped with a differential refractive index detector using phosphate buffer (pH 
8.2) as the eluent at a flow rate of 1.0 mL.min-1. Narrow molecular weight PEO 
standards (100 - 1.26 × 106 g.mol-1) were used for calibration using a second order 
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polynomial fit. Infrared absorption spectra were recorded on a Bruker VECTOR-22 
FTIR spectrometer using a Golden Gate diamond attenuated total reflection cell. 
Mass spectra were recorded using a Micromass Autospec apparatus. Partition 
coeffecients (LogP) were estimated using ACD labs software 4.5.3 Synthetic 
procedures 
 
Synthesis of poly(glycidyl methacrylate): To an oven dried Schlenk tube, ethyl 2-
bromoisobutyrate (0.55 g, 2.81 mmol), glycidyl methacrylate (40 g, 281 mmol), 
copper (I) bromide (0.40 g, 2.81 mmol) and anisole (80 mL) were added. The tube 
was sealed and subjected to four freeze-pump-thaw cycles and left under a blanket of 
nitrogen. N-Ethyl-2-pyridylmethanimine (1.25 mL, 8.44 mmol) was added to the 
solution via a degassed syringe and the Schlenk tube immersed in an oil bath at 50 
°C. Samples were taken hourly and analysed by 1H NMR and GPC. After 6 hours, 
the reaction was quenched by immersing the flask in liquid nitrogen. The solution 
was then bubbled with air for 12 hours, passed through a short column of neutral 
alumina and the solvent removed under vacuum. The resulting crude mixture was 
redissolved in dichloromethane, precipitated three times into diethyl ether and dried 
under vacuum to yield the product as a white solid. Conversion (NMR): 84.2 %; Mn 
(theoretical): 12000 g.mol-1; Mn (SEC) = 22900 g.mol-1; Mw/Mn (SEC) = 1.20. 
 
Synthesis of poly(2-hydroxy-3-azidopropyl methacrylate): Poly(glycidyl 
methacrylate) (1) (7.34 g, 0.051 mmol of polymer repeat unit) was dissolved in DMF 
(250 mL). Sodium azide (10.07 g, 0.155 mmol) and ammonium chloride (8.29 g, 
0.155 mmol) were added to the solution and the mixture stirred for 24 hours. After 
this time, the mixture was poured into water and the solid collected by filtration. The 
	  	  
 
 
121 
polymer was washed several times with water and dried to leave an off-white solid. 
Mn (SEC) = 26000 g.mol-1, Mw/Mn = 1.8. 	  
Example Acylation Reaction using Benzoyl chloride: Poly(2-hydroxy-3-
azidopropyl methacrylate) (200 mg, 8.73 µmol) was dissolved in anhydrous THF (50 
mL), along with triethylamine (0.45 mL, 3.24 mmol – 3 eq. for each polymer repeat 
unit). Benzoyl chloride (0.46 g, 3.24 mmol - 3 eq. for each polymer repeat unit) was 
dissolved in 50 mL of anhydrous DCM and added dropwise to the solution over a 
period of 30 minutes. Following complete addition, the solution was left to stir at 
room temperature for 24 hours. A further portion of triethylamine (0.45 mL, 3.24 
mmol) and benzoyl chloride (0.46 g, 3.24 mmol) were added to the solution and 
allowed to stir for a further 24 hours. The solution was then diluted with 100 mL of 
DCM and quenched with 100 mL of water. The organic layer was washed with water 
(2 × 50 mL), dried over anhydrous MgSO4, filtered and the solvent removed. The 
crude polymer solution was then redissolved in 50 mL of THF and twice precipitated 
into a 1:1 mixture of diethyl ether/petroleum ether. The solids were isolated by 
centrifugation and dried under vacuum to yield the product as a off-white powder. 
 
Example 1,3-Dipolar Cycloaddition Reaction of Benzoyl Chloride-Modified 
Polymer with Galactose Alkyne: Polymer (100 mg, 345.67 µmol), Cu(I)Br (4.9 
mg, 34.16 µmol) and galactose alkyne (226 mg, 1.04 mmol) was dissolved in DMSO 
(8 mL) in a Schlenk tube. This solution was degassed by a minimum of 3 freeze-
pump-thaw cycles and frozen with liquid nitrogen. The Schlenk tube was then 
opened, 2,2’-bipyridyl (10.8 mg, 69.15 µmol) was added and the tube re-sealed. The 
frozen solution was evacuated three times, back-filled with dry nitrogen and left to 
defrost. After stirring at ambient conditions for 4 days, the solution was diluted with 
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distilled water and dialysed against water for 3 days. The resulting suspension was 
centrifuged and the supernatant was lyophilised to leave an off-white powder. 
 
4.5.4 Inhibitory assays 
Example fluorescence-linked sorbent assay for inhibitory activity against 
cholera toxin B subunit (CTxB): 96-well microtitre plates were incubated for 16 h 
with 150 µL of 100 µg.mL-1 galactocerebroside (GCS) (in 95% ethanol, 5% water 
and heated to 45 °C). Unbound GCS was removed by washing extensively with 
water. Polymer solutions were made up as serial dilutions (up to 10 dilutions per 
sample from either 1 mg.mL-1 or 0.1 mg.mL-1 in water). 10 µL of 100 µg.mL-1 CTx-
FITC in 10 mM Tris with 0.1 mM CaCl2 and 0.5 mM NaCl (pH 8) was added to 90 
µL of polymer solution to a final concentration of 11 µg.mL-1. 100 µL of the 
PNA/polymer solutions were then added to GCS coated wells and incubated at 37 °C 
for 30 mins. After this the wells were extensively washed with water and 
fluorescence was measured at excitation/emission wavelengths of 485/528 nm. All 
experiments were carried out in triplicate. Percentage inhibition was compared to 
relative to controls of pure CTx-FITC (with no polymer). 
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Chapter 5 
Investigation of glycopolymer–lectin 
interactions using QCM-d: comparison 
of surface binding with inhibitory 
activity 
Y. Gou, S-J. Richards, D. M. Haddleton, M. I. Gibson, Polym. Chem., 2012, 3, 
1634-1640 
This chapter consists of a paper where the main focus was the determination of 
inhibitor efficacy. Two techniques were used to determine the activity of 
glycopolymers for the inhibition of Concanavalin A, quartz crystal microbalance 
with dissipation monitoring (QCM-d) and a fluorescent-linked sorbent assay 
(FLSA). These results were also related to another paper I contributed to – Y. Gou, J. 
Geng, S-J. Richards, J. Burns, J., C. R. Becer, D. M. Haddleton, J. Polym. Sci., Part 
A: Polym. Chem. 2013, 51, 2588–2597.  
Yanzi Gou synthesised the polymers and carried out the QCM-d work. I tested the 
polymers using a FLSA and analysed the data. I helped in the preparation of the 
manuscript.   
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5.1 Abstract 
Glycopolymers offer many opportunities for interfacing synthetic materials with 
biological systems. However, the nature of the interactions between glycopolymers 
and their biological targets, lectins, and the structural features necessary to obtain 
high-affinity materials are not fully understood. Here, the enhancement in binding 
affinity of multivalent glycopolymers to their corresponding lectins is investigated 
by quartz-crystal microbalance with dissipation monitoring. This technique allows 
the conformation of the adsorbed polymers to be probed and the direct observation 
of spanning of multiple binding sites on lectin-functional surfaces. The measured 
affinity was compared to the anti-adhesion activity of the polymers in solution, and it 
is shown that increased association constants did not directly correlate with 
inhibitory activity.  
5.2 Introduction 
Carbohydrates control many critical recognition events in biological systems, which 
are mediated by a class of carbohydrate binding proteins termed lectins.1 Although 
these interactions are highly specific, determined by the number, branching pattern 
and stereochemistry of the carbohydrates, the observed sugar-protein association 
constants are actually quite weak. This is overcome in nature through the 
presentation of multiple copies of identical carbohydrates on cell surfaces, which due 
to the ‘cluster glycoside effect’,2 results in an enhancement in the binding affinity 
greater than the simple linear sum of the individual carbohydrates. The exact 
mechanism for this binding enhancement is still unknown but is thought to arise 
from several complementary components: receptor clustering; chelation of multiple 
binding sites and statistical rebinding of carbohydrate ligands.3-5 In order to probe 
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these phenomena and to develop new bioactive constructs capable of interfacing 
with biological signalling processes, synthetic glycopolymers have emerged as 
useful tools. By presenting tens or hundreds of copies of carbohydrates on a polymer 
backbone a significant increase in binding affinity compared to free sugars is 
observed. For example Lee et al. demonstrated that a tetravalent lactoside bound its 
lectin 100-fold stronger than the free sugar.6 Haddleton and co-workers have 
demonstrated that poly(mannosylated) glycopolymers can bind to DC-SIGN 
(Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin) 
with nanomolar affinities.7 Many pathogenic species exploit carbohydrate binding as 
a first stage of infection: for example Mycobacteria (tuberculosis) and HIV both 
bind to DC-SIGN8 and cholera toxin binds to galactose residues in the intestine.9 
Therefore, high-affinity multivalent constructs that can out-compete the pathogenic 
adhesion process can be used to prevent infection without actually killing the 
pathogen, which will help reduce evolutionary resistance. This process is termed 
anti-adhesion therapy, and has been reviewed extensively.10-13 There are many 
examples of glycopolymers in the literature, with most studies focused on their 
preparation by traditional,14 controlled polymerisation15-18 or post-polymerisation 
modification19-21 techniques, followed by simple lectin precipitation assays.22 
Cameron et al. have reported ITC (isothermal titration calorimetry) studies between 
galactosylated glycopolymers and the lectins peanut agglutinin23 and ricinus 
communis agglutinin.24 These studies indicated that entropic and enthalpic 
contributes, respectively, were important for the multivalent enhancement observed. 
Brewer and co-workers have undertaken detailed studies of the complex binding 
mechanisms of multivalent systems, using thermodynamic data. This suggests that 
the total affinity can be described by a series of micro-equilibria between each 
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binding event allowing the lectin to “bind and slide” across a carbohydrate surface.25, 
26 This results in a decreased dissociation rate constant (koff) and hence an increase in 
overall affinity despite the weak and reversible, carbohydrate-lectin interactions. The 
complexity of these interactions is highlighted by studies showing that modification 
of carbohydrate density and linker length can improve the inhibition of cholera 
toxin27 or the incorporation of a secondary sugar can improve inhibition of shiga-like 
toxins.28 Rigidity also plays an important role.29 In this work, we make use of quartz-
crystal microbalance with dissipation monitoring (QCM-d) in conjunction with 
inhibitory assays to probe the actual mechanism of the multivalent enhancement and 
compare the relative activity in solution and solid-state assays. By using this 
technique, we reveal dramatic differences in the binding modes of glycopolymers as 
a function of their chain length. We provide fresh insight into the complementarity 
of different biophysical assays that must be tuned to their desired application, to 
avoid false interpretation of results. 
 
5.3 Results and Discussion 
To probe multivalent interactions we used the α-D-mannose/Concanavalin A (Con A) 
pairing. The rationale for using this lectin was based on there being a good 
understanding of its tertiary structure and its ready availability, allowing us to access 
traditional clustering (precipitation) assays in addition to the biophysical assays. To 
access a panel of α-D-mannosylated glycopolymers a post-polymerisation 
modification approach was used, which we have previously optimised.20 Briefly, 
poly(propargylmethacrylate) was obtained by either cobalt catalysed catalytic chain 
transfer (CCT) or copper-mediated living radical polymerisation (CMLRP) 
according to published procedures Scheme 5.1 and Table 5.1.20, 30 CCT is 
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particularly useful to obtain oligomers, which are challenging to access by 
conventional controlled radical polymerisation techniques.  
 
Scheme 5.1: General Synthetic Route A); structure of polymers, including end-
groups obtained by CM-LRP (B) and CCT (C). 	  
Table 5.1: α-D-mannose glycopolymers used in this study. 
Polymer Method Mn(SEC)[a]  
(g.mol-1) 
Mw/Mn[a] DP(NMR)[b] I[c] (nm) 
P1 CCT 4900 1.10 8 2.01 
P2 CCT 11200 1.21 23 5.77 
P3 CM LRP 14000 1.38 42 10.4 
[a] Determined by size exclusion chromatography in DMF against PEG standards. 
[b] Determined by 1H NMR end group analysis. [c] Approximated fully extended 
chain length assuming dihedral angle of 109.5 ° and C-C bond length of 0.154 nm.   
  
Three distinct assays were selected to probe the multivalent interactions: 
QCM-d, fluorescence-linked sorbent assay (FLSA) and lectin 
precipitation/turbidimetry. Con A was immobilised onto a carboxylated quartz chip 
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using standard coupling protocols.31 Figure 5.1A shows the frequency shift (Δf) 
observed when solutions of P2 were flowed over the chip, giving a clear dose-
dependent response, and Figure 5.1B summarises the equilibrium Δf for all polymers 
as function of concentration. Control experiments (at 2 mg.mL-1) using β-D-
galactosylated polymers gave frequency shifts below 2 Hz ruling out non-specific 
surface absorption.  
 
Figure 5.1: QCM of Con A functional chips and polymer. A) Frequency shift as a 
function of P2 concentration. B) Equilibrium frequency shifts (Δfmax) for P1-P3 as a 
function of concentration.  
 
In the standard interpretation of QCM (or SPR) analysis, increased mass of glycoside 
binding to the lectin surface is interpreted as being due to a higher binding affinity 
between the sugar-protein pairing and it is used a screening method for new 
inhibitors.32 The general trend with glycopolymers is that longer polymers display 
greater binding affinity and therefore would be expected to give larger values of 
Δf.11, 24, 33 Considering this, it was surprising to find that P1 and P2 gave larger 
frequency shifts than P3, although careful consideration showed that P3 reached 
equilibrium at far lower concentrations. The association constants of the 
glycopolymers were estimated using a Langmuir-type isotherm (which only gives an 
estimate of Ka, due to the complex micro-equilibria involved in multivalent 
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interactions24-26, 33) and compared to the total frequency shift, Table 5.2. Clearly, the 
total mass of P3 absorbed onto the lectin surface was significantly less than P1 and 
P2, but the association constant was significantly larger. 
Table 5.2. Results of the protein binding assays. 
 QCM FLSA Turbidity/Clustering 
 Ka[a] 
(M-1mannose) 
Ka [a] 
(M-1 polymer) 
Δfmax[b] 
(Hz) 
MIC50 [c] 
(mM ) 
ki[d] 
(AU.min-1) 
ConA: 
Polymer[e] 
 
MIC50[f] 
(mM mannose) 
P1 3.83 × 104 3.07 x 105 67 0.09 ± 0.0046 n/a n/a n/a 
P2 5.56 × 104 1.28 x 105 79 0.012 ± 0.0023 1.31 7 (3.28) 73.48 
P3 1.51 × 105 6.33 x 106 28 0.017 ± 0.0034 3.75 10 (4.2) 71.48 
[a] Association constant determined by QCM. [b] Maximum frequency shift 
observed at saturation. [c] MIC50 value (correct to total mannose concentration) for 
polymers to inhibit binding of Con A (0.5 µM) to mannosylated surface. [d] Rate of 
clustering of Con A/polymer in solution. [e] Quantitative precipitation assay. 
Number of Con A’s precipitated per polymer. Number in parentheses is ratio of 
mannose residues per Con A tetramer precipitated). [f] MIC50 value for the 
concentration of mannose required to reverse solution aggregation of polymer/Con A 
mixtures. QCM = quartz crystal microbalance, FLSA = fluorescence-linked sorbent 
assay. 
 
In Table 5.2, the association constant is expressed in terms of moles of polymer 
chains, and also concentration of carbohydrate, which is essential to avoid over-
estimation of the multivalent enhancement for longer polymers (which have lower 
concentration of chains at equal concentration of sugars compared to short 
polymers). Corrected to affinity per sugar, P1 and P2 have very similar association 
constants, but P3 is approximately double, indicating that chain length is important, 
but only above a certain length (vide infra). The huge discrepancies between these 
observations raise the simple questions: which polymer has the highest affinity for 
the lectin, and why is there such a difference?  
To probe into this further, solid-phase inhibitory assays were undertaken 
using fluorescently labelled Con A and a mannosylated surface. Fluorescein-labelled 
Con A was incubated with a dilution series of the polymers on a mannosylated 96-
well plate for 30 mins at 37 °C, the plates were washed and the total fluorescence 
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measured. This allowed construction of the inhibitory curves and determination of 
the minimum concentration to inhibit 50 % binding of the lectin (MIC50), Figure 5.2.  
 
Figure 5.2: A) Solid phase inhibitory assay of Con A onto a mannosylated surface. 
[Con A] = 0.5µM, normalised to total mannose concentration. B-D) Frequency (Δf) 
verses dissipation plots (ΔD) function of polymer concentration. B) P1; C) P2; D) 
P3. 
The inhibitory assay is representative of a “real” application of anti-adhesion 
therapies at cell surfaces and probes the activity of the inhibitors rather than their 
actual binding affinities.  
P2 and P3 were approximately 10x more efficacious at inhibiting the Con A 
compared to P1, which is in agreement with previous inhibitory studies.18 This is in 
contrast to the QCM studies though, which suggest that P3 has far high binding 
affinity than P2, but is capable of absorbing far less mass onto the immobilised 
lectin. It also suggests that binding affinity/surface absorption may not be predictive 
of MIC50 and hence therapeutic potential. Classic turbidometric cluster assays 
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indicated P3 had a faster clustering rate than P2 and that it was capable of 
precipitating more Con A per mannose residue, with the absolute value in agreement 
with previous studies, even though the number of Con A per chain appears large, 
considering the relative size of the species in solution.34 Interestingly, the 
concentrating of free mannose required to break these clusters was identical for P2 
and P3 indicating that the rate of clustering is less important than the strength of the 
clusters in determining inhibitory activity. Toone et al. have previously discussed the 
discrepancies between different assays and cautioned against using single assays.2, 35 
It has been shown by ITC and haemagglutinin assays, using multivalent mannosides, 
that binding affinity and agglutination capacity are not predictive of each other.16 In 
an attempt to shed light on these apparently contradictory observations and to gain a 
deeper mechanistic insight, the QCM experiments were repeated with parallel 
dissipation monitoring. Dissipation monitoring probes the viscoelasticity of the 
formed films on a surface. Large changes in dissipation (ΔD) indicate a flexible film, 
compared to smaller increases in D, which suggest a rigid, non-flexible coating. ΔD 
vs ΔF plots for P1 and P2 show that the dissipation signal increases in a non-linear 
fashion at concentrations above 1 mg.mL-1, which is interpreted as the formation of a 
viscoelastic film. Conversely, P3 shows a linear response with very low increases in 
D as F increases which is indicative of a flat, rigid film. 
This difference in film structure as a function of polymer chain length 
indicates a significant difference in the polymers’ conformation at the lectin surface. 
A discussion of these observations follows, which does not include consideration of 
the micro-equilibrium between bound and free carbohydrate, but rather the average 
conformation assumed by the polymer, which generates the signal in QCM-d.  
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Scheme 5.2: Proposed binding mechanism of low A) and high B) molecular weight 
polymers onto the Con A surface. This model ignores the competition from 
carbohydrates on the already bound polymer chain and only represents the extreme 
cases when the polymer is fully extended.  
Scheme 5.2A shows the case of a short (< 6.5 nm) polymers (P1/P2) which can only 
bind a single site on Con A, which are separated by ~ 6.5 nm.18 As the concentration 
is increased, polymers from solution can either displace this binding, or bind to 
another vacant site (along with competition from carbohydrates on the already bound 
polymer). As polymer concentration increases more Con A binding sites are filled 
and hence a significant mass increase is observed by QCM, and the polymers adopt a 
brush like conformation, in agreement with the dissipation observations; agreeing 
with the near-identical association constants for P1/P2 on a per sugar basis (Table 
2). In Scheme 2B, a large (> 6.5nm) polymer (P3) is used. Following an initial 
binding event, there are two options (ignoring competition from carbohydrates on 
the already bound polymer): either another polymer from solution can bind to the 
Con A, or the already bound polymer can span to another, vacant site (bind and 
slide). If further polymers from solution were binding (i.e. competing) to vacant sites 
then as polymer concentration increases a larger mass increase would be expected, 
which would be more than seen for small (< 6.5 nm) polymers, and the dissipation 
signal would indicate a flexible brush like film. As this is not observed, then the 
mechanism must be that the already bound polymer preferentially spans multiple 
binding sites, which gives an increase in avidity, preventing polymers in solution 
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from displacing it (Scheme 5.2). This will result in a lower total mass of polymer 
compared to the short polymers and a thin, rigid, film as demonstrated by QCM-d. It 
should be noted that these rearrangements are only possible due to the reversible 
nature of the lectin-carbohydrate interactions. A previous report by Munoz et al. 
showed that different generations of mannosylated dendrimers which were too small 
to span multiple binding sites did not have significantly higher affinity constants 
towards Con A under conditions where lectin-lectin crosslinking was not possible.33 
Conversely, they showed that in inhibitory assays, increased dendrimer size led to 
increased potency. Similar results were observed in the present study, with P2/P3 
having equal inhibitory activity, but P3 having a greater Ka, and the ability to span 
multiple binding sites. Therefore, taking into account the evidence presented in this 
report, and by Munoz et al. it would seem that in the design of inhibitors for lectin 
binding, that lectin-lectin crosslinking, or reduced dissociation rate constants (not 
obtained here) are more important than spanning binding sites (although this may 
play a role) on a single lectin. This can also help to explain why low valency 
inhibitors can display high inhibitory potency despite limited cross-linking 
potential.2  
 
5.4 Conclusions  
We have probed the mechanism of how multivalent polymeric glycoconjugates span 
multiple binding sites with the use of QCM-d. Glycoconjugates that are sufficiently 
large to span binding sites in solid phase assays-show a large Ka this did not translate 
to increased inhibitory potential in solution-phase assays. Furthermore, as a result of 
spanning binding sites, the polymers with the highest Ka actually showed the least 
total mass binding, due to the formation of a flat film, rather than extended brush 
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structures that are seen for short polymers. When screening multivalent 
glycopolymers, single-concentration measurements will not reveal the highest 
affinity binders unlike with monovalent carbohydrates. This work also serves to 
highlight the challenges in designing efficient multivalent (glycopolymer) inhibitors 
of lectins. Different assays identify different ‘most active’ polymers. Therefore, the 
assays most relevant to the intended application (anti-adhesion, receptor-mediated 
uptake etc.) must be used, preferably in combination with others to fully assign the 
mode of action. It was only possible to obtain these insights through the use of 
complimentary polymerisation techniques (CCT and CMLRP) that gave access to 
the oligomeric glycoconjugates coupled with QCM-d which reveals additional 
information compared to SPR or fluorescent microarray analysis. There is no 
intention to imply that higher valency conjugates are not useful (as it is not true), nor 
less active. It is also important to highlight that the present study did not probe many 
of the features of multivalency, such as statistical rebinding and chain flexibility or 
entropic contributions, but rather attempts to link surface binding to solution 
inhibition. While many fundamental studies have been undertaken with discrete, low 
molecular weigh species, synthetic polymers are more complex due to their inherent 
dispersity and potential differences in local chain conformation.  Future studies are 
focusing on applying these insights to medically relevant systems and comparisons 
between high and low valency inhibitors. 
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5.5 Experimental Section 
5.5.1 Materials  
Copper(I) bromide, tetrabutylammonium ﬂuoride (TBAF) in THF (1.0 M), acetic 
acid, 2,2’-bipyridyl (bipyridine), 2-chloro-1,3-dimethylimidazolinium chloride 
(DMC), sodium azide, L-fucose, mannan, concanavalin A (Con A) and FITC-
labelled Con A were purchased from Sigma-Aldrich. Triethylamine was purchased 
and used directly from Fisher Scientiﬁc. 3-(Trimethylsilyl)-2-propyn-1-ol, D-(+)-
mannose was purchased from Alfa-Aesar. CoBF, 2-bromo-2-methyl-propionic acid 
benzyl ester initiator36 and the ligand N-ethyl-2-pyridylmethanimine37 were prepared 
as described previously. All other reagents and solvents were purchased at the 
highest purity available from Sigma-Aldrich and used without further puriﬁcation 
unless stated. Ultrahigh quality water with a resistance of 18.2 MΩ cm (at 25 °C) 
was obtained from a Millipore Milli-Q gradient machine ﬁtted with a 0.22 µm ﬁlter. 
 
5.5.2 Physical and analytical methods 
1H and 13C NMR spectra were recorded on Bruker DPX-300 and DPX-
400 spectrometers using deuterated solvents obtained from Sigma-Aldrich. SEC was 
conducted on a Varian 390-LC system in DMF (1 g.L-1 LiBr) at 50 °C, equipped 
with refractive index and viscometry detectors, 2  x PLgel 5 µm mixed-D columns 
(300 x 7.5 mm), 1 x  PLgel 5 µm guard column (50 x 7.5 mm) and an autosampler. 
Data were analysed using Cirrus 3.2 software. Molecular weight was determined 
relative to narrow poly(methyl methacrylate) standards. All the QCM-d experiments 
were performed using the Q-Sense E4 System with four sensor chambers for four 
parallel measurements at 25 °C The system was equipped with QE 401 Electronics 
Unit, QCP 401 Chamber Platform, and QFM 401 Flow Module with Ismatec IPCN 
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Pump. The quartz crystal chip was an optically polished Au coated quartz sensor 
(AT-cut; diameter: 14 mm; thickeness: 0.3 mm; surface roughness of electrode <3 
nm; electrode layer: 10–300 nm) with fundamental resonant frequency 5 MHz. UV-
vis and fluorescence measurements were undertaken on a Biotech Synergy HT and 
processed using the Gen5 software package or Microcal Origin. 
 
5.5.3 Synthetic procedures  
Trimethyl-silyl propargyl methacrylate: A solution of trimethylsilyl propyn-1-
ol (40.0 g, 312 mmol) and triethylamine (TEA) (56.6 mL, 406 mmol) in diethyl ether 
(250 mL) was cooled to 0 °C. A solution of methacryloyl chloride (45 mL, 406 
mmol) in diethyl ether (150 mL) was added dropwise into the mixture using a 
dropping funnel. The mixture was stirred at this temperature for 1 h and at ambient 
temperature overnight under nitrogen. The solution was passed through a basic 
alumina column and washed with diethyl ether. After removal of the volatiles under 
reduced pressure, the crude product was puriﬁed by kugelrohr distillation. 47.4 g of 
colourless oil was obtained as the product (yield = 77.4 %) 
1H NMR (400 MHz, CDCl3, 298 K): δ(ppm) = 0.20 (s, 9H, Si(CH3)3), 1.94 (s, 3H, 
CH3C=CH2), 4.80 (s, 2H, OCH2), 5.58 (s, 1H, C=CHH), 6.07 (s, 1H, C=CHH);  
13C NMR (100 MHz, CDCl3, 298 K): δ(ppm) = 0 (3C, Si(CH3)3) 17.9 (1C, 
CH3C=CH2), 52.7 (1C, OCH2), 91.1 (1C, C=CSi(CH3)3), 100.3 (1C, C≡CSi(CH3)3), 
126.7 (1C, CH3C=CH2), 135.3 (1C, CH3C=CH2), 166.6 (1C, C=O). ESI-MS: 
m/z = 219.0 [M + Na]+. 
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CCTP of TMS-protected propargyl methacrylate: In a typical polymerisation, 
CoBF (5.0 mg) was dissolved in MEK (10 mL), which was previously freeze–
pump–thawed 3 times. AIBN (50 mg) was added to a Schlenk tube containing a 
magnetic stirrer, followed by addition of TMS-protected propargyl methacrylate (10 
mL). The solution was freeze–pump–thawed three times and then ﬁlled with 
nitrogen. The CoBF solution (500 µL) was added into the Schlenk tube and the 
mixture was stirred at 60 °C under nitrogen overnight. At the end of the reaction, the 
mixture was diluted with 20 mL of MEK and bubbled with air for 2 hours. The 
volatiles were removed by distillation under reduced pressure and the polymer was 
used for deprotection (conversion = 88%; Mn = 3100 g.mol-1, Mw/Mn = 1.4). 
 
Deprotection of TMS-protected polymers: The TMS-protected polymers (2 g, 
10.2 mmol TMS groups) and acetic acid (3 g, 51 mmol) were dissolved in THF (100 
mL) bubbled for ten minutes and the solution was cooled to 20 °C. A 0.2 M solution 
of TBAF (15.3 mmol) in THF was added dropwise into the mixture. The resulting 
solution was stirred at this temperature for 1 hour and then warmed to ambient 
temperature. After stirring overnight an Amberlite IR-120 ion-exchange resin was 
added and stirred with the reaction mixture for 2 hours. The resin was removed by 
ﬁltration and the resulting solution was concentrated under reduced pressure. The 
polymer was puriﬁed by precipitation in petroleum ether (boiling fraction 30–40 °C, 
0.6 g, yield = 47.6%; Mn = 5400 g.mol-1, Mw/Mn = 1.34). 
 
Synthesis of α-D-Mannopyranosyl azide: D-(+)-Mannose (10 g, 55.5 mmol) 2-
chloro-1,3-dimethylimidazolinium chloride (28.2 g, 0.167 mol) 
diisopropylethylamine (DIPEA) (96.7 mL, 0.55 mol) and sodium azide (36.1 g, 0.55 
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mol) were dissolved in H2O (200 mL). After stirring for 5 h at 0 °C, the reaction 
mixture was concentrated under reduced pressure and ethanol (200 mL) was added. 
The resulting white solid was removed by ﬁltration and the volatiles were removed 
under reduced pressure. The yellowish crude product was dissolved in H2O (80 mL) 
again and washed with dichloromethane (3 x 100 mL), before being passed through 
a short column of prewashed Amberlite IR-120. The resulting aqueous solution was 
freeze-dried to give α-D-mannopyranosyl azide as an off-white solid. 
1H NMR (400 MHz, D2O, 298 K): δ(ppm) = 3.65 (m, 1H, CHCH2), 3.74 (m, 1H, 
CH), 3.77 (m, 2H, CH2), 3.89 (m, 1H,CH), 3.94 (m, 1H, CH), 5.48 (d, J = 1.7 Hz, 
1H, CH); 13C NMR (100.59 MHz, D2O, 298 K): δ(ppm) = 60.82 (CH2), 66.40 (CH), 
69.77 (CH), 69.84 (CH), 74.65 (CHCH2), 89.74 (CHN3). ESI-MS: m/z = 228.1 [M + 
Na]+.  
 
Alkyne–azide cycloaddition: The alkyne-functional polymer (0.1 g, 0.81 mmol 
alkyne groups), α-D-mannopyranosyl azide (0.305 g, 1.61 mmol), 2,2’-
bipyridine (25.2 mg, 0.16 mmol) and TEA (23 mL, 0.165 mmol) were dissolved in 
DMSO (3 mL). The solution was freeze–pump–thawed 3 times before being 
cannulated over to another Schlenk tube which was previously evacuated and ﬁlled 
with nitrogen, containing Cu(I)Br (12 mg, 0.084 mmol). The resulting brown 
solution was stirred at ambient temperature for 3 days. At the end of the reaction, the 
solution was passed through a short neutral alumina column and washed with 
DMSO. The mixture was transferred to a dialysis tube and dialysed against water for 
3 days, followed by freeze-drying to give the glycopolymer as a white solid (0.21 g, 
yield = 79% conversion = 100%; Mn = 14 000 Da, Mw/Mn = 1.38). 
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5.5.4 Inhibitory assays  
Quartz Crystal Microbalance: Functionalisation of Au chip with concanavalin A. 
Au chips were cleaned in a mixture of 35% of NH3, 33% of H2O2 and Milli-Q water 
(1 : 1 : 5, v/v) for 10 min and then rinsed with Milli-Q water and dried by a stream of 
nitrogen. Then the chips were immediately immersed into the solution of 10 mM 11-
mercaptoundecanoic acid (MUA) in ethanol and kept over-night at ambient 
temperature to obtain a thiol self-assembled monolayer (SAM) on the gold surfaces. 
The gold chips were washed with ethanol and Milli-Q water sequentially and then 
immersed into a freshly prepared water solution of 0.4 M 1-[3-
(dimethylamino)propyl]-3-ethyl carbodiimide (EDC) hydrochloride and 0.1 M N-
hydroxysuccinimide (NHS) (1 : 1, v/v) to activate the carboxyl groups on the Au 
surface. After being washed with Milli-Q water and dried with a stream of nitrogen, 
the gold chips were mounted in the QCM-d cell. HBS buffer was run through the 
system until ﬂat baselines of frequency and dissipation were achieved. Con A was 
immobilised on the surface by passing Con A buffer solution (0.1 mg mL-1) over the 
quartz crystal chip until no further changes in frequency were observed, followed by 
ethanolamine hydrochloride (1 M, pH  8.5) until a stable baseline was observed, to 
block any residual NHS groups.  
HBS buffer (10 mM HEPES, 0.15 M NaCl, pH 7.4) containing 1 mM metal 
ions (Ca2+, Mg2+, and Mn2+) was pumped through the QCM-d system at a ﬂow rate 
of 50 mL.min-1 until stable baselines of both frequency and dissipation signals were 
obtained. Solutions of the glycopolymers, in the same buffer, were then injected at 
concentrations between 0.05 and 2 mg.mL-1 and the experiment continued until 
equilibrium was reached. To estimate the association constant, a Langmuir isotherm 
was used, according to eqn (1), which is then rearranged to eqn (2): 
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∆! =   ∆!!"# !!  [!"#$%&]!!!!   !"#$%&             (1) !∆! =    !∆!!"#!!  [!"#$%&] +    !∆!!"#       (2) 
where Δf is the measured frequency shift; Δfmax the frequency shift at saturation; 
Ka the association constant; and [ligand] the concentration of analyte. The 
association constant can be obtained by a linear ﬁt to the plot of 1/Δf against 
1/[ligand]. 
 
Fluorescence Linked Sorbent Assay: Microtitre plates were incubated for 16 h 
with 180 µL of 0.1 mg ml-`1 mannan dissolved in phosphate-buffered saline (PBS) 
per well. Unattached mannan was removed by washing extensively with PBS. 
Polymer solutions were made up as serial dilutions in PBS from 0.1 mg mL-1. 20 µL 
of 0.3 mg mL-1 Con A–FITC in PBS was added to 80 µL of each polymer solution to 
result in 0.5 µM ConA–FITC. 100 µL of the polymer Con A-FITC solutions were 
added to the mannosylated surfaces and incubated at 37 C for 30 min. Fluorescence 
was then measured at excitation/emission wavelengths of 485/528 nm. All 
experiments were carried out in triplicate. Percentage inhibition was compared to 
relative to controls of pure Con A (with no polymer). 
 
Quantitative precipitation: The assay was followed a modiﬁed procedure.4, 21 Con 
A was dissolved in the HBS buffer (0.1 M HEPES, 0.9 M NaCl, 1 mM MgCl2, 1 
mM CaCl2 and 1 mM MnCl2, pH 7.4) to make fresh stock solution and the 
concentration was 60 mM (assuming Con A tetramers with a molecular weight of 
106 kDa). Glyco polymer solutions in HBS buffer were also prepared with a series 
of different concentrations. Then Con A solution and the glycopolymer solution 
were mixed (1 : 1, v/v) and incubated for 5 hours at 22 °C. The ﬁnal concentration of 
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Con A was 30 µM. White precipitates were separated from solution by 
centrifugation at 5000 x g for 2 minutes, followed by removal of the supernatants 
very carefully using a pipette. Then the pellets were resuspended in cold buffer 
again. These washing steps were repeated twice. After removal of the supernatants, 
the precipitates were dissolved in a HBS buffer solution of methyl-α-D-
mannopyranoside (1 mL, 1 M). With complete dissolution, the Con A content was 
determined by measuring the absorbance at 280 nm. 
 
Lectin agglutination assay: This was conducted according to previously published 
procedures.21 Con A was dissolved in HBS buffer (approximately 1 mg.mL-1). The 
exact concentration of Con A was determined by measuring the absorbance at 280 
nm (A280 = 1.37 x [mg.mL-1 Con A]). The solution was then diluted to 1 µM. After 
addition of 0.5 mL of glycopolymer (50 mM) into a dry polycarbonate cuvette (1 
mL, 1 cm pathlength), the cuvette was placed in the UV spectrometer. By adding 0.5 
mL of the diluted Con A solution into the cuvette via a pipette, the absorbance of the 
mixture was quickly recorded at 420 nm for 10 min every 0.12 s. The relative rate of 
interaction was determined by a linear ﬁt of the steepest portion of the initial 
aggregation. Each experiment was repeated 3 times. 
 
Reverse aggregation assay: As previously described,4 following the turbidity 
measurement, the absorbance A420 of the solution after 2 hours at room temperature 
was recorded as A420 (t = 0). Then 0.1 mL of methyl-α-D-mannopyranoside (54 mM) 
in HBS buffer solution was added to the cuvette. The mixed solution was quickly 
placed in the spectrometer and the absorbance at 420 nm was recorded for 10 
minutes. A420 (t = 10) was calculated as an average of the last 10 seconds of each 
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experiment. The percent change in absorbance was determined as (A420 (t = 0) -
 A420 (t = 10))/A420 (t = 0). 
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Chapter 6 
Gold nanoparticle-linked analysis of 
carbohydrate-protein interactions, and 
polymeric inhibitors, using unlabelled 
proteins; easy measurement using a 
‘simple’ digital camera. 
L. Otten, S.-J. Richards, E. Fullam, G. S. Besra, M. I. Gibson, J. Mater Chem. B., 
2013, 1, 2665-2675 
This chapter contains the published paper describing a novel inhibitor detection 
method. Here we used gold nanoparticles synthesised by the citrate reduction method 
to determine inhibitor efficacy by illuminating the protein concentration. 
Lucienne was a project student that I supervised. Together we did all the synthesis, 
testing and prepared the manuscript. 
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6.1 Abstract 
Traditional methods of measuring the affinity of lectins (or other carbohydrate-
binding proteins) to their target carbohydrates rely on the use of 
chemically/recombinantly-modified proteins in sorbent assays, microarrays, or the 
use of expensive label-free methods such as surface plasmon resonance 
spectrometry. In this work we exploit the extremely high extinction coefficient (i.e. 
colour) of gold nanoparticles as resolving agents in sorbent assays. The anionic 
nanoparticles adhere strongly to immobilised proteins, but not to the carbohydrate-
surfaces allowing investigation of protein binding and screening of novel multivalent 
inhibitors. Furthermore, the use of a simple digital camera (or mobile phone) to 
obtain the data is shown, providing an ultra-low cost route to the detection of native, 
carbohydrate-binding proteins.  
 
6.2 Introduction 
Carbohydrate-protein recognition events are responsible for a plethora of biological 
processes including host-pathogen interactions, immune signalling, fertilisation, 
cancer metastasis, blood group markers and many more. Pathogenic infection is 
often driven by an initial carbohydrate-protein binding event such as neuraminic 
acid/heamaglutinin (influenza),1, 2 GM1 ganglioside/cholera toxin (cholera)3 and 
gp120/DC-SIGN (HIV)4, often through binding to lectins: a subset of carbohydrate-
binding proteins which are neither enzymes nor antibodies. Inhibition of these 
binding events, to prevent infection, is termed anti-adhesion therapy and has been 
extensively studied for both mono- and multivalent carbohydrate derivatives.5-9 The 
binding affinity of carbohydrates (and hence their potential utility) is often enhanced 
by the multivalent presentation of individual carbohydrates on a polymeric/dendritic 
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scaffold (‘glycopolymer’10), due to the ‘cluster glycoside effect’,5, 11 where the 
polymer binding affinity increases to an extent greater than the linear sum of the 
individual carbohydrates’ binding affinities. The mechanisms and applications of 
these materials are currently under intensive investigation, but are often focused on 
model lectins, which are widely available and have well characterised interactions. 
Despite there being many carbohydrate-protein interactions being known, there still 
remains a huge number of carbohydrate-mediated processes (covering recognition, 
uptake, trafficking and binding) which are poorly characterised and hence causes a 
bottle-neck in the design of new therapeutics or diagnostics.12 For example, the 
structure of the oligosaccharide responsible for human sperm binding was only 
recently elucidated despite many years of intense study.13 In part, this is due to the 
challenge associated with obtaining usable quantities of complex glycans or their 
derivatives, compared to other biomacromolecules (DNA, proteins) that can be 
recombinantly expressed and/or amplified and obtained by solid-phase chemical 
synthesis.14, 15 In order to evaluate carbohydrate-protein interactions; there is also a 
need to isolate and characterise usable quantities of the protein prior to any analysis. 
Standard methods for evaluating these interactions include both solution and solid 
phase based assays. Isothermal Titration Calorimetry (ITC) provides detailed 
information about the energetics of the binding interactions, but is time consuming, 
not high throughput and can consume a relatively large amount of material and 
requires specialised equipment.16 Sometimes, direct fluorescence assays probing 
tryptophan/tyrosine residues can be used, but this is not always the case. A further 
problem of solution interactions is that many carbohydrates are normally 
immobilised on the surface of a cell/virus, providing an adhesion site, rather than as 
mobile solutes. To address this, surface plasmon resonance (SPR) is frequently 
 152 
employed. SPR allows direct measurement of the binding of a biomacromolecule 
onto an appropriately functionalised gold surface using minimal quantities of each 
compound.17, 18 However, SPR equipment is specialised, often not high-throughput, 
is expensive and not routinely available in all laboratories. Other surface methods 
such as quartz-crystal microbalance (QCM) and optical waveguide lightmode 
spectroscopy (OWLS) have similar problems and benefits.19 It should be noted that 
immobilisation of the protein on surfaces, rather than carbohydrates is convenient 
but limited by the signal detection (which is essentially proportional to mass) which 
cannot detect small molecule binding. ELISA (enzyme-linked immunosorbent assay) 
and fluorescence-linked assays have found wide-spread use due to their lower 
equipment level requirement (microplate reader) and excellent sensitivity limits.20, 21 
A key challenge of sorbent assays is the need to use labelled proteins, rather than 
unmodified versions. Recombinant methods can introduce enzymatic or antigen tags 
which themselves can alter the function of the protein and direct chemical labelling 
of isolated proteins with fluorophores (such as fluorescein isothiocyanate) can 
provide detection, but gives rise to heterogeneous distributions of labels, which leads 
to well-known problems in terms of altering ligand binding affinities.22-24 
Fluorescent labels are often not photostable presenting challenges in quantitative 
analysis.25 the challenges associated with carbohydrate immobilisation, or the 
generation of labelled carbohydrates should not be underestimated.26  
Considering that monitoring of these interactions has huge potential in the 
development of novel anti-adhesion therapies or diagnostics, any technology which 
simplifies this process, is compatible with native proteins and relies on readily 
available imaging platforms could have profound benefit. Gold nanoparticles 
(AuNPs), which display an extremely strong coloration due to their surface plasmon 
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band have been shown to strongly adhere to proteins by electrostatic interactions. 
For example, colloidal gold has been used to stain native proteins separated by 
electrophoresis on gels,27 or those on microplates28 allowing colourimetric detection. 
While useful, this technique has not found widespread use, has not been optimised in 
terms of particle size, nor has it been used to screen for novel inhibitors of lectin 
binding. Other uses of AuNPs in imaging has also been reviewed extensively,29-31 
especially with regard to their aggregation-sensitive properties,32 contrast agents in 
biological electron microscopy33 and photothermal imaging.34  
 Herein we describe the use of AuNPs as resolving agents to allow 
quantification of protein absorption onto carbohydrate functionalised microplate 
surfaces and to use it as an accessible tool to probe multivalent inhibitors which are 
potential prophylactic antibacterial agents without the need for fluorescence 
detection is investigated. This visualisation should reduce the need for expensive, 
complicated and low throughput analytical facilities and inaccessible, labelled, 
protein samples. The use of a simple digital camera to probe these interactions is also 
studied as an ultra-low cost alternative. 
 
6.3 Results and Discussion  
The aim of this work was to use citrate-stabilised AuNPs as resolving agents for 
direct measurement of (unlabelled) protein binding onto carbohydrate-functional 
surfaces, taking advantage of their extremely strong colouration. Here it is exploited 
to screen novel anti-adhesion therapies without the need for labelled proteins, and to 
test the validity of direct ‘visual’ analysis of protein binding using a simple digital 
camera as an ultra-low cost platform.35 The concept is outlined in Figure 6.1.  
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Figure 6.1: Overview of the approach used to allow direct measurement of lectin-
carbohydrate binding by visualisation of surface-bound protein using AuNP on 
microtitre plates.  
A small panel of citrate-stabilised AuNP were obtained using the standard 
citrate/HAuCl4 reduction approach.36, 37 This method was chosen as it is simple, 
scalable and gives rise to charged nanoparticles, which are essential for strong non-
specific protein interactions (vide infra). Table 6.1 summarises the synthesis of 
AuNPs used in this study that characterised by UV-visible spectroscopy and 
dynamic light scattering (DLS) to provide an estimate of their dimensions, which 
were in the range of 30 – 70 nm. 
Table 6.1: Citrate-stabilised AuNP used in this study. 
Code [Citrate]:[Gold][a] λspr[b] 
(nm) 
Particle size 
(UV)[c] (nm) 
Particle size   
(DLS) (nm) 
PDI[d] 
AuNP1 3.5:1 526 36 nm 36 0.35 
AuNP2 2.5:1 541 76 nm 76 0.58 
AuNP3 1.5:1 545 70 nm 130 0.38 
[a] Molar ratio of trisodium citrate to HAuCl4 used in the synthesis of the 
nanoparticles. [b] Location of the surface plasmon peak in the UV-visible spectrum 
of the particles. [c] Particle size estimated by the method of Haiss et al.38 [d] 
Polydispersity index of the particles, obtained by DLS. 
 
The key requirement of this study is that the citrate-coated AuNP interact 
with proteins that have bound to carbohydrates immobilised onto the surface of 
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microtitre plates, providing the necessary visualisation (red colour) to determine the 
extent of protein binding. To test the hypothesis, two different surfaces were 
prepared in 96-well microtitre plates designed to promote or inhibit AuNP binding. 
BSA (bovine serum albumin) was directly adsorbed onto high-binding plates to 
provide a ‘protein rich’ surface and the GM1 ganglioside, which presents a 
carbohydrate-surface, was also immobilised. These surfaces were subsequently 
exposed to a 0.3 mg.mL-1 solution of AuNP 1 for 30 minutes, washed with Milli-Q 
water, and then their UV-Vis spectra measured, Figure 6.2A. The BSA surface 
clearly shows absorbance at ~ 520 nm, attributable to AuNP absorbing to the protein 
surface, whereas the GM1 surface shows no signal. The branched oligosaccharide 
component of GM1 presents a highly hydrated (‘non-fouling’ type39) surface that 
will not interact electrostatically with the anionically charged AuNPs. The three 
different AuNPs listed in Table 1 were subsequently evaluated with BSA surfaces as 
a function of AuNP concentration to determine the optimum conditions and 
detection limits Figure 6.1B. Across the AuNP concentration range of 0–1 mg.mL-1, 
the smallest nanoparticles (3.5:1 [citrate]:[Au]) gave the largest signal intensity. To 
maximise the signal intensity, all subsequent tests were undertaken by exposing the 
protein-bound surfaces to AuNP1 at 1 mg.mL-1 (total Au mass). 
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Figure 6.2: Evaluation of AuNP-surface interactions. A) UV-Visible spectra of 
BSA-coated surface (black trace) and GM1 coated surface (red trace) following 
addition of AuNP1. B) Absorbance intensity of the protein-bound wells at 525 nm as 
a function of added AuNP concentration, onto to BSA-coated microtitre plates. 
Legend shows ratio of [citrate]:[Au] used in preparation of the nanoparticles.  
 
To evaluate the utility of AuNP as a reliable, scalable, accessible and 
economic alternative to standard SPR/QCM/ELISA type measurements of 
carbohydrate-protein interactions a representative panel of lectins were selected with 
and without, fluorescent labels to allow us to validate this approach. Mannose-
functional surfaces were obtained by coating microtitre plates with mannan, and 
galactose-functional plates by coating with GM1. Concanavalin A (Con A) was used 
as a mannose-specific lectin, and peanut agglutinin (PNA) and the B-subunit of the 
cholera toxin (CTxB) as distinct galactose-specific lectins, Table 6.2. 
Table 6.2: Coatings and lectins used in this study. 
Coating Carbohydrate-ligand Lectin 
Mannan α-D, 1-6 linked mannose Concanavalin A 
GM1 β-D Galactose Cholera Toxin B-subunit 
GM1 β-D Galactose Peanut Agglutinin 
 
Figure 6.3 shows the dose-dependant binding of PNA to GM1 as a function of PNA 
concentration, with binding measured by fluorescence (A) or by addition of 50 µL of 
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1 mg.mL-1 AuNP-1. (B). Both binding curves have similar profiles and give 
calculated Kd’s of 72.7 nM  (AuNP) and 90.9 nM (fluorescence) respectively. The 
strong agreement shows that AuNPs are useful and can be used to analyse complex 
interactions without the need for specialised equipment, or labelled proteins.  
 
Figure 6.3: Dose-dependant binding curves of PNA onto GM1 functional surfaces. 
A) Fluorescence measurements (FITC - excitation/emission 485/528 nm). B) AuNP 
absorbance at λmax. Errors bars represent ± standard deviation from a minimum of 3 
repeats. 
 
Similar results were obtained when the Con A/Mannan system were analysed 
(Appendix 4). Furthermore, the AuNPs-resolved microplates were not observed to 
degrade overtime. After two weeks storage, identical data was obtained in contrast to 
fluorescence or enzymatic methods that suffer from photo bleaching or denaturation, 
respectively. It should be noted that although the AuNPs will most likely bind each 
protein to a different extent, this does not affect the measurements shown here, 
which are probing equilibrium process and hence all that is required is a dose-
response curve with clear start and end points. 
A more medically relevant subset of lectins for study is those secreted by 
pathogenic bacteria that are key targets for prophylactic anti-adhesion therapy. The 
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toxin secreted by the pathogen Vibrio cholerae binds to GM1 on epithelial cells and 
is the causative agent of cholera infection. Figure 6.4. Kd values obtained for CTxB 
by were AuNP was 0.19 µM and by fluorescence 0.18 µM again showing 
exceptional agreement. 
 
Figure 6.4: Dose-dependant binding curves of CTxB onto GM1 functional surfaces. 
A) Fluorescence measurements (FITC - excitation/emission 485/528 nm). B) AuNP 
absorbance at λmax. Errors bars represent ± standard deviation from a minimum of 3 
repeats. 
 
The data presented above shows that AuNP based measurement of protein 
binding is comparable to fluorescence methods. We are ultimately interested in 
probing the inhibition of pathogenic toxins, and therefore the Au-system was applied 
to a competitive binding experiment. We and others have demonstrated that synthetic 
glycopolymers, presenting many copies of a single carbohydrate on their side chain 
display high binding affinities to lectins due to the cluster glycoside effect.40, 41 
Recently we demonstrated that modulation of the distance between polymer 
backbone and carbohydrate can improve the affinity of poly(galactoside)s for CTxB 
due to an improved fit to its (relatively) deep binding site (See Chapter 2). Here, 
three synthetic glycopolymers which were prepared by tandem post-polymerisation 
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modification42 with precise control over valency and linker length were assayed for 
their ability to inhibit CTxB binding, Figure 6.5.  
 
Figure 6.5: Inhibition of CTxB binding by β-D galacto-functional glycopolymers. A) 
Structure of glycopolymeric inhibitors. B), C), D) Inhibitory curves of Polymers 1, 2 
and 3 respectively, with CTxB, measured using AuNP method. Errors bars represent 
± standard deviation from a minimum of 3 repeats. 
 
P1 with a short linker showed the highest MIC50 values (lowest affinity) of 
56 µg.mL-1 whereas the polymers with longer linkers (P2/P3) had approximately 
identical MIC50 values or 23 and 24 µg.mL-1 respectively (on a per-carbohydrate and 
mass–basis), which is in strong agreement with previously published observations.41 
On a per-polymer basis, P3 was the most active, but this is biased by its higher 
molecular weight and hence lower molar concentration. MIC50 corrected to 
carbohydrate concentration indicates that P3 and P2 have identical activity and 
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therefore in the case of CTxB, there is no additional benefit of increasing chain 
length above 18 units (although further benefit by even larger polymers cannot be 
discounted). Compared to free galactose, all polymers were at least 100 x more 
active highlighting the cluster glycoside effect (Table 3). This method is therefore 
suitable, and amenable to high-throughput screening of lectin inhibition using 
unlabelled proteins. 
Table 6.3: Inhibitory potency of glycopolymers against CTxB determined by gold 
nanoparticle method. 
Polymer DPn[a] Linker[b] MIC50 
 
MIC50[c] 
[Polymer] 
MIC50 
([Galactose]) 
P1 18 Short 56 ± 2.4 µg.mL-1 9.4 ± 0.4 µM 0.169 ± 0.072 mM 
P2 33 Long 23 ± 18  µg.mL-1 1.6 ± 1.2 µM 0.055 ± 0.43 mM 
P3 18 Long 24 ± 11  µg.mL-1 3.2 ± 1.46 µM 0.057 ± 0.027 mM 
 [a] Number average degree of polymerisation of polymer (= galactose/chain). [b] 
Refers to length of spacer between polymer and carbohydrate shown in Figure 5. [c] 
MIC50 adjusted in terms of concentration of polymer chains; [d] MIC50 adjusted in 
terms of total galactose concentration. The polymers used were reported in a 
previous study.41 Error bars represent the standard deviation in the individual IC50 
from each individual measurement (minimum of 3 repeats). 
 
6.3.1 Measuring binding using digital photography 
During the above-described experiments, it was observed that upon addition of 
AuNPs to the protein-functional plates, sufficient gold was deposited to allow visual 
examination of protein binding, due to the intense red colouration of AuNPs (their 
extinction coefficients are typically 100 – 1000 larger than fluorescence dyes). 
Figure 6.6A shows a photograph of a GM1 microplate following incubation with a 
dilution series of CTxB, revealed by addition of AuNPs. Strong red colouration can 
be seen at high concentrations of CTxB, with the colour decreasing in line with 
decreasing protein concentrations. This visual read-out is potentially useful for low-
cost diagnostic applications, rapid protein-binding assays in laboratories or 3rd world 
applications, particularly if it can be linked to a mobile phone or digital camera 
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system. This would remove the need for a plate reader or similar whilst maintaining 
the ability to obtain quantitative data.35 The AuNP-exposed plates were 
photographed using a standard digital camera (see Experimental section) and 
imported into image analysis software. The average pixel intensity of each well was 
measured and plotted against concentration of protein added, Figure 6.6B. 
Impressively, near identical binding curves were obtained compared to those in 
Figure 6.5 (CTxB by absorbance/fluorescence), with Kd values close to that obtained 
by either fluorescence or absorbance. 
 
Figure 6.6: Direct optical analysis of protein binding. A) Digital photograph of GM1 
functional microplates treated with a dilution series of CTxB and following 
developing with AuNPs for 30 minutes. B) Binding curve obtained by pixel-
counting direct from digital photographs. 
 
Figure 6.7 shows the correlation between average pixel intensity and both total 
fluorescence or absorbance. This analysis gave a strong positive correlation linear 
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fits with R2 values above 0.98. This offers the opportunity for quantitative evaluation 
of lectin binding/inhibition in laboratories lacking in dedicated glycomics facilities 
and would be compatible with a cellular-phone based analytical system. 
 
Figure 6.7: Comparison of signal intensities obtained by pixel-counting methods 
verses AuNP and traditional fluorescence measurements. 
 
6.4 Conclusions 
In this study, we have investigated the use of citrate-coated AuNPs as resolving 
agents to analyse protein binding to surfaces, as a low-cost, accurate glycomics tool. 
Carbohydrate-coated surfaces were incubated with their corresponding lectins and 
their binding isotherms were measured by direct fluorescence-linked assays and by 
absorbance measurements based on AuNP absorption. Strong correlation was found 
between the two methods; with the AuNP method having the advantage that it 
removes the need to use labelled proteins and can be read with a standard microplate 
reader, without the need for fluorescence measurements. To demonstrate the 
applicability of this, a series of multivalent glycopolymers were screened for their 
ability to inhibit the binding of CTxB, as a model of a pathogenic infection process. 
Finally, due to the extremely strong colouration of the AuNP resolved surfaces, it 
was possible to use a digital camera to simply image the microplates and use image 
 163 
analysis software to extract binding isotherms, which showed strong correlation to 
those obtained by fluorescence or absorbance measurements. This presents the 
opportunity to use AuNP resolving agents for label free, low cost, high-throughput 
evaluation of carbohydrate-protein interactions that may have diagnostic or 
screening applications. In particular, it allows rapid testing of inhibitors and 
concentrations ranges prior to more detailed biophysical analyses (e.g. SPR/QCM).  
 
6.5 Experimental Section 
 
6.5.1 Materials  
Concanavalin A (Con A), fluorescein isothiocyanate (FITC) labelled Con A, peanut 
agglutinin (PNA) from Arachis hypogaea, FITC labelled PNA, 
monosialotetrahexosylganglioside (GM1), bovine serum albumin (BSA), cholera 
toxin subunit B (CTxB), FITC labelled CTxB, mannan, preformulated phosphate 
buffered saline tablets (PBS), calcium chloride (CaCl2), sodium chloride (NaCl), 
HEPES, Tris buffer, trisodium citrate dehydrate and chloroauric acid (HAuCl4) 
where all purchased from Sigma-Aldrich, UK. 96-well high binding microtitre plates 
were purchased from Greiner Bio-one. Galactose-functional polymers used in this 
study have been previously reported and their synthesis is summarised in the 
Appendix 4.43 Phosphate buffered saline (PBS) was prepared using preformulated 
tablets dissolved in 200 mL of Milli-Q water (with resistance >18 MΩ) cm, to give 
final concentration of NaCl = 0.138 M, [KCl] = 0.0027 M and pH = 7.4. 10 mmol 
Tris buffer containing 0.1 mmol CaCl2 and 0.5 mmol NaCl (pH 8, TBS) was 
prepared in 250 mL of Milli-Q water (with a resistance >19 MΩ cm).  
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6.5.2 Physical and analytical methods 
Absorbance and fluorescence measurements were made using a BioTek Synergy HT 
multi-detection microplate reader and Gen5 software. Dynamic light scattering was 
conducted using a Nano Zetasizer ZS from Malvern Instruments, UK. Scattered light 
was detected at 173 ° and the observed count rated recorded. Hydrodynamic radii 
(where appropriate) were determined using the manufacturer’s software. Diameters 
are an average of three measurements using at least 10 scans. All protein binding 
curves were plotted in OriginPro (version 8.6) and the built in nonlinear curve fitting 
tool was used to fit a logistic curve to the data and to calculate the MIC50 values are 
defined as being the concentration of inhibitor required to reduce the binding of the 
lectin to the carbohydrate surface by 50 % of its maximal value. Absorbance graphs 
were produced by plotting the absorbance measurement at 530 nm against 
concentration. A linear regression analysis for the paired cholera toxin data was 
preformed in the open-source statistical package R (version 2.14.1). Picture of AuNP 
modified wells were taken using a Nikon D60 camera with automatic exposure 
settings from a distance of 30 cm using ambient light conditions.  
 
6.5.3 Synthetic procedures 
 
Functionalisation of multiwall plates: High binding 96-well plates were incubated 
for 16 h with 180 µL of 0.1 mg.mL-1 mannan, GM1 or BSA dissolved in PBS per 
well. After incubation, unbound mannan, GM1 or BSA was removed by washing 
with distilled water, after which the plates were dried and stored at 4 °C. The same 
procedure was also used for GM1 (0.1 mg.mL-1), bovine serum albumin (BSA) (0.1 
mg.mL-1). 
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Gold nanoparticle synthesis: Sodium citrate capped gold nanoparticles were 
produces by chemically reducing chloroauric acid (HAuCl4) with trisodium citrate 
dehydrate as the capping agent. An aqueous solution of trisodium citrate dehydrate ( 
2 mL, 0.13 mmol) was added to a boiling solution of HAuCl4 (35 mL, 0.35 mmol) 
under reflux and vigorous stirring producing a ratio of 3.5:1 (sodium 
citrate:HAuCl4). After addition of the trisodium citrate dihydrate the solution went 
from pale yellow to dark blue before eventually turning deep red (about 30 minutes	  
after addition of the trisodium citrate dihydrate). After which the solution was cooled 
and then stored in the dark at 4 °C. Solutions were also produced using the ratios 
2.5:1 and 1.5:1 following the same procedure but using different ratios of HAuCl4 to 
trisodium citrate dihydrate. 
Lectin binding assays: 96-well microtitre plates were incubated for 16 h with 180 
mL of 0.1 mg.mL-1 GM1 dissolved in PBS, per well. Unbound GM1 was removed 
by washing extensively with PBS and then water. Polymer solutions were made up 
as serial dilutions (up to 10 dilutions per sample in TBS from 1 mg.mL-1). 20 µL of 
12.5 mg.mL-1 CTxB in TBS was added to 100 µL of each polymer solution to result 
in a final concentration of 2 µg.mL-1 CTxB per well. 100 µL of the polymer/CTxB 
solutions were then added to the GM1-coated wells and incubated at 37 °C for 30 
min. After this time, they were extensively washed with Milli-Q water.	   50 µL of 
AuNP solution was then added to each well before incubation at 37 °C for 30 min. 
After extensive washing with Milli-Q water, absorbance in each well was measured 
between 450 and 700 nm in 1 nm steps. All experiments were carried out in 
triplicate. 
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Digital camera-linked assay and image analysis: Microplates were prepared as 
described above, and the CTxB lectin applied, washed and AuNP added following 
the above described procedures. A digital photograph of the AuNP-	  modified plates 
was taken from a distance of 30 cm using ambient light and the tiff image file 
uploaded into the open-source image processing package ImageJ (version 1.46a) 
where a region of interest (ROI) saturation and brightness (HSB) stack of images and 
the saturation image used. The ROIs drawn on the original image were added to the 
saturation image using the ROI manager and average pixel intensity in each region 
of interest was measured using an inbuilt function in ImageJ. An example image 
showing the colour change achieved by gold binding to protein bound to GM1 is 
shown in Figure 6.6. 
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Section 2: Detection 
Chapter 7 
Discrimination between bacterial 
phenotypes using glyconanoparticles 
and the impact of polymer coating on 
detection readouts 
S-J. Richards, E. Fullam, G. S. Besra, M. I. Gibson, J. Mater Chem. B., 2014, 2, 
1490-1498 
This chapter consists of the paper describing the used of glyco-gold nanoparticles as 
a detection method for bacteria based on their colourimetric properties. Saline 
stability and speed of read-out were investigated and their effect on detector efficacy. 
I carried out the particle synthesis and the lectin and bacterial testing. Elizabeth 
started the overnight cultures for me and assisted in the bacterial testing work. I 
prepared the manuscript.   
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7.1 Abstract 
The identification and treatment of bacterial infections remains a major healthcare 
challenge, especially to ensure appropriate application of a limited spectrum of 
antibiotics. Here we describe a system capable of discriminating between different 
strains of Escherichia coli using multivalent, carbohydrate-functionalised, gold 
nanoparticles based upon their different expression levels of the FimH adhesin. 
Upon binding of the glycosylated nanoparticles to FimH positive bacteria, the 
nanoparticles’ optical properties change enabling the identification of bacteria strain. 
Comparison between direct conjugation, or via a linker, of the carbohydrate to the 
nanoparticle revealed significant effects on the performance of the detection system. 
Using a poly(ethylene glycol) spacer increased the stability, and specificity, of the 
glycosylated nanoparticles but also reduced aggregation upon bacterial binding. This 
prevented the well-know red to blue gold colour change, meaning 
spectrophotometric, rather than optical, assessment methods were required. Using 
this method, FimH positive bacteria could be detected at approximately 1.5 x 107 
colony forming units/mL. 
 
7.2 Introduction 
Due to their widespread overuse, and the emergence of resistance, antibiotics are 
becoming less effective and agents that were once last resort are now being used 
more frequently. This has lead to a looming major healthcare crisis, with few new 
antibiotics in the pipeline, new strategies to treat and identify bacterial infections are 
urgently required.1, 2 Standard clinical methods for the detection and identification of 
bacterial pathogens such as E. coli, rely upon selective conventional culturing and 
plating of bacteria from a contaminated sample and conclusive results typically 
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require 24 hours or more. Despite being sensitive and accurate, it does not provide 
real-time, on-site feedback and requires sophisticated equipment and often 
immunoassays using fluorescence or radiolabelling.3-5 A direct, label-free method for 
bioanalyte detection that is easy, sensitive even at low sample volume, high-
throughput and quantifiable in real-time is critical to applications in clinical 
diagnostics and the real-time detection of environmental and biological toxins.6  
Gold nanoparticles (AuNPs) have been intensively studied in bioanalytical 
applications due to their characteristic optical properties. They are also good 
alternatives to fluorescently or radiolabelled substrates used in bioassays because 
they are inexpensive, simple to synthesise, have high photo-stability and can be 
conjugated efficiently to biological molecules.6, 7 AuNPs exhibit an intense colour in 
the visible region due to a local surface plasmon resonance (LSPR) that arises due to 
the collective oscillation of the conduction-band electrons of the gold core.6, 8-10 
These optical properties are strongly correlated with their size, shape, dispersion 
media and degree of aggregation making them ideal sensors. Aggregation of AuNPs 
leads to a dramatic colour change from red to blue/purple. This is due to electric 
dipole-dipole interactions and coupling between the plasmons of neighbouring 
particles.6, 8-10 Triggered changes in their aggregation can be readily observed by eye 
and quantitative analysis only requires a UV-Vis spectrometer. It is for this reason 
that AuNPs are attractive for the detection of biomolecules.8, 11 The colour changes 
associated with AuNP aggregation have been exploited in the development of 
colourimetric assays using AuNPs functionalised with biomolecules such as 
proteins,7, 12 peptides,11 antibodies,13-18 and DNA.19, 20 The detection of bacterial 
DNA using AuNPs originated in the pioneering work of Mirkin et al.,20 who 
demonstrated that as little as 10 fmol of an oligonucleotide analyte could be detected 
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by exploiting the aggregation phenomenon of AuNPs. Many groups have used 
AuNP-based sensors in an immunoassay format, whereby disease markers can be 
detected using AuNPs conjugated to appropriate antibodies.12, 14, 16, 17 The in situ 
generation of gold nanoparticles guided by enzymes has also been exploited to create 
ultra sensitive sensors for the detection of prostate cancer and HIV antigen p24.21 
Rotello et al. have developed gold nanoparticle sensors, whereby bacteria adhesion 
to the nanoparticles releases β-galactosidase from the surface, activating a pro-
fluorescent label, providing detection of the presence of bacteria, but not the 
phenotype.22  
Protein-carbohydrate interactions mediate many critical biological 
recognition processes, such as those involved in cell signalling, fertilisation, and 
inflammation, and in particular, they mediate the adhesion of viruses and bacterial 
toxins to their native targets.23, 24 The proteins responsible for deciphering this 
information are termed lectins, which specifically (and noncovalently) bind 
carbohydrates.25, 26 The protein–saccharide interactions are usually weak, but are 
amplified by clustered saccharides, resulting in a binding constant, which is greater 
than the simple sum of the total number of ligands. This observation is referred to as 
the ‘cluster glycoside’ effect.27, 28 Considering this information, carbohydrate 
functionalised AuNPs (glycoAuNPs) are attractive biosensors as they are inherently 
multivalent and should give optical responses upon protein binding to their surface, 
providing the platform for new sensors.8, 10, 29 There have been many reports of using 
mannose or glucose functional AuNPs to interact with Concanavalin A (Con A) as a 
model protein.8-10, 29-32 Con A, however, is not an indicated target for biosensing. A 
more relevant target for carbohydrate-based bioanalytical platforms are outer 
membrane-exposed lectins on the surface of bacteria (or indeed viruses), which are 
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involved in cellular adhesion to the glycocalyx of mammalian cell33, 34 One of the 
most important and most investigated bacterial lectins is the mannose/glucose-
specific protein FimH, which is expressed on the tips of type 1 fimbriae on E. coli. 
These fimbriae are uniformly distributed on Enterobacteriaceae, commonly between 
100 and 400 fimbriae per cell.34 Alexander and co-workers have employed 
thermoresponsive glycopolymers to reversibly aggregate FimH expressing bacteria 
upon changing the external temperature.35 Disney et al. used fluorescent 
glycopolymers to detect FimH positive bacteria, but this required an isolation step 
limiting the sensory application.4 AuNPs have been reported to bind to fimbriae, but 
identification was achieved via electron microscopy, and did not exploit their 
colourimetric properties.31 The colourimetric (red to blue) shift associated with 
AuNPs aggregation has been exploited for the detection of isolated lectins, and 
different strains of influenza36 but not to identify bacterial phenotype.   
In this work we investigate the development of a colourimetric glycoAuNP 
assay for the rapid, point-of-care, detection of particular bacteria phenotypes based 
on their surface lectin expression patterns. The role of particle structure including 
polymeric spacer on the sensitivity, specificity and outputted signal is investigated.  
 
7.3 Results and Discussion 
In order to obtain glycosylated nanoparticles that could selectively interact with the 
FimH adhesin on E. coli, AuNPs were synthesised using the one-pot method of 
Watanabe et al.,8 using chemical reduction of HAuCl4 using a thio-sugar as the 
reducing and stabilising agent. Different sized particles were obtained by tuning the 
molar ratio of thioglucose:Au3+, Scheme 7.1. Although glucose is not the native 
ligand for FimH (mannose), there are several reports of multivalent glucose binding 
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FimH so was a suitable starting point.35 Table 7.1 summarises the initial particles 
used in this study. By varying the ratio of thioglucose relative to Au3+ it was possible 
to control the diameter of the AuNPs in the range of 30 – 60 nm, as confirmed by 
UV-Vis and dynamic light scattering (DLS). 
 
Scheme 7.1. Synthesis of AuNPs by in situ reduction using 1-thioglucose. 
 
Table 7.1: AuNPs synthesised by in situ reduction. 
Code Molar ratio  
Thioglucose:Au3+ 
Wavelength of SPR 
peak (nm) 
Diameter37  
(nm) 
AuNP1 0.55 525 32 
AuNP2 0.50 530 48 
AuNP3 0.45 536 60 
 
 To probe the utility of the glycoAuNPs as colourimetric readouts of the 
presence of lectins, Con A was selected due to its well-known affinity for 
glucose/mannose residues. During the initial experiments, it became clear that the 
glycoAuNPs could not tolerate significant quantities of salt in the buffer, so the NaCl 
concentration had to be reduced (see below for solutions to this – it is crucial for 
point-of-care diagnostics) to prevent unwanted aggregation. Addition of Con A to 
the AuNPs resulted in a shift in the location of the SPR peak to longer wavelengths 
(i.e. blue colouration) and a general increase in absorption at 700 nm, Figure 7.1. By 
plotting Abs700 against Con A concentration, it was possible to obtain binding 
isotherms that indicated larger nanoparticles had increased affinity to Con A, 
compared to the smaller ones. However, unravelling relative affinity/avidity in 
	   176 
multivalent systems is non-trivial,38, 39 and the experiments shown here simply serve 
to demonstrate that the response of the AuNPs to Con A has a size dependency. To 
probe the underlying mechanism of this shift in the absorption behaviour of the gold, 
the process was monitored kinetically, by both UV-Vis and DLS, Figure 7.1C. The 
increase in diameter observed by DLS correlated well with Abs700 confirming that 
lectin/nanoparticle crosslinking was the macroscopic effect. This observation is 
crucial if a red-blue colour shift is to be obtained. If lectin adhesion does not lead to 
particle crosslinking the spectral changes would be more subtle and require different 
analysis, and is described later.  
 
 
 
 
 
 
	   177 
 
Figure 7.1: Interaction of glucose-functional AuNPs with Con A. A) UV-Vis 
spectrum of AuNP2 upon addition of increasing concentrations of Con A (0.1 – 100 
nM) following 30 minutes of incubation. B) Binding isotherms (at 37 °C) of AuNPs 
with Con A. C) Comparison of kinetics of nanoparticle responses to Con A by both 
UV-Vis spectroscopy and dynamic light scattering. D) Aggregation of AuNPs by 
Con A tetramer giving rise to colour changes (E).  
 
Encouraged by the colour shift in response to addition of Con A, AuNP2 was 
selected to interrogate two distinct strains of E. coli; K-12 (strain K-12 JM109) 
which expresses FimH, mannose-binding adhesin on its fimbriae; TOP10, which 
does not express FimH. The nanoparticles were incubated with a dilution series of 
each bacteria in a range of ODs (Optical Density – bacteria density in solution by 
measuring absorbance at 600 nm) from 0 to 1, for 30 minutes and their absorption 
spectra recorded, Figure 7.2. As can be clearly seen in Figure 7.2A, addition of 
AuNP2 to K-12 resulted in a large shift in the SPR maximum to longer wavelength 
and an increase in absorbance at 700 nm (after correcting for the background 
absorbance of the bacteria), in agreement to what was observed with Con A. With 
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TOP10 (no FimH), the observed changes were smaller, and only occurred at higher 
bacteria concentrations, indicating either non-specific (fouling) interactions or 
unintended interactions with unknown proteins such as glucose transporters. Figure 
2C shows the binding isotherm, which shows the particles responded to the K-12’s at 
far lower concentration (100 fold) than the TOP10’s, demonstrating in principle the 
nanoparticle’s ability to discriminate. Figure 2D shows photographs of the 
nanoparticles with bacteria showing the very obvious colour changes from red to 
blue in the presence of K-12s, but not with TOP10 until very high concentrations are 
applied which could form the basis of a point of care diagnostic if selectivity could 
be improved. This limited range of selectivity is probably due to the earlier 
observations that the AuNPs have limited stability in complex media (and saline) 
and hence some aggregation will occur over time giving false-positive readouts.  
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Figure 7.2: Interactions of AuNP2 with K-12 and TOP10 bacteria. A) Absorption 
spectra of AuNP2 upon addition of K-12 bacteria of OD 0.001 to 1. B) Absorption 
spectra of AuNP2 upon addition of TOP10 bacteria of OD 0.001 to 1. C) 
Comparison of binding isotherm of glycoparticles to both bacteria at 37 °C. D) 
Photographs of AuNP2 with serial dilution of bacteria and associated colour 
changes. 
 
7.3.1 Improving glyconanoparticle stability and selectivity 
Encouraged by the results described above, a strategy was developed to 
improve the selectivity and stability of the nanoparticles. To improve solution 
stability, it is common to immobilise hydrophilic ‘non-fouling’ polymers which 
confer both saline stability and reduce non-specific absorption of proteins onto the 
nanoparticle surface, most commonly with poly(ethyleneglycol) (PEG).40 
Furthermore, to improve binding to FimH, mannose was selected as the more 
specific ligand, compared to glucose. Installation of the mannose onto thiol-
terminated PEG was achieved by cycloaddition of α-D-propargyl mannoside with the 
ω-terminal azide (‘click’), followed by purification by dialysis, Scheme 7.2. The 
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mannose-functional PEG was subsequently immobilised onto pre-formed 40 nm 
AuNPs by a simple mixing strategy and excess polymer removed by centrifugal 
dialysis. Upon polymer coating an increase in hydrodynamic diameter from 40 – 55 
or 57 nm was observed, along with a shift in the SPRmax indicating successful 
functionalisation, Table 7.2. 
 
 
Scheme 7.2: Synthesis of PEGylated glyconanoparticles. 
 
Table 7.2: Glyconanoparticles with PEG spacer. 
Code Carbohydrate SPRuncoated[a] 
(nm) 
SPRPEG[b] 
(nm) 
Diameter[c] 
(nm) 
NP-Man α-Man 525 527 55 
NP-Gal β-Gal 525 529 57 
[a] SPR maximum of 40 nm uncoated AuNPs. (b) SPR maximum of AuNPs after 
coating with pyranoside-PEG-SH. (c) Diameter determined by DLS. 
 
As saline stability was a problem with the directly carbohydrate-conjugated AuNPs, 
resulting in false positive aggregation effects, the stabilising effect of the PEG was 
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assessed, Figure 7.3. The PEGylated nanoparticles were stable across all NaCl 
concentration ranges (up to 1 M, which is well above that required for a sensor) 
whereas the non-PEGylated particle aggregated even at 0.005 M NaCl. This assay 
ensures that any aggregation effects observed with live bacteria can be assigned to 
particle-bacteria interactions and not to non-specific aggregation. 
 
Figure 7.3: Comparison of saline stability of A) uncoated and B) PEG-coated 
AuNPs.  
 
As with AuNP 1-3, Con A was added to the particles and their responses measured 
by UV-Vis. Unlike the previous examples, addition of Con A did not appear to cause 
a shift in the SPR maximum, but did induce a large increase at 700 nm, and a 
decrease in intensity of the SPR peak, Figure 7.4. Kinetic analysis (at Abs700) 
showed the rate of change in absorbance for the PEGylated particles was 
significantly slower than with AuNP2. AuNP2 aggregated in less than 25 minutes, 
but the PEGylated particles were still increasing at 700 nm even after 4.5 hours of 
incubation. This is interpreted as being due to the increased stability of the 
PEGylated particles in the buffer, which means there are no non-specific aggregation 
events. The increased separation between carbohydrate residues at the termini of 
PEG-chains (relative to directly-conjugation to gold surface) may also slow the rate 
of binding due to spacing effects.  
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Figure 7.4: Interactions of NP-Man with Con A. A) Absorption spectra of particles 
upon addition of Con A at 37 °C for 30 minutes; B) Kinetic analysis of nanoparticle 
interaction with Con A, compared to non-PEGylated glycoAuNP, AuNP2. 
 
To unravel the processes that occur with both types of glycoAuNP, and to aid the 
development of the optimum readouts for a sensor, the responses of AuNP2 and NP-
Man are compared in Figure 7.5. The change in absorption at 700 nm (after 30 
minutes) for both nanoparticles as a function of Con A concentration is almost 
identical, with similar inflection points. However, the changes in the SPR absorption 
band are in stark contrast. AuNP shows a dose–dependent shift in SPRmax as [Con A] 
increases. NP-Man however, does not show any shift in the SPR and hence there is 
no red to blue colour shift, suggesting more analysis is required if there are to be 
used as a diagnostic tool. DLS analysis (Appendix 5) showed no aggregation of NP-
Man upon addition of Con A. We therefore propose that the SPR shift (red – blue) 
seen for AuNP1-3 is associated with the interparticle distance decreasing, due to 
Con A crosslinking the particles or due to binding events leading to reduced solution 
stability. The change in absorption at 700 nm for NP-Man is not a turbidity effect 
(due to no increase in particle diameter for PEGylated particles) and we therefore 
suggest this is associated with protein binding to the AuNPs and affecting their 
hydration, and hence refractive index. These observations raise a question for the use 
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of AuNPs as biosensors, in that the commonly applied polymer coatings improve 
stability, but inhibit the convenient visual read-out commonly associated with nano-
gold red to blue colour shift. Therefore, absorption at 700 nm will be used from this 
point. It should be noted that the effect of polymer coating will vary on the analyte 
being detected (including size of analyte: e.g. bacteria/virus), and the length of the 
polymer itself.36  
 
 
Figure 7.5: Comparison of spectral response between particles with and without 
PEG spacer. A) Change in absorbance at 700 nm; B) Changes in the location of the 
SPR absorption band as a function of lectin concentration. 
 
Before progressing to testing with the bacteria, an additional control experiment was 
undertaken. Peanut agglutinin (PNA), which has preference for β-galactose was 
added to NP-Man. Pleasingly, no change was observed indicating that the polymer 
coating efficiently prevents non-specific interactions with proteins, and only the 
carbohydrate motifs are associated with recognition/output events, Figure 7.6.  
	   184 
 
Figure 7.6: Assessment of lectin specificity of glycoAuNPs. A) UV-Vis spectra of 
NP-Man upon addition of PNA (0.001 – 1 mg.mL-1); B) Comparison of change in 
absorbance at 700 nm of NP-Man upon addition of Con A (mannose binding) and 
PNA (galactose binding). 
 
With the above information to hand, a series of experiments were designed to probe 
bacterial specificity and the optical responses of the AuNPs. To provide a negative 
control, galactose functional nanoparticles were also synthesised by identical 
synthetic methods, NP-Gal. NP-Gal should not interact with either of the bacterial 
strains, whereas NP-Man should interact with K-12 (FimH adhesin) but not TOP10, 
and therefore providing a rigorous panel of measurements to probe sensitivity and 
selectivity. Figure 7.7 shows the UV-Vis spectra of NP-Man with K-12 and TOP10. 
As was observed with the protein studies, there was no shift in the SPR maximum 
with either bacteria but there were decreases in the SPR intensity and increases in 
absorbance at 700 nm. The changes observed were far more significant, and 
occurred at lower bacteria concentrations in the case of K-12 compared for TOP10. 
The changes observed when NP-Gal was added to both bacterial strains was 
significantly less (Appendix 5).  
 
 
	   185 
 
Figure 7.7. UV-visible spectra of NP-Man with A) K-12 and B) TOP10 bacteria.  
 
The changes in absorbance at 700 nm for each bacterium at a variety of optical 
densities (proportional to bacteria concentration), with both particles is summarised 
in Figure 7.8. To aid visualisation, the change in Abs700 as a function of OD was 
plotted as a heat map, with the z-axis (colour) set to show large changes as blue, and 
small changes as red (allowing facile comparison with standard nano-gold assays). 
Using this visualisation, it became very obvious that only Mannose-functional 
particles and K-12 together gave rise to positive responses. Changing to either 
TOP10 or Gal functional particles did not result in positive responses. The best 
responses were obtained with intermediate concentration of K-12, OD = 0.03 to 
0.125 where the response to K-12 was largest without any response to TOP10. Very 
high concentrations of K-12 (> OD 0.5) actually led to a reduction in signal from 
NP-Man. We hypothesise that this is due to the bacteria binding sites saturating the 
AuNP, such that there are insufficient particles to statistically bind close together, to 
give the desired optical outputs. Future studies will investigate this in more detail. 
The actual number of bacteria (colony forming units) was estimated (Appendix 5) 
indicated that the nanoparticle system could detect K-12 bacteria at concentrations as 
low as 1.5 x 107 CFU/mL. These tests shows that glycoAuNPs can discriminate 
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between strains of bacteria based solely upon interrogation of membrane-exposed 
carbohydrate-binding proteins and could form the basis of new point-of-care 
diagnostics. 
 
Figure 7.8. Responses of both NP-Man and NP-Gal to both K-12 and TOP10 
bacteria. A) Absorbance at 700 nm for each system in response to bacteria, following 
subtraction of background absorbance of bacteria; B) Heat map showing change in 
Abs700 (relative to ODbacteria = 0) for all particles. Blue colouration indicates a larger 
response and red indicates no response. Error bars indicate ± standard deviation from 
3 experiments. 
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7.4 Conclusions 
 
We have developed a sensitive and rapid colourimetric bioassay for the quantitative 
detection of lectins and type 1 fimbriated bacteria based upon the binding of 
glycoAuNPs. AuNPs with carbohydrates directly immobilised on their surface 
showed very rapid responses to both lectins and lectin-expressing bacteria. However, 
these particles also displayed low saline stability and nonspecific interactions with 
the bacteria limiting their discriminatory capacity. To overcome this a PEG layer 
was inserted between the particles and the carbohydrate. This dramatically increased 
the saline stability of particles whilst retaining their bio-recognition properties. An 
interesting side effect of the PEG layer was no red to blue colour change was 
observed upon lectin binding, which was hypothesised to be due to steric shielding 
effects of the PEG layer. Despite this, an assay was developed based on monitoring 
the absorbance at 700 nm with UV-Vis spectroscopy in which the mannose-
functional particles specificity generated an output in the presence of K-12 bacteria 
and not TOP10. K-12 expressed type 1 fimbriae that bind mannose residues, but 
TOP10 does not. This system represents the first step in making nanoparticles that 
can ‘read’ the surface lectin composition of bacteria to enable rapid (point-of-care) 
phenotyping with a visual output. 
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7.5 Experimental Section 
 
7.5.1 Materials 
D-(+)-mannose, propargyl alcohol (99 %), copper bromide (99%), HEPES and 
phosphate buffered saline (PBS) were purchased from Sigma Aldrich. Triethylamine 
(99 %) and Hydrogen tetrachloroaurate (III) trihydrate were purchased from Acros.  
β-D-thioglucose sodium salt was purchased from Carbosynth. D-(+)-galactose 
anhydrous was purchased from MP Biomedicals. DMSO was purchased from Fisher 
Scientific at laboratory grade. Peanut Agglutinin and Concanavalin A were 
purchased from Vector Laboratories. Azido PEG thiol (N3-(PEG)-SH, Mn = 3000 
g.mol-1) was purchased from NANOCS. Tris-(benzyltriazolylmethyl)amine (TBTA) 
was synthesised according to literature procedures.41 Microtitre plates were 
purchased from Greiner Bio-one. 10 mmol HEPES buffer containing 0.15M NaCl, 
0.1mM CaCl2 and 0.01mM Mn2+  (pH 7.5, HEPES) was prepared in 200 mL of 
milliQ water (with a resistance >19 mOhms). 40 nm gold nanoparticles were 
obtained from BBI International. K12 JM109 (referred to as K12 in text) and TOP10 
were both grown in LB media from frozen stocks prior to use. Bacteria were isolated 
by centrifugation and the resuspended to the desired optical densities in PBS. 
7.5.2 Physical and analytical procedures 
Absorbance measurements of the nanoparticles incubated with Con A were recorded 
on a BioTek SynergyTM HT multi-detection microplate reader obtained using Gen5 
1.11 multiple data collection and analysis software. DLS measurement were carried 
out using a Malvern Instruments Zetasizer Nano-ZS. A Thermoscientific NanoDrop 
2000 UV-Vis Spectrophotomer was used to measure the OD600 of the E. coli cells.  
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7.5.3 Synthetic procedures 
Synthesis of Glucose Functionalised Gold Nanoparticles: Thioglucose-capped 
gold nanoparticles were synthesized according to the method of Wantanabe et al.8 
An aqueous 1-thioglucose solution (5.0 mL 2-20 nM) was added to a boiling 
solution of HAuCl4 (50 mL, 0.5 mM) under reflux and vigorous stirring. On addition 
of the 1-thioglucose, the solution changed colour from pale yellow to ruby red 
almost immediately. Then the reaction was heated under reflux for a further 10 
minutes. The reaction mixture was cooled and dialysed overnight against water to 
remove unreacted thioglucose using dialysis tubing (Spectra/Por, Cellulose ester, 
MWCO = 5000, Spectrum Laboratories Inc., USA). 
 
Synthesis of Propargyl-Pyrannosides: To mannose or galactose (500 mg,) in 
propargyl alcohol (5 mL), 250 µL of 3 M HCl was added.  Stirred overnight at room 
temperature. Concentrated in vacuo. Employed immediately for alkyne azide 
cycloaddition reaction. 
1H NMR (D2O, 300 Hz) δppm  : 4.48 (1H, d, J = 7.7 Hz, CH, H3),   4.40 (2H, t, J = 2.2 
Hz, CH2-C≡CH, H2a+b), 3.84 (1H, d, J=3.4 Hz, CH, H5), 3.68 (2H, d, J = 3.0 Hz, CH2 
H8a+b), 3.65 (1H, d, J = 2.6, CH, H6) 3.60 (1H, t, J = 3.9, CH, H5), 3.45 (1H, m, CH, 
H7), 2.82 (1H, t, J = 2.4, C≡CH, H1) 
13C NMR (D2O, 100 Hz) δppm: 101.0 (CH, C4), 76.13 (CH2-C≡CH, C1), 75.20 
(CH2-C≡CH, C2), 72.65 (CH, C8), 71.1 (CH, C6), 70.45 (CH, C5), 68.51 CH, C7), 
60.68(CH2 C9), 56.0(CH2-C≡CH, C3). 
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Copper-catalysed [3+2] cycloaddition of propargyl-pyrannosides and azide-
(PEG)3K-SH: N3-(PEG)3K-SH (20 mg, 5.9 µmol),  (50 mg, 0.23 mmol), TEA (10 
mg, 0.072 mmol), and CuBr (2 mg) dissolved in DMSO (4 mL) were charged in an 
ampoule and deoxygenated through three freeze–pump–thaw cycles before being 
placed under nitrogen. TBTA (8 mg, 0.14 mmol) was added and the reaction was 
degassed and left under nitrogen for 48 h. The polymer was purified by dialysis 
against water using dialysis tubing with MWCO of 1000 g.mol-1.  
IR ν : 3600-3200 (OH), 2890 (CH2), 1105 (C-O) cm-1, 
 
Preparation of Pyrannoside-(PEG)3K functionalised gold nanoparticles: To 5 mL 
of 40 nm AuNPs, pyrannoside-(PEG)3K-SH (5 mg) was added and left for 30 mins at 
room temperature. The particles were then centrifuged at 6000 rpm for 15 mins and 
resuspended in HEPES buffer.  
 
Size Characterisation of Glucose Functionalised Gold Nanoparticles using 
Absorbance Spectra: 50 µL of each glycoAuNP were loaded into a 96-well 
microtitre plate, 50 µL of 10 mM HEPES buffer with 0.5 mM CaCl2, 0.5 mM MnCl2 
and 0.5 mM MgCl2 was added to each and a spectrum was taken between 450 nm 
and 700 nm. 
  
Concanavalin A Induced Aggregation Assays: A stock of 24 µg.mL-1 Con A was 
made up in 10 mM HEPES buffer with 0.5 mM CaCl2, 0.5 mM MnCl2 and 0.5 mM 
MgCl2. 50µL serial dilutions of ConA were made up in the same buffer in a 96-well 
microtitre plate so that when the nanoparticles were added the resultant 
concentration was 12nM – 0.01 nM and a control with 0 µg.mL-1 of ConA. 50 µL of 
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the glycoAuNP was added to each concentration of Con A and incubated at 37 °C 
for 30 minutes with medium shaking and then an absorbance spectra between 450 
nm and 700 nm was recorded. Each measurement was done in triplicate.  
 
Concanavalin A Induced Aggregation Kinetics Studies using Absorbance 
Spectra: 50 µL of the nanoparticle solution was incubated with 50 µL of Con A at 
the Kd concentration. Readings of the absorbance at 700 nm were taken every minute 
for 30 seconds with medium shaking between recordings. 
  
Concanavalin A Induced Aggregation Kinetics Studies using Dynamic Light 
Scattering: 300 µL of AuNP was made up in 240 µL of MilliQ water and filtered 
through a 0.22 µm syringe filter. 60 µL of Con A was added that would make the 
concentration of Con A around the Kd value. Average diameter measurements at 
ambient temperature were taken every 15 seconds for 30 minutes. 
 
Bacterial Detection Assay: An adapted procedure was used of that conducted by 
Seeberger et al.4 TOP10 (nonfimbriated) and K-12 (fimbriated) Escherichia coli 
cells were cultured overnight in LB media at 37 °C. The culture was then washed 
twice and resuspended in HEPES buffer with 0.5 mM CaCl2, 0.5 mM MnCl2 and 0.5 
mM MgCl2. 100 µL serial dilutions of the bugs were made up in microtitre plates 
and 100 µL of the gold nanoparticles were added to the cells. The suspensions were 
incubated at room temperature for 30 minutes. The absorbance spectra of the 
nanoparticle cell suspensions were taken using the cells alone as a background.   
Colony forming units were estimated, assuming that OD600nm 1 = 109 CFU.mL-1. 
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Chapter 8 
Optimisation of the polymer coating for 
glycosylated gold nanoparticle 
biosensors to ensure stability and rapid 
optical readouts 
S-J. Richards, M. I. Gibson, ACS Macro Lett., 2014, 3, 1004-1008   
This chapter consists of the paper detailing the development of optimised polymer-
gold nanoparticle composites for lectin detection. This improves on the saline 
stability and speed of readout issues observed in Chapter 7. Using a water soluble 
polymer of a range of sizes the optimum linker length was determine for stability at 
physiological saline concentration, but also gave a fast readout (in less than 15 
minutes). 
I proposed the use of RAFT polymerised water-soluble polymers as a method to 
improve the saline stability, by methodically probing different length linkers. I 
carried out all the synthesis and characterisation of the polymers and particles and 
the testing of the response of the differently functionalised particles to a range of 
lectins. I also prepared the manuscript and dealt with reviewers’ comments.  
 197 
8.1 Abstract  
 
The development of new analytical tools to probe pathogenic infection processes and 
as point-of-care biosensors is crucial to combat the spread of infectious diseases or to 
detect biological warfare agents. Glycosylated gold nanoparticles that change colour 
due to lectin (carbohydrate-binding protein) mediated aggregation may find use as 
biosensors but require a polymer coating between the particle surface and sugar to 
ensure stability in complex media. Here, RAFT polymerisation is employed to 
generate glycosylated polymers to coat gold nanoparticles. Rather than being a 
passive component, it is shown here that the polymer coating has to be precisely 
tuned to achieve a balance between saline (steric) stability and speed of the readout. 
If the polymer is too long it can prevent or slow aggregation and hence lead to a poor 
readout in sensing assays. The optimised glyco nanoparticles are also demonstrated 
to be useful for rapid detection of a ricin surrogate. 
 
8.2 Introduction 
 
Protein-carbohydrate interactions mediate a multitude of important biological 
processes including; cell-cell signalling, inflammation and fertilisation, however, 
bacteria, toxins, and viruses also use the carbohydrate moieties on cell surfaces for 
cell adhesion as the first stage in infection. Lectins are carbohydrate-binding 
proteins, (other than enzymes and antibodies) which interact with carbohydrates non-
covalently and reversibly with a high level of specificity.1, 2 The binding affinity of a 
monosaccharide to its lectin target in typically very weak (Kd = 10-3-10-6 M). This is 
circumvented in nature by the presentation of multiple copies of the saccharide on 
the cell surface, this is known as ‘the cluster-glycoside effect’ and hence 
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macromolecular structures with polyvalent presentation of carbohydrates are of 
interest.3, 4  
 Examples of pathogens that exploit the protein-carbohydrate interactions are 
the FimH adhesin found on the fimbriae of some pathogenic Escherichia coli (E. 
coli) that bind to mannose residues on the cell surface of the urinary tract.5, 6 Vibrio 
cholerae secretes a carbohydrate-binding toxin that binds to the GM1 ganglioside on 
intestinal epithelial cells.7-9 Ricin is a toxic lectin that presents a potential security 
threat. It is a lethal, type 2 ribosome-inactivating protein found in the castor bean 
plant Ricinus communis.10 It is an A-B toxin whereby its B-chain adheres to terminal 
galactose residues on mammalian cell surfaces, facilitating the delivery of the toxic 
A-chain into the cytosol of the cell. The A-chain catalyses the hydrolytic cleavage of 
a single base from eukaryotic ribosomal RNA, leading to a shutdown in protein 
synthesis and ultimately cell death.11 The median lethal dose (LD50) of ricin for an 
adult is estimated to be around 22 µg.Kg-1 of body weight (> 1.8 mg for an average 
adult). Due to its high toxicity and accessibility, its potential as a bio-warfare agent 
has long been recognised, with several recent incidents in the UK and the US 
resulting in threats to public safety, therefore its rapid detection is highly desirable. 
Gold nanoparticles (AuNPs) have been extensively studied as potential 
biosensors due to their characteristic optical properties and ease of functionalisation 
with a number of biological molecules.12-22 AuNPs exhibit an intense colour in the 
visible region due to local surface plasmon resonance (LSPR), which arises due to 
the collective oscillations of the conduction-band electrons of the gold core.10, 23-25 
These optical properties are strongly correlated with their size, shape, dispersion 
media and degree of aggregation. Particles larger than 10 nm and smaller than 200 
nm exhibit a red colouration; upon aggregation dramatic colour change can be 
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observed from red to blue. This is attributed to electric dipole-dipole interactions and 
coupling between the plasmons of neighbouring particles.14, 23 Carbohydrate-
functionalised AuNP (glycoAuNPs) are attractive biosensors due to the inherent 
multivalency of the particles and lectins. The presence of lectins should lead to an 
optical response as a result of AuNP aggregation, providing the platform for new 
sensors without the need for expensive equipment and fluorescent- or radio-labelling 
of proteins. The colourimetric change associated with the aggregation of AuNPs 
using protein-carbohydrate interactions has been exploited in the detection of 
lectins10, 26, 27 and different strains of influenza.28 We have shown that mannosylated 
glycoAuNPs can be used to distinguish between bacteria with and without type 1 
fimbriae, but that the mode of presentation of the carbohydrates and their distance 
from the gold surface impacts on the detection read-outs with very slow responses 
(aggregation) being observed with polymer coatings limiting their application as 
point-of-care diagnostics (See Chapter 7).29  
Herein we employ RAFT polymerisation to generate heterotelechelic 
polymers that can be conjugated with a glycan at one end, and the RAFT-derived 
thiol at the other to immobilise onto AuNPs. By varying the chain length the crucial 
balance between stability in saline media and speed of colourimetric detection is 
probed, for the rapid detection of a series of lectins, including Ricinus communis 
Agglutinin (RCA120) a surrogate for ricin.  
 
8.3 Results and Discussion 
Inspired by the glycocalyx on eukaryotic cell surfaces, which has a non-fouling 
membrane component (phospholipid betaines) with surface immobilised 
carbohydrates, telechelic polymers were designed with a conjugatable 
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pentafluorophenyl ester at one end and masked thiol (RAFT agent) at the other for 
gold immobilisation, Table 8.1. The synthetic scheme is shown in Figure 1A. 
Poly(N-hydroxyethyl acrylamide) (pHEA) was chosen for its water solubility and 
non-LCST behaviour (unlike PEG methacrylates for example).  
 
Table 8.1: pHEA precursor polymers. 
[M]:[CTA][a
] 
Conversion 
[%][b] 
Mn(Theo) 
(g.mol-1)[c] 
Mn(SEC) 
(g.mol-1) [d] 
Mw/Mn[d] DP[e] 
10 78 1680 2800 1.14 8 
15 87 2250 3500 1.19 13 
20 82 2850 4100 1.16 16 
25 81 3400 6200 1.10 20 
50 80 6300 9400 1.14 40 
75 88 9200 12500 1.20 66 
[a] Feed ratio of monomer to chain transfer agent. [b] Determined by 1H NMR 
spectroscopy. [c] Theoretical number average molecular weight, calculated from the 
feed ratio and percent conversion. [d] Determined by SEC in dimethylformamide 
(DMF) using poly(methyl methacrylate) standards. Mw = weight average molecular 
weight, Mn = number average molecular weight [e] Theoretical number-average 
degree of polymerisation. 
 
A pentafluorophenol (PFP) trithiocarbonate RAFT agent was chosen to enable facile 
end-group modification with amino-glycosides30 and to afford good control with 
acrylamide monomers.31, 32 The post-polymerisation route also means that all the 
polymers have the same initial chain length distribution and therefore reduces the 
variability between particle types. Polymers with a degree of polymerisation (DP) of 
10, 15, 20 25, 50 and 75 were synthesised and their molecular weight distribution 
was determined by size exclusion chromatograph (SEC) (Figure 8.1B) indicating 
low dispersites (< 1.2). The carbohydrates were introduced by reaction of the PFP 
end-group with 2-deoxy-2-amino mannose (ManNH2) and 2-deoxy-2-amino 
galactose (GalNH2). Infrared spectroscopy confirmed the disappearance of the C=O 
stretch attributable to the carbonyl of the PFP end-group (Appendix 6). An 
advantage of this route is that the glycosylation step also cleaves the trithiocarbonate 
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(RAFT) end group to generate a ω-terminal thiol group. In a subsequent step, the 
glycosylated, thiol-terminated polymers were incubated with 60 nm AuNPs to enable 
a monolayer to form. Excess polymer was removed by simple centrifugation-
resuspension cycles. 60 nm AuNPs were chosen as the core, as this size range can 
give lower detection limits in colourimetric assays, as shown previously.29 
 
 
The key aim of this work is to establish the ideal coating parameters to enable rapid 
and specific sensing of lectins. We have previously shown29 that saline stability of 
AuNP sensors is crucial to avoid false positives, and therefore the polymer-coated 
AuNPs were evaluated by a NaCl titration starting from 1 M, Figure 8.2A. It was 
observed that polymers of DP 15 or less were unstable at high salt (>0.2 M which is 
close to physiological (0.137 M)) concentrations, making them unsuitable. Whilst 
longer polymers (predictably) improved saline stability, it is important to consider 
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Figure 8.1: (A) Synthesis of polymer stabilised glycoAuNPs; B) SEC traces of 
various molecular weight pHEA polymers; C) SBA induced aggregation of AuNPs 
gives rise to colour changes with correct lectin glycan pairing.  
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the effects of having polymers that are too long; these can prevent/slow the rate of 
aggregation upon addition of the lectins by steric stabilisation. The kinetics of 
particle aggregation (red to blue colour change) triggered by the addition of Con A 
(preferentially binds to α-mannosides) was measured using UV/Vis spectroscopy. 
The change in absorbance at 700 nm (Abs700) was monitored over a period of 1 hour 
for ManNH2-pHEA-AuNPs with polymer linker lengths of DP20, DP50 and DP75. 
It was found that the shorter linkers resulted in faster aggregation rates (Figure 8.2B) 
with the DP 75 polymer having no observable changes even after 1 hour incubation. 
This serves to highlight the delicate balance between stability and sensing for metal 
nanoparticles, which are modulated by the polymer coating. Guided by these results, 
a panel of mixtures of DP10/DP20 polymer stabilised particles were synthesised and 
it was found that a mixture (1:1) of DP10/DP20 polymers affords a coated particle 
which is saline stable up to 1 M NaCl but retains the ultra-fast kinetics of interaction 
with the partner lectin (blue colouration noted < 5 mins). Figure 8.2C shows images 
of AuNPs with both NaCl and Con A to highlight the optimal formulation and 
demonstrating that macromolecular engineering is essential to obtained precise and 
rapid nano-biosensors. 
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With this optimal polymer coating composition determined, the next stage was to 
investigate these particles with a series of other lectins to ensure i) specificity is 
maintained; ii) that the coating is universally applicable. In place of ManNH2, Gal 
NH2 was introduced into the polymers to evaluate their binding to SBA (Soybean 
Agglutinin) and RCA120 (Ricinus communis Agglutinin). RCA120 is particularly 
important as it is a safe to handle relative of the biological warfare agent ricin, and 
obviously any new sensory systems for this could find broad applicability. Figure 
8.3A shows the change in UV-Vis spectra of GalNH2-pHEA-AuNPs upon addition 
of 0 nM - 85 nM SBA, clearly showing the shift in spectral features from red-blue 
and an increase in absorbance at 700 nm. The rapid kinetics of the process are shown 
Figure 8.2: Saline stability and kinetics of Con A induced aggregation; A) NaCl 
titration to determine saline stability of polymer coated AuNPs; B) Kinetics of 
response of ManNH2-terminated polymer coated AuNP to Con A by UV-Vis 
spectroscopy; C) Evaluation of the saline stability determined by colour remaining 
red in buffer and speed of colour change determined by the colour changing from red 
to blue in after 5 minutes.  
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in Figure 8.3B highlighting that ultra-fast responses are maintained, relative to 
longer polymer coatings. To ensure specificity, the interaction of SBA with both 
GalNH2 and ManNH2 particles were evaluated, and shown in Figure 8.3C. The 
GalNH2 particles show a clear dose-dependent response to the SBA with a low Kd of 
8 nM, whereas the ManNH2 particles do not show a Kd in the concentration range 
tested. Pleasingly, similar results were found for RCA120, (Figure 8.3D) which shows 
lectin selectivity towards galactose terminal glycans. The GalNH2 functional 
particles have a Kd of 17 nM, whereas ManNH2 has a far greater Kd of 61 nM, which 
is to be expected and agrees well with microarray data.33 Dynamic light scattering 
was also employed to ensure that aggregation of the particles was the cause of the 
colour change (rather than just surface-binding or precipitation) (Appendix 6). The 
size changes of the particles were monitored following addition of 85 nM SBA 
resulting in the GalNH2 particles rapidly aggregating (as seen by UV-Vis) but the 
ManNH2 particles showed no changes, confirming specificity of this system which 
should find broad applicability for large-scale screening of carbohydrate-lectin 
interactions and point-of-care biosensors.  
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Figure 8.3: Interaction of GalNH2 and ManNH2 functional AuNPs with SBA. A) 
UV-Vis spectrum of GalNH2-AuNP upon addition of increasing concentrations of 
SBA (0–80 nM) following 30 minutes of incubation; B) Kinetics of AuNP responses 
to SBA by monitoring Abs700 over 30 mins; C) Binding isotherms (at 37 °C) of 
GalNH2 and ManNH2 AuNPs with SBA; D) Binding isotherms (at 37 °C) of GalNH2 
and ManNH2 AuNPs with RCA120. 
 
8.4 Conclusions 
In this work, it is shown that coating AuNPs with carbohydrate-functionalised 
polymers will not always result in a colourimetric assay for lectin binding due to 
hindrance from the polymer coating. It is crucial to ensure that the polymer is 
sufficiently long to endow saline stability for use in biological media, but must be 
balanced against the competing effect that if the polymer is too long, no aggregation 
events occur (in a reasonable time-scale). Using RAFT polymerisation to probe this, 
it was found that glycosylated poly(N-hydroxyethyl acylamides) with a DP above 50 
were unable to generate a response to lectins, even with the correct sugar in place 
due to steric stabilisation. Through an optimisation study, it was found that mixtures 
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of DP10 and DP20 polymers gave rise to stable particles with rapid colourimetric 
responses. These optimised particles were then employed to study the binding 
interactions with three different lectins, including a surrogate for ricin – a biological 
warfare agent and may form the basis of new point-of-care diagnostics, especially 
for low-resource environments.  
 
8.5 Experimental  
8.5.1 Materials  
All chemicals were used as supplied unless otherwise stated. Acetone, 
dichloromethane, toluene, methanol, diethyl ether were purchased from Fischer 
Scientific at laboratory grade.  Dodecane thiol (≥ 98 %), potassium phosphate 
tribasic (≥ 98 %), carbon disulfide (99 %), N-Hydroxethylacrylamide (97 %), 4,4′-
Azobis(4-cyanovaleric acid) (98 %), mesitylene (reagent grade), N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (≥ 98 %) were all 
purchased from Sigma-Aldrich. 2-bromo-2-methylpropionic acid (98 %), 4-
(Dimethylamino)pyridine (99 %), pentafluorophenol (99 %), Triethylamine (99 %) 
were purchased from Acros. Clear, polystyrene, flat-bottom, half-area 96-well 
microtitre plates were purchased from Greiner Bio-one. 10 mmol HEPES buffer 
containing 0.05 M NaCl, 0.1 mM CaCl2 and 0.01 mM MnCl2 (pH 7.5, HEPES) was 
prepared in 200 mL of milliQ water (with a resistance >19 mOhms). 60 nm gold 
nanoparticles were obtained from BBI Solutions. Concanavalin A, Ricinus 
Communis Agglutinin and Soybean Agglutinin were purchased from Vector Labs.  
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8.5.2 Physical and Analytical Methods 
NMR spectra were recorded on Bruker DPX-300 and DPX-400 spectrometers for 1H 
NMR (400 MHz) and 13C NMR (125 MHz). Chemical shifts are reported in ppm 
relative to the deuterated solvent resonances and spectra analysed with WIN-NMR 
software. GPC (DMF) was performed on a Varian 390-LC MDS system equipped 
with a PL-AS RT/MT autosampler, a PL-gel 3 µm (50 × 7.5 mm) guard column, two 
PL-gel 5 µm (300 × 7.5 mm) mixed-D columns equipped with a differential 
refractive index, using DMF (with 1 mg.mL-1 LiBr) as the eluent with a flow rate of 
1.0 mL.min-1 at 50 °C. Narrow molecular weight PMMA standards (200 - 1.0 × 106 
g.mol-1) were used for calibration using a second order polynomial fit. Infrared 
absorption spectra were recorded on a Bruker VECTOR-22 FTIR spectrometer using 
a Golden Gate diamond attenuated total reflection cell. Absorbance measurements 
were recorded on a BioTek SynergyTM multidetection microplate reader using Gen5 
1.11 multiple data collection and analysis software. DLS measurements were carried 
out using a Malvern Instruments Zetasizer Nano-ZS.   
 
8.5.3 Synthetic procedures  
Synthesis of 2-(Dodecylthiocarbonothioylthio)-2-methylpropionic acid (DMP): 
Dodecane thiol (4.00 g, 19.76 mmol) was added dropwise to a stirred suspension of 
K3PO4 (4.20g, 19.76 mmol) in acetone (60 mL) over 25 minutes. CS2 (4.10 g, 53.85 
mmol) was added and the solution turned bright yellow. After stirring for ten 
minutes 2-bromo-2-methylpropionic acid (3.00 g, 17.96 mmol) was added and a 
precipitation of KBr was noted. After stirring for 16 hours, the KBr precipitate was 
removed by filtration and then the solvent was removed under in vacuo and the 
residue was extracted into DCM (2 x 200 mL) from 1 M HCl (200 mL). The organic 
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extracts were washed with water (200 mL) and brine (200 mL) and further dried 
over MgSO4. The solvent was removed under reduced pressure and the residue was 
purified by column chromatography on silica using an eluent comprising 75:24:1 40 
– 60 °C petroleum ether: diethyl ether: acetic acid to yield a bright yellow solid (4.01 
g, 61 %). 
1H NMR (300 MHz, CDCl3) δppm: 3.26 (2H, t, J12-11 = 7.40 Hz, H12); 1.70 (6H, s, 
H13); 1.65 (2H, m, H11); 1.36 (2H, m, H10); 1.23 (16H, br. s, H2-9); 0.86 (3H, t, J1-2 = 
6.5 Hz, H1); 13C NMR (500 MHz, CDCl3) δppm: 220.19 (C13); 177.76 (C16); 54.91 
(C14); 36.46 (C12); 31.31, 29.02, 28.95, 28.84, 28.74, 28.50, 28.36, 22.08 (C2-9 ); 
28.59 (C10); 27.19 (C11); 24.60 (C15); 13.52 (C1); IR ν: 2921 (CH2); 1714 (C=O); 
1070 (S-(C=S)-S) cm-1. 
Synthesis of 2-(Dodecylthiocarbonothioylthio)-2-methylpropionic acid 
pentafluorophenyl ester (PFP-DMP): DMP (0.5 g, 1.37 mmol), N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) (0.39 g, 2.05 
mmol), and 4-(dimethylamino)pyridine (DMAP) (0.25 g, 2.05 mmol) in 40 mL 
DCM was stirred for 20 minutes under N2. Pentafluorophenol (0.78 g, 4.24 mmol) in 
5 mL DCM was added. The reaction was stirred overnight at room temperature. The 
reaction was washed successively with 3 M HCl, 1 M NaHCO3 and 0.5 M NaCl. The 
reaction was then dried over MgSO4, filtered and then concentrated in vacuuo.  
1H NMR (300 MHz, CDCl3) δppm: 3.29 (2H, t, J12-11 = 7.3 Hz, H12); 1.84 (6H, s, H13); 
1.67 (2H, q, J = 7 Hz, H11); 1.37 (2H, m, H10); 1.23 (16H, br. s, H2-9); 0.86 (3H, t, J1-2 
= 6.5 Hz, H1);13C NMR (500 MHz, CDCl3) δppm: 220.19 (C13); 169.77 (C16); 54.91 
(C14); 36.46 (C12); 31.31, 29.02, 28.95, 28.84, 28.74, 28.50, 28.36, 22.08 (C2-9 ); 
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28.59 (C10); 27.19 (C11); 24.60 (C15); 13.52 (C1); IR ν: 2921 (CH2); 1779 
(C6F5C=O);  1070 (S-(C=S)-S) cm-1. 
Polymerisation of hydroxyethylacrylamide using PFP-DMP: In a typical 
reaction, N-Hydroxyethyl acrylamide (HEA) (0.5 g, 4.34 mmol), Pentafluorophenyl 
2-(Dodecylthiocarbonothioylthio)-2-methylpropionic acid (PFP-DMP) (0.115 g, 
0.22 mmol), 4,4′-Azobis(4-cyanovaleric acid) (ACVA) (0.0122 g, 0.043 mmol were 
dissolved in 50:50 Toluene:Methanol (4 mL). Mesitylene (150 µL) was added as an 
internal reference. An aliquot was taken for NMR analysis in CDCl3. The solution 
was degassed under N2 for 30 mins. The reaction was stirred at 70 °C for 90 mins. 
An aliquot was taken for NMR analysis in MeOD. The reaction was rapidly cooled 
in liquid nitrogen and precipitated into diethyl ether. The polymer was reprecipitated 
into diethyl ether from methanol twice to yield a yellow polymer product, which was 
dried under vacuum. 90 % conversion by NMR, Mn (Theoretical) = 2800 g.mol-1 Mn 
(SEC)  = 4100 g.mol-1 Mn/Mw (SEC) = 1.14.  
 
End group modification of PFP-pHEA using mannosamine and galactosamine: 
In a typical reaction, PFP-pHEA (50 mg, 0.018 mmol) and mannosamine (15 mg, 
0.088 mmol) were dissolved in DMF (5 mL) with TEA (0.05 M). The reaction was 
stirred at 50 °C for 16 hrs. The polymer was precipitated into diethyl ether from 
methanol three times and dried under vacuum. IR analysis indicated loss of C=O 
stretch corresponding to the PFP ester.  
 
Gold nanoparticle functionalisation using a mixture of DP10 and DP20 pHEA: 
1 mg of polymer in water (100 µL) was added to 1 mL of 60 nm particles and left for 
30 minutes at room temperature. The particles were centrifuged at 6000 rpm, the 
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supernatant with any unattached polymer was removed and the particles were 
resuspended in water.  
 
Lectin induced aggregation studies by Absorbance: A stock solution of the lectin 
was made up (0.1 mg.mL-1 for Con A and 0.01 mg.mL-1 for SBA) in 10 nM HEPES 
buffer with 0.05 M NaCl, 0.1 mM CaCl2 and 0.01 mM MnCl2. 50 µL serial dilution 
was made up in the same buffer in a 96-well micro-titre plate. 50 µL of the 
glycoAuNP were added to each well. Absorbance at 450 nm and 700 nm was 
measured every minute of 30 minutes at 37 °C. After 30 minutes an absorbance 
spectrum was recorded from 450 nm -700 nm with 10 nm intervals.    
 
Lectin induced aggregation studies by Dynamic Light Scattering (DLS): 300 µL 
of lectin was added to 300 µL of the glycoAuNPs in disposable a low volume plastic 
cuvette. Average diameter measurements were taken every 30 seconds for 1 hour at 
37 °C.   
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Chapter 9 
Glyco-gold nanoparticle libraries for 
label-free, low-cost and high 
throughput evaluation of glycan/lectin 
interactions for affinity measurements 
and ratiometric biosensing 
S-J. Richards, L. Otten and M. I. Gibson, In Preparation 
This chapter consists of a manuscript to be submitted to a peer-reviewed journal. 
Using the optimised polymer linker system from Chapter 8, the natural reactivity of 
reducing sugars towards hydrazide was utilised to obtain carbohydrate functional 
gold nanoparticles for lectin discrimination. A range of monosaccharides were 
conjugated to the polymer linker and these were tested for their interaction 
(determine by a colourimetric response) with a panel of plant lectins. This 
colourimetric response can be determined spectrophotometrically or by simply using 
a digital/mobile phone camera and image analysis software. The statistical technique, 
linear discriminant analysis, was used to differentiate each lectin.  
I carried out all the synthesis, characterisation and testing and Lucienne Otten 
conducted the linear discriminant analysis. I also prepared the manuscript.  
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9.1 Abstract  
Carbohydrate functional gold nanoparticles may find wide applicability as 
biosensors for infectious diseases and biological warfare agents due to their 
characteristic aggregation-induced colour change. Here, the ability to discriminate 
between lectins is determined using simple, natural monosaccharides conjugated to 
gold nanoparticles. It is shown that the colour change in response to correct lectin-
glycan pairings can be determined spectrophotometrically or by using the simple 
combination of a flatbed scanner and image analysis freeware, providing a low cost 
route to investigating protein-carbohydrate interactions for low resource settings. 
These simple, carbohydrate functional gold nanoparticles are powerful tools for 
probing protein-carbohydrate interactions. Excellent separation is observed when 
linear discriminant analysis is used to differentiate the panel of lectins used based on 
the response the glycosylated nanoparticles give.  
 
9.2 Introduction 
Carbohydrates coat most cell types in nature and are involved in a multitude of 
essential biological processes such as cell signalling, cell-cell communication, 
inflammation and fertilisation.1-4 However, bacteria, their toxins and viruses can 
exploit these cell surface oligosaccharides for adhesion to host tissues and is the first 
step in many infectious diseases.4, 5 The proteins that mediate these interactions are 
known as lectins, they interact with carbohydrates non-covalently and reversibly 
with a high level of specificity.6, 7 Protein-monosaccharide interactions are typically 
weak with values for Kd in the range of 10-3-10-6 M. This intrinsically weak affinity 
is circumvented in nature by the involvement of multiple protein-carbohydrate 
interactions leading to the high affinity and specificity, this is known as the ‘cluster 
glycoside effect’, which is regarded as the enhancement in the activity of a 
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multivalent ligand beyond the simple linear sum of the total number of ligands.8, 9 
This simple, but still not fully understood enhancement effect, presents huge 
opportunities in macromolecular and nanoscale science to probe glycan function.4-6, 
10  
The ubiquitous nature of carbohydrate-lectin interactions in infectious 
diseases presents new opportunities in drug design and biosensing. For example, 
urinary tract infections in humans are strongly associated with Escherichia coli 
producing type I mannose specific adhesins.5,11 Pulmonary pathogens such as those 
typically infecting cystic fibrosis (CF) patients such as Pseudomonas aeruginosa 
bind to GalNAcβ1-4Gal residues on lung epithelia.5, 10 The Vibrio cholerae bacteria 
responsible for cholera releases an AB5 toxin (cholera toxin) that binds to galactose 
containing GM1 ganglioside on intestinal epithelial cells.12-14 Ricin is a toxic lectin 
found in castor beans from the plant Ricinus communis, which is lethal and poses a 
potential security threat as a biological warfare agent.15, 16 Also, the nature of cell-
surface carbohydrates can differ considerably between diseased and normal cells.17 
Differences in glycosylation have been detected in many cancer cells and it has been 
suggested that these differences determine the metastatic potential of tumours. 
Unique glycan markers of diseased cells can be exploited for early diagnosis, 
prevention and treatment of illnesses.17 Therefore, rapid detection of various lectin 
types is required, not only for diagnosis but also for developing effective 
therapeutics. However, glycans are inherently complex and it is observed that lectins 
are capable of binding a range of related carbohydrate structures to varying extents, 
further complicating the challenge of assigning protein-carbohydrate interactions.3 
Carbohydrate microarrays have been developed to aid in the identification of 
protein-carbohydrate interactions as new drug targets,18-21 however, they are difficult 
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to construct and require a protein-labelling step which results in heterogeneity, 
synthetic complexity and is not a truly native assay. Therefore the development of 
fast, label-free, easy and inexpensive sensors for the analysis of carbohydrate-protein 
interactions is highly desirable.  The current best methods for this are interferometry, 
quartz crystal microbalance (QCM) and surface plasmon resonance (SPR). However, 
all three of these require infrastructure and their throughput is still relatively low, 
running 10’s of samples per hour typically.22  
Nanoparticle-based materials are attractive alternatives to the fluorescence- 
or radiolabelled protein substrates, owing to their photo-stability, ease of synthesis 
and ability to conjugate to biological molecules. Gold nanoparticles (AuNPs) are 
highly attractive as biosensors, due to exhibiting an intense colour in the visible 
region as a result of collective oscillation of the conduction-band electrons of the 
gold core. Factors affecting the optical properties of nanoparticles include, size and 
shape, degree of aggregation and the dispersion medium.16 Aggregation of AuNPs 
leads to a dramatic colour change from red to blue (dependant upon interparticle 
distance) due to electric dipole-dipole interactions and coupling between the 
plasmons of neighbouring particles resulting in a broadening and a shift to longer 
wavelengths of the surface plasmon absorption band. The colour changes associated 
with AuNP aggregation has been exploited in the development of colourimetric 
assays for biomolecular interactions by utilising AuNPs functionalised with 
biomolecules such as proteins, peptides and DNA.23-27  
Carbohydrate-functionalised AuNPs (glycoAuNPs) are emerging as 
important tools for the colourimetric determination of carbohydrate-protein 
interactions as they constitute a good biomimetic model of carbohydrates at the cell 
surface (glycocalyx). The multivalent presentation of carbohydrates can compensate 
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for the low affinity of individual protein-carbohydrate interactions and the inherent 
multivalency of lectins should lead to an optical response as a result of aggregation if 
the correct lectin-carbohydrate paring is present. GlycoAuNPs have been exploited 
for the detection of lectins,16, 28-30 bacteria31, 32 and influenza.33 Whilst appealing 
scaffolds, glycosylated nanoparticles have intrinsic low colloidal stability, resulting 
in either false-positive aggregation responses or preventing high-throughput 
application. Gibson et al. have recently demonstrated that through precision 
macromolecular engineering using RAFT (reversible addition-fragmentation chain 
transfer) polymerisation it is possible to improve colloidal stability, without 
presenting a steric block to aggregation.30  
 Herein, we describe a polymer-stabilised glycosylated gold nanoparticle 
platform for the high throughput, label-free screening of carbohydrate-lectin 
interactions and demonstrate its potential in glycobiology in a range of assays. A 
mix-and-match synthetic strategy enables huge chemical space to be explored, with 
the outputs being read in a simple multi-well plate format by both a microplate 
reader, or simply using a digital camera. Through the use of a training algorithm, 
with linear discriminant analysis (LDA) it was possible to develop a platform that 
can correctly identify six distinct lectins from an unknown sample based solely on 
colourimetric readouts. 
 
9.2 Results and Discussion 
GlycoAuNPs were prepared using an optimised polymer coating method we 
developed recently that produces particles that are stable at physiological salt 
concentration and gives fast lectin detection.30 Our synthetic methodology was 
designed to enable facile and versatile conjugation of the carbohydrates to the gold 
219 
nanoparticles using native, underivatised carbohydrates, with the aim of 
circumventing the need for ‘click’ type conjugation and the synthetic burden of the 
introduction of alkynes, azides or thiols.34, 35 Scheme 9.1 shows the general method 
employed. N-hydroxyethyl acrylamide (HEA) was polymerised by RAFT 
polymerisation to a targeted degree of polymerisation (DP) of 20, which we have 
previously shown to give the precise balance between colloidal stability and rapid 
sensing (See chapter 8).30 By using a pentafluorophenyl (PFP) containing RAFT 
agent, the produced telechelic polymers had both an amine-reactive ω-terminus (for 
conjugation to sugars) and a protected thiol at the α-terminus for subsequent gold 
particle immobilisation. The PFP functionality is extremely reactive to amines, but 
has good aqueous stability, compared to NHS esters for example.36, 37 Scheme 9.1 
shows the synthetic route to glycosylated AuNPs. The PFP moiety can be used to 
install a hydrazide end group for subsequent amidation with reducing sugars.38 This 
approach enables the introduction of a range of carbohydrates, which facilitates our 
later analysis (vide infra). During carbohydrate coupling, the trithiocarbonate end-
group is aminolysed releasing the thiol enabling coating of 60 nm AuNPs by simple 
mixing. 60 nm particles were chosen, as we have found that smaller particles give 
lower colourimetric responses and lower affinities.32 This post-polymerisation route 
ensures that all the polymers have the same initial chain length distribution and 
therefore reduced the variability between particles, but allows versatile end group 
functionalisation to make libraries of a variety of glycan functional particles.  
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Scheme 9.1: Synthetic routes to carbohydrate functionalised gold nanoparticles. 
The intrinsic reactivity of reducing sugars toward hydrazides to form stable N-
glycoside end-terminated polymers was used. The reaction occurs under mild 
conditions with good conjugation efficiencies. The reducing sugars react with α-
heteroatom nucleophiles (e.g. hydrazide or alkylaminooxy groups) to give mostly 
cyclic pyranosides, but some ring-opened forms will still form, but is reduced by the 
reaction conditions employed.38 AuNPs were functionalised with a library of seven 
monosaccharides, Man, Gal, Glc, ManNAc, GalNAc, GlcNAc and Fuc. A 5 nm 
increase in particle size was noted for each polymer as determined by dynamic light 
scattering (DLS) (Appendix 7) confirming successful functionalisation of the AuNP 
surface, to give a library of seven glycosylated nanoparticles with identical sensory 
cores and hydrodynamic diameters.  
With this library at hand, the evaluation of their interactions with a panel of 
six lectins was taken forward; Concavanalin A (Con A), Ricinus Communis 
Agglutinin (RCA120, which is a non-toxic variant of Ricin), Soybean Agglutinin 
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(SBA), Peanut Agglutinin (PNA), Wheat Germ Agglutinin (WGA) and Ulex 
Europaeus agglutinin (UEA). To assess the binding interaction, the glycosylated 
AuNPs were added to 96-well plate at a concentration of 0.06 M of Au. The 
appropriate lectins were then added as a dilution series into these wells, and 
incubated for 30 minutes. After this time, if binding was occurring the particles will 
crosslink (aggregate) causing a red to blue shift, as shown in the digital photograph 
of an example plate in Figure 9.1A, where high concentrations of lectins cause an 
increasing blue shift. This can be monitored using a UV-Vis microplate reader, to 
give a full spectrum for each sample, Figure 9.1B, which can then be collated to 
visualise the overall change in as shown in Figure 9.1C. For example, the spectra in 
Figure 9.1C1 show a sample that has not interacted with the lectin, but in Figure 
9.1C2 there is a clear dose dependant response. These curves can then be converted 
into binding isotherms, based on the change in absorbance at 700 nm, Figure 9.1D. 
Figure 9.1: Overview of the approach used to allow direct measurement of 
carbohydrate-lectin interactions by monitoring a colourimetric change (red to blue) 
due to aggregation of glycoAuNPs bound to lectins.  
Using the methodology outlined above, the serial dilutions of each lectin with 
each nanoparticle was conducted and analysed. In this set, a total of 336 individual, 
label-free, interaction measurements were conducted (7 sugars, 6 lectins, 8 
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concentrations). Figure 9.2 summarises the data as dose-dependant binding 
isotherms for all of these, by plotting the Abs700 against protein concentration. As 
can clearly be seen, a huge amount of data is readily obtained by this method, which 
would be challenging, expensive and time consuming to extract from SPR type 
methods, for example. 
	  
Figure 9.2: Dose-dependent binding isotherms of Man, Gal, Glc, ManNAc, 
GalNAc, GlcNAc and Fuc functionalised particles with A) Con A B) RCA C) SBA 
D) WGA E) PNA F) UEA. 
	  
To enable these curves to be used to understand their binding interactions, all 
the data were fitted to Hill functions to obtain the apparent dissociation constants 
(Kd) as a measure of the relative affinity of each glycan to the lectin partner. These 
values are summarised in Table 9.1. The selectivity of each lectin for 
monosaccharide agreed well with microarray data from the Consortium for 
Functional Glycomics (CFG) database.39 It is important to highlight that this data 
shows that monosaccharides (and even more complex glycans) do not bind a single 
lectin (and that any given lectin can bind many different carbohydrates) and that it is 
crucial to not study these interactions in isolation, but as a panel of lectins in order to 
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truly probe specificity and affinity. For example, SBA is β-N-acetylgalactosamine 
specific and shows the highest affinity to GalNAc functional particles and Con A is 
α-mannose/α-glucose specific and shows the highest affinity for mannose and UEA 
is fucose specific and interacts highly specifically with fucose and showed 
essentially zero binding to other carbohydrates in the concentration range used here. 
This broad set of data also shows the challenges intrinsic to developing biosensors 
based on glycans, due to their broad binding potential that makes specific ‘lock and 
key’ style interaction challenging. This particular point is addressed later in the 
manuscript.                  
Table 9.1: Dissociation constant (Kd) in nM for each glycoAuNP and lectin 
combination determined by Abs700. 
 
9.2.1 Measuring interactions using a scanned image 
Due to the strong colouration of the gold particle solutions, the colour change upon 
binding is obvious to the naked eye (Figure 9.1A). Previously, we demonstrated that 
citrate stabilised-AuNPs could be used as resolving agents in sorbent assays of 
lectins to carbohydrates by measuring the amount of non-specifically bound gold to 
a lectin bound surface, and that a simple mobile phone camera, and image analysis 
software could be used to measure inhibition.40 Due to the high extinction coefficient 
of AuNPs we employed a similar technique here to determine the degree of 
aggregation and hence affinity from a scanned image of the 96-well plate (Figure 
9.3A) and simple, open access visualisation software, ImageJ to obtain pixel 
 Con A RCA SBA PNA WGA UEA 
Man 20.4 ± 1.6 7.6 ± 2.5 124.5 ± 16.5 57.6 ± 16.3 317.3 ± 16.1 N/A 
Gal 58.7 ± 8.7 7.1 ± 3.3 74.6 ± 4.2 64.2 ± 14.3 319.9 ± 26.4 N/A 
Glc 42.2 ± 3.8 11.7 ± 3.6 42.0 ± 3.7 23.7 ± 19.8 187.7 ± 20.5 N/A 
ManNAc 140.2 ± 22.3 19.0 ± 1.9 92.8 ± 22.7 52.5 ± 11.3 326.2 ± 24.0 N/A 
GalNAc 96.6 ± 11.1 13.4 ± 2.3 18.5 ± 2.4 27.7 ± 14.9 80.1 ± 4.4 N/A 
GlcNAc 52.2 ± 9.0 15.1 ± 1.5 33.7 ± 11.8 26.5 ± 8.8 113.5 ± 4.4 N/A 
Fuc 177.8 ± 33.9 9.2 ± 0.8 N/A N/A 415.6 ± 24.2 100.5 ± 6.9 
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intensity (Figure 9.3B). Figure 9.3C shows the comparison of Kd value determined 
by UV-Vis and by pixel intensity. Figure 9.3D shows the correlation between the 
apparent Kd values determined by the two methods. It shows strong positive 
correlation between the techniques with an R2 value of 0.977, demonstrating that this 
analysis is also possible in laboratories without a microplate reader, or in low 
resource settings. All extracted Kd values are also given in Table 9.2. 
 
Figure 9.3: Direct optical analysis of protein binding. A) Scanned image of 
glycoAuNPs with a dilution series of WGA after 30 minutes. B) Saturation image 
used for pixel intensity measurement (high intensity = red, low intensity = blue). C) 
Comparison of Kd calculated by Abs700 and pixel intensity. D) Correlation between 
Kd values determined by Abs700 and pixel intensity.    
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Table 9.2: Dissociation constant (Kd) in nM for each glycoAuNP and lectin 
combination determined by pixel intensity from a scanned image. 
 Con A RCA SBA WGA UEA 
Man 18.2 ± 1.2 4.7 ± 0.4 97.6 ± 9.1 234.2 ± 18.3 N/A 
Gal 54.4 ± 9.0 1.5 ± 0.1 62.2 ± 22.3 235.9 ± 20.3 N/A 
Glc 36.7 ± 6.9 5.5 ± 1.6 57.4 ± 11.6 157.8 ± 22.0 N/A 
ManNAc 109.4 ± 10.6 16.1 ± 1.5 N/A 265.6 ± 29.6 N/A 
GalNAc 70.1 ± 6.0 7.5 ± 0.4 11.2 ± 0.8 29.8 ± 7.2 N/A 
GlcNAc 49.1 ± 14.1 7.9 ± 0.4 30.5 ± 4.4 91.5 ± 6.8 N/A 
Fuc 169.5 ± 32.9 6.6 ± 0.6 N/A 318.6 ± 39.7 42.6 ± 3.3 
 
9.2.2 Differentiation of lectins 
As a final demonstration of the utility of this methodology, we sought to apply the 
rapid colour change as a versatile lectin discrimination tool, which could be used in 
diagnostics. Due to the relatively low specificities of monosaccharides to lectins 
(compared to complex glycans) glycoconjugates often show a broad range of binding 
affinities to several lectins (as exemplified in Table 9.1, above). However, we have 
previously shown that by replacing a single glycoconjugate, with a panel of them, it 
is possible to use multiplexed (or ratiometric) assays to discriminate between a panel 
of fluorescently labelled Gal-specific lectins as a ‘chemical tongue’, based on the 
differences in relative affinity between sugars. We therefore reasoned that the 
colour-changing assay described here could be extended to a label free, multiplexed 
diagnostic platform. Therefore, a panel of six glyconanoparticles with a range of 
carbohydrates attached, were incubated with our panel of six lectins, and the total 
change in Abs700 recorded, and plotted in Figure 9.4A. As can be clearly seen, any 
individual lectin binds multiple sugars, and vice versa. However, the pattern of 
binding is unique to each lectin. For example, SBA gives a greater response to 
GalNAc particles than ManNAc particles whereas Con A gives a greater response to 
ManNAc than GalNAc. We can mathematically express these differences using 
linear discriminant analysis (LDA), which is a statistical approached used to separate 
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two or more classes of objects. LDA takes an input training matrix of the initial 
particles bound to the different glyconanoparticles (the data displayed in Figure 
9.4A) and generates distinct binding profiles for all the lectins with maximum 
separation between groups in order to generate a robust model for identifying 
unknown lectin samples without any fluorescent labels (Figure 9.4B).  
 
Figure 9.4: Lectin Discrimination A) Absorbance at 700 nm of Man, Gal, Glc, 
ManNAc, GalNAc, GlcNAc and Fuc functionalised particles with 6.25 µg.mL-1 Con 
A, RCA, SBA, WGA, PNA, UEA. Each is the average of 5 measurements. B) Linear 
Discriminant plot showing excellent segregation between lectins. The centres of the 
ellipses represent the mean values of that class and the boundaries of the ellipses are 
one standard deviation from the mean. 
	  
Figure 9.4B clearly shows that excellent segregation between each lectin is achieved. 
Using a leave one out approach, where a model is produced from the rest of the data, 
all lectins can be correctly identified with a high level of confidence. The minimum 
variables required to correctly predict the lectins can be determined. In this instance, 
there are a number of two glycoAuNP pairings that will correctly predict all the 
lectins, including Man and GalNAc or GlcNAc and GalNAc, however the certainty 
decreases with fewer variables. This glycoAuNP technique therefore constitutes a 
robust and versatile platform for investigating carbohydrate-protein interactions and 
can also be used to identify lectin samples.  
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9.4 Conclusion  
We have developed a high throughput screening technique based on the 
colourimetric response of glycoAuNPs in response to a panel of plant lectins. A 
facile conjugation route is used that allows for the incorporation of any reducing 
sugar onto polymer-stabilised AuNPs. The lectin-induced colourimetric response of 
these glycoAuNPs can be determined spectrophotometrically or by the simple 
combination of a flatbed scanner and image analysis software. Good correlation 
between the values determined by the two techniques suggests that this could be a 
low cost/low-tech route to the discrimination between lectins.  Excellent separation 
between all the lectins testing was achieved using LDA, allowing successful 
differentiation of all the lectins using only simple monosaccharide functionalities.  
 
9.5 Experimental Section 
9.5.1 Materials 
All chemicals were used as supplied unless otherwise stated. Acetone, 
dichloromethane, toluene, methanol, diethyl ether and dimethylformamide were 
purchased from Fischer Scientific at laboratory grade. 2-
(Dodecylthiocarbonothioylthio)-2-methylpropionic acid pentafluorophenyl ester, 
(PFP-DMP) was synthesised as previously described (See Chapter 8),30 N-
Hydroxethylacrylamide (97 %), 4,4′-Azobis(4-cyanovaleric acid) (98 %), mesitylene 
(reagent grade), N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (≥ 
98 %), hydrazine hydrate solution (78-82 %) D-(+)mannose, α-D-glucose, D-
(+)galactose, D-galactosamine hydrochloride (98 %), D-mannosamine hydrochloride 
(98 %), D-glucosamine hydrochloride (< 98 %) and N-acetyl-D-mannosamine were 
228 
all purchased from Sigma-Aldrich. 2-bromo-2-methylpropionic acid (98 %), 4-
(Dimethylamino)pyridine (99 %), pentafluorophenol (99 %), Triethylamine (99 %) 
were purchased from Acros. Low bind, low volume, clear, flat bottom, microtitre 
plates were purchased from Greiner Bio-one. N-acetylgalactosamine, N-
acetylglucosamine and fucose were purchased from Carbosynth. 10 mmol HEPES 
buﬀer containing 0.05 M NaCl, 0.1 mM CaCl2 and 0.01 mM MnCl2 (pH 7.5, 
HEPES) was prepared in 200 mL of milliQ water (with a resistance >19 mOhms). 60 
nm gold nanoparticles were obtained from BBI Solutions. Concanavalin A, Soybean 
Agglutinin, Ricinus Communis Agglutinin, Peanut Agglutinin, Wheat Germ 
Agglutinin and Ulex Europeaus Agglutinin were purchased from Vector Labs. 
9.5.2 Physical and Analytical Methods 
NMR spectra were recorded on Bruker DPX-300 and DPX-400 spectrometers for 1H 
NMR (400 MHz) and 13C NMR (125 MHz). Chemical shifts are reported in ppm 
relative to the deuterated solvent resonances and spectra analysed with WIN-NMR 
software. GPC (DMF) was performed on a Varian 390-LC MDS system equipped 
with a PL-AS RT/MT autosampler, a PL-gel 3 µm (50 × 7.5 mm) guard column, two 
PL-gel 5 µm (300 × 7.5 mm) mixed-D columns equipped with a differential 
refractive index, using DMF (with 1 mg.mL-1 LiBr) as the eluent with a flow rate of 
1.0 mL.min-1 at 50 °C. Narrow molecular weight PMMA standards (200 - 1.0 × 106 
g.mol-1) were used for calibration using a second order polynomial fit. Infrared 
absorption spectra were recorded on a Bruker VECTOR-22 FTIR spectrometer using 
a Golden Gate diamond attenuated total reflection cell. Absorbance measurements 
were recorded on a BioTek SynergyTM multidetection microplate reader using Gen5 
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1.11 multiple data collection and analysis software. DLS measurements were carried 
out using a Malvern Instruments Zetasizer Nano-ZS.   
9.5.3 Synthetic procedures 
Polymerisation of hydroxyethylacrylamide using PFP-DMP DP20: 
Hydroxyethylacrylamide (HEA) (0.5 g, 4.34 mmol), Pentafluorophenyl 2-
(Dodecylthiocarbonothioylthio)-2-methylpropionic acid (PFP-DMP) (0.115 g, 0.22 
mmol), 4,4′-Azobis(4-cyanovaleric acid) (ACVA) (0.0122 g, 0.043 mmol were 
dissolved in 50:50 Toluene:Methanol (4 mL). Mesitylene (150 µL) was added as an 
internal reference. An aliquot was taken for NMR analysis in CDCl3. The solution 
was degassed under N2 for 30 mins. The reaction was stirred at 70 °C for 90 mins. 
An aliquot was taken for NMR analysis in MeOD. The reaction was rapidly cooled 
in liquid nitrogen and precipitated into diethyl ether. The polymer was reprecipitated 
into diethyl ether from methanol twice to yield a yellow polymer product, which was 
dried under vacuum. 90 % conversion by NMR, Mn (Theoretical) = 2800 g.mol-1 Mn 
(SEC)  = 4100 g.mol-1 Mw/Mn (SEC) = 1.14.  
 
 
End group modification of PFP-poly(hydroxyethylacrylamide) using hydrazine: 
PFP-pHEA (500 mg, 0.18 mmol), hydrazine (50 µL 1.5 mmol) were dissolved in 5 
mL DMF. The reaction was stirred at 50 °C for 16 hrs. The polymer was precipitated 
into diethyl ether from methanol three times and dried under vacuum. IR indicated 
loss of C=O stretch corresponding to the PFP ester.  
 
Carbohydrate functionalisation of hydrazide-pHEA: In a typical reaction, 
hydrazide-pHEA (10 mg, 0.0043 mmol), reducing sugar (3 mg) in 1 mL 100 mM 
acetate containing 1 mM aniline. Left at 50 °C over night. Employed immediately 
for goldnanoparticle functionalisation 
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Gold nanoparticle functionalisation using a carbohydrate terminated pHEA:  
1 mg of polymer in 100 µL water was added to 1 mL of 60 nm particles (OD600 = 1, 
0.288 mM Au) and left for 30 minutes at room temperature. Following incubation 
the particles were centrifuged at 6000 rpm, the supernatant was removed along with 
any unattached polymer, the particle were then resuspended in water.  
 
Particle size determination by Dynamic Light Scattering (DLS): 400 µL of 
glycoAuNPs in a disposable low volume cuvette. 3 measurements comprised of 10 
runs were made of each sample at 25 °C.  Average size and distribution were 
recorded.  
 
Lectin induced aggregation studies by Absorbance: A 0.1 mg.mL-1 stock solution 
of the lectin was made in 10 nM HEPES buffer with 0.05 M NaCl, 0.1 mM CaCl2 
and 0.01 mM MnCl2. 25 µL serial dilution was made up in the same buffer in a 96-
well micro-titre plate. 25 µL of the glycoAuNP were added to each well. After 30 
minutes an absorbance spectrum was recorded from 450 nm -700 nm with 10 nm 
intervals.   
The plates were then scanned using a canon flatbed scanner, the images were 
converted to a HSB stack and the saturation image was used for tiff image file 
uploaded into the open- source image processing package ImageJ (version 1.46a) 
where a region of interest was drawn around every well. The colour (RGB) image 
was then converted into a hue saturation and brightness (HSB) stack of images and 
the saturation image used. The regions of interest drawn on the original image were 
added to the saturation image using the ROI manager and average pixel intensity in 
each region of interest was measured using an inbuilt function in ImageJ. 
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A fixed concentration of 6.25 µg.mL-1 lectin was added to glycoAuNPs. 5 repeats 
were made for each carbohydrate functionalised particle and the absorbance at 450 
nm and 750 nm were recorded for linear discriminant analysis.  
 
Linear discriminant analysis: Every lectin was added to every surface as described 
in the lectin binding assay section. This was repeated 5 times to generate a training 
data matrix of 6 particles x 6 lectins x 5 replicates, which was then subjected to a 
classical linear discriminant analysis (LDA) in R (version 2.14.1). 
 
9.6 References 
 
1. C. R. Bertozzi and L. L. Kiessling, Science, 2001, 291, 2357-2364. 
2. L. L. Kiessling, J. E. Gestwicki and L. E. Strong, Angew. Chem. Int. Ed., 
2006, 45, 2348-2368. 
3. K. T. Pilobello and L. K. Mahal, Curr. Opin. Chem. Biol., 2007, 11, 300-305. 
4. N. Sharon, Biochim. Biophys. Acta, 2006, 1760, 527-537. 
5. R. J. Pieters, Org. Biomol. Chem., 2009, 7, 2013-2025. 
6. M. Ambrosi, N. R. Cameron and B. G. Davis, Org. Bio. Chem., 2005, 3, 
1593-1608. 
7. H. Feinberg, D. A. Mitchell, K. Drickamer and W. I. Weis, Science, 2001, 
294, 2163-2166. 
8. Y. C. Lee, R. R. Townsend, M. R. Hardy, J. Lonngren, J. Arnarp, M. 
Haraldsson and H. Lonn, J. Biol. Chem., 1983, 258, 199-202. 
9. J. J. Lundquist and E. J. Toone, Chem. Rev., 2002, 102, 555-578. 
10. N. P. Pera and R. J. Pieters, Med. Chem. Comm., 2014, 5, 1027-1035. 
11. M. Hartmann and T. K. Lindhorst, Eur. J. Org. Chem., 2011, 3583-3609. 
232 
12. T. R. Branson and W. B. Turnbull, Chem. Soc. Rev., 2013, 42, 4613-4622.
13. M. W. Jones, S. J. Richards, D. M. Haddleton and M. I. Gibson, Polym.
Chem., 2013, 4, 717-723.
14. S.-J. Richards, M. W. Jones, M. Hunaban, D. M. Haddleton and M. I.
Gibson, Angew. Chem. Int. Ed., 2012, 51, 7812-7816.
15. M. Fais, R. Karamanska, S. Allman, S. A. Fairhurst, P. Innocenti, A. J.
Fairbanks, T. J. Donohoe, B. G. Davis, D. A. Russell and R. A. Field, Chem.
Sci., 2011, 2, 1952-1959.
16. C. L. Schofield, B. Mukhopadhyay, S. M. Hardy, M. B. McDonnell, R. A.
Field and D. A. Russell, Analyst, 2008, 133, 626-634.
17. M. C. Galan, D. Benito-Alifonso and G. M. Watt, Org. Biomol. Chem., 2011,
9, 3598-3610.
18. J. Hirabayashi, M. Yamada, A. Kuno and H. Tateno, Chem. Soc. Rev., 2013,
42, 4443-4458.
19. P. H. Seeberger and D. B. Werz, Nature, 2007, 446, 1046-1051.
20. S. Park, J. C. Gildersleeve, O. Blixt and I. Shin, Chem. Soc. Rev., 2013, 42,
4310-4326.
21. D. N. Wang, S. Y. Liu, B. J. Trummer, C. Deng and A. L. Wang, Nat.
Biotechnol., 2002, 20, 275-281.
22. G. Safina, Anal. Chim. Acta, 2012, 712, 9-29.
23. J. E. Ghadiali and M. M. Stevens, Adv. Mater., 2008, 20, 4359-4363.
24. A. Laromaine, L. L. Koh, M. Murugesan, R. V. Ulijn and M. M. Stevens, J.
Am. Chem. Soc., 2007, 129, 4156-4157.
25. A. J. Haes, L. Chang, W. L. Klein and R. P. Van Duyne, J. Am. Chem. Soc.,
2005, 127, 2264-2271.
233 
26. R. Elghanian, J. J. Storhoff, R. C. Mucic, R. L. Letsinger and C. A. Mirkin,
Science, 1997, 277, 1078-1081.
27. P. Englebienne, Analyst, 1998, 123, 1599-1603.
28. C. C. Lin, Y. C. Yeh, C. Y. Yang, G. F. Chen, Y. C. Chen, Y. C. Wu and C.
C. Chen, Chem. Commun., 2003, 2920-2921.
29. H. S. N. Jayawardena, X. Wang and M. Yan, Anal. Chem., 2013, 85, 10277-
10281. 
30. S.-J. Richards and M. I. Gibson, ACS, ACS Macro Lett., 2014, vol. 3, pp.
1004-1008.
31. C. C. Lin, Y. C. Yeh, C. Y. Yang, C. L. Chen, G. F. Chen, C. C. Chen and Y.
C. Wu, J. Am. Chem. Soc., 2002, 124, 3508-3509.
32. S.-J. Richards, E. Fullam, G. S. Besra and M. I. Gibson, J. Mater. Chem. B,
2014, 2, 1490-1498.
33. M. J. Marin, A. Rashid, M. Rejzek, S. A. Fairhurst, S. A. Wharton, S. R.
Martin, J. W. McCauley, T. Wileman, R. A. Field and D. A. Russell, Org.
Biomol. Chem., 2013, 11, 7101-7107.
34. A. Dondoni, Chem. Asian J., 2007, 2, 700-708.
35. A. Dondoni and A. Marra, Chem. Soc. Rev., 2012, 41, 573-586.
36. M. Eberhardt, R. Mruk, R. Zentel and P. Theato, Eur. Polym. J., 2005, 41,
1569-1575.
37. P. Theato, J. Polym. Sci. A Polym. Chem., 2008, 46, 6677-6687.
38. K. Godula and C. R. Bertozzi, J. Am. Chem. Soc., 2010, 132, 9963-9965.
39. CFG, http://www.functionalglycomics.org.
40. L. Otten, S.-J. Richards, E. Fullam, G. S. Besra and M. I. Gibson, J. Mater.
Chem. B, 2013, 1, 2665-2672.
234 
Chapter 10 
Conclusions 
Glycopolymers with high selectivity may feature in the development of sensitive and 
precise sensors or anti-adhesive therapies, which has so far limited the application of 
synthetic glycopolymers. In this work, it is shown that combining structural biology 
tools with macromolecular chemistry enables the creation of synthetic glycopolymers 
that can mimic glycan architecture without the need for multi-step oligosaccharide 
synthesis, could find applications in anti-adhesive therapy and biomolecular sensors.  
A series of glycopolymers with varying saccharide density, linker length, and 
chain length were synthesised by a variety of tandem post-polymerisation 
modification techniques. These techniques enable precise control over not only chain 
length (and hence valency), but also carbohydrate-polymer backbone linker distance 
and the introduction of secondary binding (branched) motifs onto the linker. Firstly, a 
combination of active esters and alkyne-azide chemistry was used to install variable 
linkers lengths and carbohydrate density onto a polymer backbone. It was shown that 
a longer linker resulted in increased inhibition of the B subunit of the cholera toxin 
(CTxB), which is attributed to the depth of the binding pocket. 
Secondly, the versatility of poly(azlactone)s as a scaffold for both direct, and 
tandem, post-polymerisation modification was explored. In particular, the 100 % atom 
efficiency and the ability to conduct polymerisation and functionalisation in a one-
pot, two-step process are highly favourable. Glycopolymers synthesised using this 
method showed good inhibitory activity towards CTxB due to the increased linker 
length. 
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To mimic the branched structure of the nature CTxB ligand GM1, a new, three-
step, tandem post-polymerisation methodology was developed. Sequential variation 
of this branched motif was found to dramatically alter both the affinity and the 
selectivity of the glycopolymers towards two lectins; CTxB and PNA.  
These measurements demonstrated that in the design of biomimetic 
macromolecules for anti-adhesion or other therapeutic applications, structural 
biological information must be considered, in conjunction with using the relevant 
assays. Therefore, methods to determine the inhibitory activity were compared. It was 
found that glycopolymers that are sufficiently large to span binding sites, lead to the 
highest activity in a fluorescent-linked sorbent assay (FLSA) however, as a result of 
spanning binding sites, these glycopolymers actually showed the least total mass 
binding by quartz crystal microbalance (QCM), which was determined to be due to 
the formation of a flat film, rather than extended brush structures that are seen for 
short polymers. Hence, when screening multivalent glycopolymers, single-
concentration measurements are unlikely to reveal the highest affinity binders. 
Therefore, the assays most relevant to the intended application must be used, 
preferably in combination with others to fully assign the mode of action.  
Techniques to investigate protein-carbohydrate interactions can require highly 
expensive, sophisticated equipment. In this work, citrate-coated AuNPs were used as 
resolving agents to analyse protein binding to surfaces, as a low-cost, accurate 
glycomics tool. A strong correlation was found between the AuNP method and more 
traditional fluorescence techniques; with the AuNP method having the advantage that 
it does not require labelled proteins. Due to the high extinction coefficient (hence high 
colouration) of the AuNP resolved surfaces, it was possible to simply use a digital 
camera to image the microplates combined with image analysis software to extract 
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binding isotherms, which showed strong correlation to those obtained by fluorescence 
or absorbance measurements. This presents the opportunity to use AuNP resolving 
agents for label free, low cost, high-throughput evaluation of carbohydrate-protein 
interactions that may have diagnostic or screening applications.  
 
Due to the threat of antibiotic resistance, it is important that the limited arsenal of 
antibiotics left to use are administered correctly. In this work, a sensitive and rapid 
colourimetric bioassay for the quantitative detection of lectins and type 1 fimbriated 
bacteria based upon the binding of glycosylated gold nanoparticles (glycoAuNPs) was 
developed. AuNPs with carbohydrates directly immobilised on their surface showed 
very rapid responses to both lectins and lectin-expressing bacteria. However, these 
particles also displayed low saline stability and nonspecific interactions with the 
bacteria limiting their discriminatory capacity. To overcome this a PEG layer was 
inserted between the particles and the carbohydrate. This dramatically increased the 
saline stability of particles. However, these particles took far longer to lectins no red 
to blue colour change was observed upon lectin binding, which was hypothesised to 
be due to steric shielding effects of the PEG layer.  
Therefore, through an optimisation study, the correct length of polymer to 
stabilise particles but also give rapid colourimetric response was determined. It was 
found crucial to ensure that the polymer is sufficiently long to endow saline stability 
for use in biological media, but must be balanced against the competing effect that if 
the polymer is too long, no aggregation events occur (in a reasonable time-scale). 
These optimised particles were then employed to study the binding interactions with 
three different lectins, including a surrogate for ricin – a biological warfare agent and 
may form the basis of new point-of-care diagnostics, especially for low-resource 
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environments.  It was also noted that the lectin-induced colourimetric response of 
these glycoAuNPs could be determined by the simple combination of a flatbed 
scanner and image analysis software. Good correlation between the values determined 
by the two techniques suggests that this could be a low cost/low-tech route to the 
discrimination between lectins.  Excellent separation between all the lectins testing 
was achieved using linear discriminant analysis (LDA), allowing successful 
differentiation of all the lectins using only simple monosaccharide functionalities.  
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Appendix 1 
Supplementary Information: Chapter 2 
 
Synthesis of 1-Azido-1-deoxy-β-D-galactopyranoside 
Stereopure GalN3 was synthesis by displacement of the corresponding anomeric 
bromide with sodium azide. Stereochemistry of each product was confirmed by 
NMR spectroscopy based on the H1-H2 coupling constants.  
 
 
 δppm 1H δppm 13C H1 – H2 coupling 
(Hz) 
Assignment 
Ac4GalBr 6.65 88.2 4.0 α 
Ac4GalN3 4.60 88.3 8.8 β 
GalN3 4.50 90.5 8.5 β 
Table S1.1: Characterisation of the anomeric stereochemistry of GalN3.  
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Synthesis of Alkyne 2 linker. 
The synthetic method is summarised in Scheme S2. 2-(2-Boc-aminoethoxy)ethanol1 
and Tert-butyl 2-(2-(prop-2-ynyloxy)ethoxy)ethylcarbamate2 were synthesised 
according to literature methods. 
 
 
Scheme S1.1: Amino-functionalised alkynes employed in this study. 
 
Alkyne Functional Polymers: 
Characterisation of the intermediate scaffolds obtained by aminolysis of 
poly(pentafluorophenylmethacrylate) are shown in Table 2.1 (Chapter 2). These 
were used to obtain the glycopolymers shown in Table S2, main text.  
 
Table S1.1: Alkyne/hydropropylamine copolymers. 
Polymer Mol % 
Alkyne 1(a) 
Mol % 
Alkyne 2(a) 
Mol % 
HOPrNH2(a) 
Mn(b) Mw/Mnb) 
P4 100 - - 6100 1.24 
P5 100 - - 7000 1.21 
P6 100 - - 9000 1.17 
P7 - 100 - 10800 1.29 
P8 - 100 - 12700 1.22 
P9 - 100 - 13500 1.24 
P10 - 50 50 10800 1.20 
P11 - 25 75 10700 1.21 
P12 - 10 90 10600 1.23 
(a) Determined by feed ratio of each amine; (b) Determined by SEC in DMF verses 
PMMA standards. HOPrNH2 = hydroxypropylamine. 
 
 241 
Over the course of the tandem post-polymerization process, there was no evidence of 
fractionation, and all the polymers obtained were well defined with dispersities 
below 1.3. Example SEC data showing a series of modifications are shown in Figure 
S1. It should be noted that due to the differential solubility of each polymer used, it 
was not possible to use a single SEC eluent system for all polymers. 
 
 
Figure S1.1. Molecular weight distributions obtained by SEC showing tandem-
modification procedure.  
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Fluorescence-linked sorbent assay for inhibitory activity. 
Figure S1.2. Inhibitory curve for GP1 – 6 against cholera toxin B-subunit. 
References 
1. R. B. Greenwald, Y. H. Choe, C. D. Conover, K. Shum, D. Wu, M. Royzen,
J. Med. Chem. 2000, 43, 475
2. S.-Y. Chang, S. J. Bae, M. Y. Lee, S.-H. Baek, S. Chang, S. H. Kim, Bioorg.
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Additional Characterisation 
N-(2-methyl-1-oxo-1-(prop-2-ynylamino)propan-2-yl)acrylamide 
Figure S2.1: IR spectra of VDMA before (blue) and after (red) reaction with 
propargyl amine 
 244 
Figure S2.2: NMR analysis of the ring opened product upon treatment of VDMA 
with propargyl amine. 
 
N-(1-(allylamino)-2-methyl-1-oxopropan-2-yl)acrylamide 
 
 
Figure S2.3: IR spectra of VDMA before (blue) and after (red) reaction with allyl 
amine 
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Figure S2.4: IR and NMR analysis of the ring opened product upon treatment of 
VDMA with allyl amine. 
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Propargyl Amine Modification of PVDMA 
 
 
Figure S2.5: 1H NMR analysis of the post polymerisation modification of PVDMA 
with propargyl amine. 
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Allyl Amine Modification of PVDMA 
 
 
 
 
Figure S2.6: IR and SEC analysis of the post polymerisation modification of 
PVDMA with allyl amine. 
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Figure S2.7: 1H NMR analysis of the post polymerisation modification of PVDMA 
with propargyl amine. 
 
 
Tyramine Modification of PVDMA 
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Figure S2.8: IR and SEC analysis of the post polymerisation modification of 
PVDMA with tyramine. 
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Figure S2.9: 1H NMR analysis of the post polymerisation modification of PVDMA 
with tyramine. 
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Furfuryl amine modification of PVDMA 
Figure S2.10: IR and SEC analysis of the post polymerisation modification of 
PVDMA with furfurylamine. 
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Figure S2.11: 1H NMR analysis of the post polymerisation modification of PVDMA 
with furfuryl amine. 
 
 
Glucosamine modified PVDMA 
4.5 mL of the crude PVDMA solution (containing 10.8 mmol of azlactone 
functionality) was added to a round-bottomed flask and diluted with 5 mL of DMSO. 
Glucosamine hydrochloride (3.487 g, 16.2 mmol) was added to the polymer solution 
in 10 mL of DMSO, along with triethylamine (1.63 g, 16.2 mmol) and the solution 
allowed to stir at room temperature overnight. Volatiles were then removed and the 
crude polymer solution diluted with water and dialysed against water (MWCO 1000 
Da) for 3 days to remove low molecular weight species. The water was removed by 
lyophilisation to yield the product as a white fluffy powder. 
Infra-red analysis of the obtained polymer showed complete disappearance of the 
signals corresponding to the azlactone ring, along with the appearance of a strong 
signal corresponding to the two amide moieties generated upon ring opening. SEC 
analysis revealed a clear mass increase upon ring opening with glucosamine. SEC 
Analysis (Aqueous) – Mn 11,900 gmol-1, PDi 1.40. 
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Figure S2.12: IR and SEC analysis of the post polymerisation modification of 
PVDMA with glucosamine. 
 
Galactosamine modified PVDMA 
4.5 mL of the crude PVDMA solution (containing 10.8 mmol of azlactone 
functionality) was added to a round-bottomed flask and diluted with 5 mL of DMSO. 
Galactosamine hydrochloride (3.487 g, 16.2 mmol) was added to the polymer 
solution in 10 mL of DMSO, along with triethylamine (1.63 g, 16.2 mmol) and the 
solution allowed to stir at room temperature overnight. Volatiles were then removed 
and the crude polymer solution diluted with water and dialysed against water 
(MWCO 1000 Da) for 3 days to remove low molecular weight species. The water 
was removed by lyophilisation to yield the product as a white fluffy powder. 
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Infra-red analysis of the obtained polymer showed complete disappearance of the 
signals corresponding to the azlactone ring, along with the appearance of a strong 
signal corresponding to the two amide moieties generated upon ring opening. SEC 
analysis revealed a clear mass increase upon ring opening with galactosamine, and a 
well-defined final polymer observed. SEC Analysis (Aqueous) – Mn = 11,400 gmol-
1, Đ = 1.44. 
 
 
Figure S2.13: IR and SEC analysis of the post polymerisation modification of 
PVDMA with galactosamine. 
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Mannosamine modified PVDMA 
4.5 mL of the crude PVDMA solution (containing 10.8 mmol of azlactone 
functionality) was added to a round-bottomed flask and diluted with 5 mL of DMSO. 
Mannosamine hydrochloride (3.487 g, 16.2 mmol) was added to the polymer 
solution in 10 mL of DMSO, along with triethylamine (1.63 g, 16.2 mmol) and the 
solution allowed to stir at room temperature overnight. Volatiles were then removed 
and the crude polymer solution diluted with water and dialysed against water 
(MWCO 1000 Da) for 3 days to remove low molecular weight species. The water 
was removed by lyophilisation to yield the product as a white fluffy powder. 
Infra-red analysis of the obtained polymer showed complete disappearance of the 
signals corresponding to the azlactone ring, along with the appearance of a strong 
signal corresponding to the two amide moieties generated upon ring opening. SEC 
analysis revealed a clear mass increase upon ring opening with mannosamine, and a 
well-defined final polymer observed. SEC Analysis (Aqueous) – Mn = 11,600 gmol-
1, Đ = 1.42. 
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Figure S2.14: IR and SEC analysis of the post polymerisation modification of 
PVDMA with mannosamine. 
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Hydrolysis of PVDMA 
 
Scheme S2.1: Ring opening of PVDMA with NaOH (red) and methanol (blue) to 
yield acid- and ester-functional polymers respectively. 
 
 
Figure S2.15: IR analysis of the products obtained from ring opening of PVDMA 
with NaOH (red trace) and methanol (blue trace). The acid functional polymer 
showed a clear signal at around 1644 cm-1, with the ester functional polymer 
displaying a signal at 1726 cm-1 
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Visualisation of protein structures 
Image of one subunit of 2CHB (Merritt, E.A., Sarfaty, S., Jobling, M.G., Chang, T., 
Holmes, R.K., Hirst, T.R., Hol, W.G. (1997) Structural studies of receptor binding 
by cholera toxin mutants Protein Science 6: 1516-1528) created with CCP4mg 
(McNicholas, S., Potterton, E., Wilson, K.S., Noble, M.E.M (2011) Presenting your 
structures: the CCP4mg molecular graphics software Acta Cryst. 67: 386-394). 
Glycan Notation and Microarray Analysis 
Table S3.1. A table of the symbols representing sugar stereochemistries. All 
symbols as described by the consortium for functional glycomics. 
Sugars Hexoses N-acetylhexosamines Hexosamines 
Galactose 
Glucose 
Mannose 
Fucose N/A N/A 
Xylose N/A N/A 
Acidic sugars Symbol 
NeuAc 
NeuGc 
KDN 
GlcA 
IdoA 
GalA 
ManA 
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To investigate the relative importance of glycan branching and secondary binding 
site interactions, microarray data for two galactose-binding proteins was extracted 
from the Consortium for Functional Glycomics database. Figure S1 shows the 
affinity of 5 sequentially modified carbohydrates to both peanut agglutinin (PNA) 
and cholera toxin (CTx). Upon changing from Gal (1) to GalNAc (2) there was no 
significant difference in lectin affinity for PNA or CTx. However, when Gal(β1-
4)GalNAc (3) is used PNA’s affinity is significantly increased compared to CTx, 
highlighting that connectivity and presentation of the sugars is crucial. Addition of a 
neuraminic acid branch (4) leads to a 200-fold increase in CTx binding, but has little 
influence on PNA binding. This is despite the neuaminic acid (5) alone having 
negligible CTx affinity. The increased binding affinity of CTx to (4) is attributable to 
allosteric interactions of the neuraminic with a secondary binding pocket within 
CTx. While not intended as a complete bioinformatic study, this limited set of 
glycans demonstrate that controlled branching can improve specific and affinity of 
glycans by several orders of magnitude, which is more than observed by 
multivalency alone in many cases. 
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Figure S3.1: Glycan Microarray analysis of galactose-terminated glycans with PNA 
and CTx lectins taken from the CFG database (values were taken for the assay 
performed with 10 µg of each lectin). 
 
 
Figure S3.2: First order kinetic plot for the polymerisation of glycidyl methacrylate 
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Figure S3.3: Molecular weight distribution curve of poly(glycidyl methacrylate) 
after 6 hour polymerisation time. 
 
 
Figure S3.4: Molecular weight distribution curve of poly(2-hydroxy-3-azidopropyl 
methacrylate). 
2 3 4 5 6 7
0.0
0.2
0.4
0.6
0.8
1.0
 
 
dw
/d
(lo
g 
M
w
)
log Mw
3 4 5 6 7
0.0
0.1
0.2
0.3
0.4
0.5
0.6
 
 
dw
/d
(lo
g 
M
w
)
Log Mw
 262 
 
Figure S3.5: Infrared spectra of poly(glycidyl methacrylate), (1), and poly(2-
hydroxy-3-azidopropyl methacrylate), (2). 
Example: Modification of (2) with acid chlorides 
Polymer (2) was modified with a series of commercially available acid chlorides and 
the reaction monitored by IR spectroscopy. 
 
Figure S3.6. Infrared spectra of poly(2-hydroxy-3-azidopropyl methacrylate), (2), 
and following modification with benzoyl chloride (3). 
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Example: Reaction of (3) with β-D-1-propargyl galactose 
 
 
Figure S3.7: Infrared spectra of azide-functional polymer (3) and following 1,3-
dipolar cycloaddition reaction with β-D-1-propargyl galactose (13). 
 
1H NMR analysis of Post-Polymerisation Modification 
The synthetic route employed to obtain the library of polymers was designed to 
enable each reaction step to be monitored by IR-spectroscopy by the 
appearance/disappearance of diagnostic peaks, rather than NMR in which there are 
many overlapping peaks. Potential side reactions (such as the ester linkage being 
broken into carboxylic acid) would also be visible in IR. To demonstrate the 
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successfully installation of the azide and carbohydrate groups, representative 1H 
NMR spectra are shown below. The functional polymers obtained here generally 
displayed low solubility in most solvents (biochemical assays were undertaken < 1 
mg.mL-1). This complicated analysis as DMSO obscured several peaks of interest, 
and the intensity was rather low.  
 
Figure S3.8:  1H NMR analysis of representative polymers showing the successful 
installation of azide and carbohydrate groups. 
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Lectin Binding to Galactocerebroside Surface 
Binding of each of the lectins to the galactocerebroside-functionalised surface was 
confirmed by measuring the fluorescence after incubation with a serial dilution of 
each lectin (Figure S28). As expected, greater binding (higher fluorescence) was 
observed with increasing lectin concentration.  
 
Figure S3.9: Binding curve of a serial dilution of PNA and CTx to a surface 
functionalised with 0.1 mg/ml of galactocerebroside. 
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Example glycopolymer inhibition curves 
As anticipated, addition of the secondary binding motifs had a dramatic influence on 
the inhibitory potential of the glycopolymers. Figure S28 shows example inhibition 
curves for 3 glycopolymers P1, P5 and P9 against PNA. Addition of 4-chlorobenzyl 
(P5) lead to a dramatic reduction in binding activity with the MIC50 value increasing 
by a factor of 5. Conversely, introduction of a methyl group (P9) greatly enhanced 
inhibitory activity, with the MIC50 decreasing by 10-fold.   
Figure S3.10: Example inhibition curves against PNA. Each point represents the 
average of 3 fluorescence measurements and the dotted line represents the line of 
best fit.  
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Correlation between Inhibition and Partition Coefficient 
In small molecule drug design the partition coefficient, which is a measure of 
hydrophobicity is often used to assign hydrophobic interactions or to predict 
pharmacokinetics. The partition coefficient of a single repeat unit of each polymer 
was plotted against the observed MIC50 against both lectins, below. There was a 
peak of lower affinity (higher MIC50) at intermediate values of LogP, but no clear 
trend emerged. 
 
Figure S3.11. Plot showing relationship between (estimated) partition co-efficient of 
a single repeat unit of the polymers verses the observed MIC50 values for both 
lectins.  
 
RCA120 Inhibitory Assay 
Table S3.2: RCA120 inhibition compared to PNA 
Polymer IC50 PNA  
(mM Gal) 
IC50 RCA120  
(mM Gal) 
P1 0.087 0.014 
P5 0.36 0.017 
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Comparison of relative affinities of polymer to each lectin 
Table S3 shows the relative affinities of each glycopolymer, relative to the control 
polymer (P1). P5 was selected as the most selective as it maintained its affinity 
towards CTx, but had significant decreased affinity towards PNA. P8 also 
demonstrates selectivity. However, this appear due to it have increase affinity 
towards both lectins. 
Table S3.3: Relative affinity of glycopolymers compared to control polymer, P1 
Polymer Px/P1 CTx Px/P1 PNA 
P1 1 1 
P4 0.52 0.32 
P5 1.21 4.20 
P6 4.98 2.36 
P8 0.10 0.39 
P9 0.18 0.11 
P10 0.31 0.11 
P11 1.45 1.12 
Px is the polymer listed in the first column.   
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Experimental Section 
Glycopolymer Synthesis and Characterisation.  The glycopolymers used in this 
study have been previously reported in a publication (See Chapter 2 and Appendix 
1).1 They were obtained by tandem post-polymerization modification and 
summarized below for completeness. The reaction scheme used is shown in Scheme 
S1 and the characterization of the polymers in the subsequent tables. For full details 
please see the indicated reference. 
Scheme S4.1: Synthesis of galactose-functional polymers with varying linker length 
y tandem post-polymerisation modification. 
Table S4.1: Molecular characteristics of glycopolymers used in this study 
Polymer DP[a] Linker[b] Mn[c]
(g.mol-1) 
Mw/Mn[c] 
P1 18 Short m = 0 5100 1.29 
P2 33 Long m = 2 10000 1.28 
P3 18 Long m = 2 7250 1.32 
[a] Theoretical number average degree of polymerization; [b] Alkyne used to modify 
PPFMA scaffold; [c] determined by SEC in DMF. 
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Additional Results 
Gold Nanoparticle-Linked Measurement of Con A-Mannan Interactions. 
Concanavalin A binding to mannan-coated multi-well plates was evaluated as 
described in the main paper and the data summarized below. 
 
 
Figure S4.1: Dose dependant binding curves of ConA onto mannam functional 
surfaces. AuNP absorbance at λmax. Errors bars represent ± standard deviation from a 
minimum of 3 repeats. 
Reference 
1. Richards, S.-J., Jones, M. W., Hunaban, M., Haddleton, D. M., and Gibson, 
M. I.,  Angew. Chem. Int. Ed. 2012, 51, 7812 - 7816. 
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Additional Figures 
Infrared analysis of PEG-azide before and after cycloaddition reaction. Appearance 
of O-H stretch at ~ 3500 cm-1 due to sugar can be seen. 
 
Figure S5.1: Infrared spectra Azido-PEG-thiol (Red) and Mannose-PEG-thiol 
(Black).   
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DLS data showing no change in particle size over 2 hour incubation with Con A.  
Figure S5.2: Kinetics of NP-Man response to Con A by dynamic light scattering 
 
 
Figure S5.3: UV-visible spectra of NP-Gal with K-12 (A) and TOP10 (B) 
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Figure S5.4: Response of NP-Man to bacteria expressed in terms of colony forming 
units.  
 
 
 
Figure S5.5. Bar chart showing response of mannose and galactose nanoparticles to 
the different bacteria, expressed in terms of colony forming units. 
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Additional Figures 
Infrared analysis of pHEA before and after reaction of pentafluorophenol end-group 
with mannosamine. Disappearance of C=O at around 1750 cm-1 attributable to the 
carbonyl associated with the PFP end-group being removed. It was not possible to 
see appearance of amide peak due to the large number of amides associated with the 
acrylamide monomer. 
	  
	  
	  
	  
	  
	  
	  
 
 
 
 
Figure S6.1: Infrared spectra of PFP-pHEA (red) and Mannosamine-pHEA 
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Differences in percentage functionalisation of DP20:DP10 pHEA-galactosamine 
polymers on their aggregation behaviour in response to SBA.  A 1:1 ratio of 
DP10:DP20 gives a far lower Kd compared to 1:3 ratio of DP10:DP20. Kd = 8 nM 
for 1:1 and 52 nM for 1:3 DP10:DP20. 
	  
Figure S6.2: Binding isotherms (at 37 °C) of GalNH2-pHEA DP10:DP20 1:3 ratio 
(black) and  GalNH2-pHEA DP10:DP20 1:1 ratio (red) AuNPs with SBA 
	  
Dynamic light scattering data to confirm the formation of aggregates upon addition 
of the correct glycan lectin pairing.  
 
 
 
 
 
 
 
 
Figure S6.3: Kinetics of AuNP responses to SBA by dynamic light scattering over 
one hour after addition of 85 nM SBA to GalNH2 functional particles and ManNH2 
functional particles. 
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Aggregation behavior of ManNH2 and GalNH2 particles in response to Con A. Kd 
ManNH2 = 109 nM and GalNH2 = 146 nM. 
Figure S6.4: Interaction of GalNH2 and ManNH2 functional AuNPs with Con A. (A) 
UV-Vis spectrum of ManNH2-AuNP upon addition of increasing concentrations of 
Con A following 30 minutes of incubation. (B) Kinetics of nanoparticle responses to 
SBA by monitoring Abs700 over 30 mins. (C) Binding isotherms (at 37 °C) of 
ManNH2 and GalNH2 AuNPs with Con A. (D) Kinetics of nanoparticle responses to 
Con A by dynamic light scattering over one hour.  
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Aggregation behavior of GalNH2 and ManNH2 particles in response to RCA120.  
	  
 
 
 
 
 
 
 
Figure S6.5: Interaction of GalNH2 and ManNH2 functional AuNPs with RCA120. 
UV-Vis spectrum of GalNH2-AuNP upon addition of increasing concentrations of 
RCA120 following 30 minutes of incubation.  
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Additional Figures 
Size determination of goldnanoparticles by DLS. Before functionalisation (60 nm) 
and after functionalisation with carbohydrate terminated polymers. There is a size 
increase of about 5 nm.  
Figure S7.1: Size characterisation of gold nanoparticles after polymer functionalisation. 
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Kd values for each lectin on each surface derived from the hill plots.  
	  
 
 
 
 
 
 
 
 
 
 
Figure S7.2: Kd values of each carbohydrate functionalised gold nanoparticles and lectin 
pairing.  
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Size increase of over time of glycogoldnanoparticles upon addition of 200 nM SBA. 	  
	  
Figure S7.3: Kinetics of size increase of gold particles over a 1-hour period in 
response to SBA by DLS.  
	  
Further demonstration of use of pixel intensity to determine apparent Kd values of 
protein-carbohydrate interactions using Con A. 
	  
Figure S7.4: Direct optical analysis of protein binding. A) Scanned image of 
glycoAuNPs with a dilution series of Con A after 30 minutes. B) Saturation image 
used for pixel intensity measurement (high intensity = red, low intensity = blue). C) 
Comparison of Kd calculated by Abs700 and pixel intensity.  
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Correlation between Kd values determined by Abs700 from UV/Vis spectrometry and 
pixel intensity for a scanned image and image analysis freeware.  
